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Summary 
In recent years there has been a considerable increase in human obesity 
levels with an associated increase in the incidence of type 2 diabetes 
mellitus (T2DM), a disorder of glucose metabolism characterised by insulin 
resistance. It is unclear why obesity and insulin resistance should frequently 
exist comorbidly but the current prevalence of polypharmacy suggests the 
underlying mechanisms may be multifactorial in origin. This project has 
highlighted plant compounds and extracts with: 
Insulin-like properties in cell culture experiments in that they induce 
phosphorylation and therefore inactivation of the transcription factor 
FOXO1a, which is a major downstream effector insulin and 
Properties similar to the T2D drugs metformin and pioglitazone, which both 
activate AMOK signalling and reduce phosphorylation of the ribosomal 
protein S6. 
The project began with an analysis of plant extracts which can mediate 
intracellular cell signalling effects on FOXO1a and AMPK. The pilot data 
established that one extract (grape seed, GSE) induces regulation of AMPK 
and FOXO1a much more readily than another (pine bark, PBE). GSE and 
PBE were subjected to multiple fractionation methods and mass 
spectrometry to learn more about the active agent(s) in the extracts. Another 
chapter adopted a candidate-approach, investigating effects of the plant 
compound gallic acid (GA) on AMPK. Although GA cannot explain the effects 
of GSE on AMPK, the availability of a variety of analogues of GA allowed 
investigation of structural requirements for cell responses. Two more 
extracts, cranberry and lingonberry, were then investigated using the 
XX 
 
techniques established earlier with GSE and PBE. These studies discovered 
that fractions containing B-type linkages were more effective at 
phosphorylating of FOXO1a than those containing A-type linkages, 
suggesting B-type linkages may be required for these effects. 
Metformin itself is a synthetic analogue of a plant compound and  metformin 
analogues known as diguanides were synthesised and structure/activity 
relationships were assessed. Diguanides and biguanides were found ti 
induce similar responses but diguanides were much more toxic than 
biguanides, suggesting they may be less specific in their mechanism of 
action, or alternatively that they have different intramitochondrial targets. 
The aims of this project were 
1. To extract polyphenolic compounds from grape seed, pine bark and 
berries using chromatography techniques and to characterise these 
compound using liquid chromatography/mass spectrometry 
2. To exclude or confirm insulin-like or metformin-like properties by 
application to cell culture models to assess effects on regulation of 
glucose and energy homeostasis by measuring phosphorylation of the 
transcription factor FOXO1a, AMPK and the ribosomal protein S6. 
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XXIII 
 
PKB protein kinase B/akt  
PKC protein kinase C 
PMSF phenyl methane sulphonyl fluoride 
PPAR  peroxisome proliferator activated  receptor  
PTB phosphotyrosine binding 
RT retention time 
S6 p70 ribosomal protein S6 
S6K p70 ribosomal protein S6 kinase  
SDS PAGE 
sodium dodecyl sulphate polyacrylamide gel 
electrophoresis 
SH2 src homology 2  
SIGN Scottish Intercollegiate Guidelines Network 
SOD superoxide dismutase  
SPE solid phase extraction 
T1D type 1 diabetes mellitus 
T2D type 2 diabetes mellitus 
TBS tris buffered saline 
TBST tris buffered saline with tween 
TG triglyceride 
TNFα tumour necrosis factor α  
TSC tuberous sclerosis complex (protein) 
TZDs thiazolidinediones 
UPW ultra pure water 
WHO World Health Organisation  
WST1 water soluble tetrazolium salt 1 
ZDF Zucker diabetic fatty (rat)  
ZMP AICAR monophosphate 
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CHAPTER 1 – INTRODUCTION 
 
1.1 Diabetes 
Diabetes mellitus is a group of metabolic disorders characterised by 
hyperglycemia either because the patient does not produce enough insulin or 
because somatic cells are resistant to it (Greenspan et al, 2011). 
In 1500BC, a condition was described in Egypt and India with these 
symptoms 
• excessive weight loss 
• extreme thirst 
• “too great an emptying of the bladder” (polyuria) 
• “honey urine” (glycosuria) and 
• ketosis 
This condition was called “diabetes” meaning “siphon” or “to pass through”. 
In 1776, the sweet tasting urine and serum of diabetic patients was 
confirmed to be due to sugar (Zajac et al, 2010). In 1788, a link between 
diabetes and the pancreas was suggested when it was noted that pancreatic 
pathology could result in diabetes and this was later confirmed by the 
discovery of insulin secretion from the pancreas by Banting and Best (Zajac 
et al, 2010).  
 
1.1.1Epidemiology 
The World Health Organisation (WHO) state that 347 million people suffer 
from diabetes world wide. In 2004 they estimated 3.4 million people died 
from the consequences of hyperglycemia. In 2012 they projected the number 
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of diabetes deaths will increase by two thirds between the years 2004 and 
2012 (WHO, 2012). 
 
1.2 Glucose 
Glucose is a monosaccharide used as a source of energy in most organisms 
(De Fronzo et al, 2004). In humans, it originates from dietary 
polysaccharides, mainly starch, and is stored predominately in the liver by 
insulin-controlled pathways as polymeric glycogen (De Fronzo et al, 2004). 
When blood glucose levels are low, the hypoglycaemic state, α-cells of the 
endocrine pancreas secrete the hormone glucagon which induces hepatic 
catabolism of glycogen to glucose (De Fronzo et al, 2004). In the post 
prandial state some glucose enters the liver via the hepatic portal vein and 
meanwhile circulating glucose stimulates pancreatic β cells to release insulin 
which promotes hepatocyte uptake of glucose and storage as glycogen (De 
Fronzo et al, 2004). It has also been proposed that when hepatic glucose 
levels exceed arterial glucose levels a ‘portal signal’ increases hepatic 
glucose uptake independently of the insulin response (Flakoll et al, 2004). 
Glucose disposal into adipocytes and muscle is also significant but these 
cells are not studied in this thesis. 
Plasma glucose levels are tightly regulated in healthy individuals. Normal 
fasting plasma glucose levels are 4 - 5 mmol/l (American Diabetes 
Association, 2006). Levels between 5.6 mmol/L and 7.0 mmolL are 
considered higher than normal range and are referred to as “pre-diabetes” 
(American Diabetes Association, 2006). Levels of 7mmol/L or higher are 
indicative of diabetes (American Diabetes Association, 2006). 
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1.3 Insulin 
The pancreas is an organ which consists of an exocrine portion which 
secretes digestive enzymes into the small intestine and an endocrine portion 
of pancreatic islets embedded within the exocrine pancreas containing α- 
and β-cells which secrete glucagon and insulin respectively (De Fronzo et al, 
2004). Insulin is an evolutionarily conserved hormone synthesised from a 
single chain precursor, preproinsulin, which consists of four domains, a 
signal peptide and an A and a B domain linked by a C domain (Rhodes, 
2004). In pancreatic β-cells, preproinsulin undergoes two proteolytic 
cleavage events involving removal of the signal peptide and the C domain 
accompanied by specific pairing of disulphide bridges. These events result in 
the production of mature insulin, which is a globular protein consisting of only 
two of the original chains, A and B, of 21 and 30 residues respectively, linked 
together by two disulphide bonds (Weiss, 2009).  
 
1.4 Insulin receptor 
The insulin receptor (IR) gene expresses two isoforms generated by 
alternative splicing (LeRoith, 2003). The isoforms differ in that they lack (IR-
A) or contain (IR-B) a 12 amino acid peptide encoded by exon 11 of the IR 
gene (LeRoith, 2003).  Stimulation of the tyrosine kinase activity of the insulin 
receptor (IR) by insulin initiates a phosphorylation cascade that mediates the 
pleiotropic actions of this hormone (Avruch, 2004). In vivo studies have 
confirmed insulin receptor physiology to be tissue specific (Almind et al, 
2004; Kadowaki , 2000). Global IR knockout (KO) mice have a severe 
diabetic phenotype which is fatal within one week postnatally (Almind et al, 
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2004; Kadowaki, 2000). Muscle specific IR KO (MIRKO) mice show defective 
fat metabolism which leads to development of metabolic syndrome (Almind 
et al, 2004; Kadowaki, 2000).  In humans, metabolic syndrome is defined as 
the presence of central obesity and two other factors from hypertension, 
hyperglycemia, raised triglyceride (TG) levels and reduced high density 
lipoprotein (HDL) levels (International Diabetes Federation, 2006). MIRKO 
mice displayed increased fat mass, elevated TG and free fatty acid (FFA) 
levels but no hyperglycemia (Almind et al, 2004; Kadowaki, 2000). Although 
hepatic IR KO mice show severe insulin resistance and glucose intolerance 
by the age of two months, by four months of age, fasting hyperglycemia 
returns to normal (Almind et al, 2004; Kadowaki, 2000), suggesting that the 
presence of intact insulin receptors in other tissues may compensate for the 
knockout. 
 
1.5 Insulin- like growth factor 
Insulin-like growth factors (IGFs) are polypeptides with high protein 
sequence homology to insulin (Ullrich et al, 1986). The IGF system includes 
two ligands, IGF1 and IGF2 and two cell surface receptors, IGF1R and 
IGF2R (Ullrich et al, 1986). IGF1 is a single chain polypeptide of 70 residues 
with a significant 49% structural sequence identity to insulin and 61% to IGF2 
(Ullrich et al, 1986).  It consists of A and B chains homologous to the A and B 
chains of insulin but linked together by a C chain analogous to the C chain of 
preproinsulin and proinsulin and also containing a short D domain absent in 
insulin (Alvino et al, 2011). Seven of the twelve amino acids considered 
important for insulin receptor (IR) binding are conserved in both IGF1 and 
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IGF2 (Alvino et al, 2011). Like insulin, IGF1 has been shown to stimulate 
glucose uptake and storage as glycogen through the insulin/ IGF1 signalling 
(IIS) pathway (LeRoith, 2003). It has been proposed that a splice variant of 
the insulin receptor, IR-A has high affinity for IGF2, but that this interaction 
mediates predominately proliferative effects rather than the metabolic effects 
produced by insulin stimulation of IR-B (LeRoith, 2003). 
 
1.6 IGF1 receptor  
The IGF1 receptor (IGF1R) is structurally and functionally related to the 
insulin receptor. Both are transmembrane receptor tyrosine kinases 
consisting of two extracellular α subunits and two transmembrane β subunits 
linked together by disulphide bonds (LeRoith, 2003). IGF or insulin binding to 
the extracellular α subunits of the receptor induces a conformational change 
in the receptor enabling autophosphorylation of tyrosine residues in the 
intracellular β subunits (Schmelzle et al, 2006). Insulin binds with high affinity 
to the insulin receptor and with lower affinity to the IGF1R whereas IGF1 has 
the opposite affinities (Ullrich, 1986). Major effects of IGF1 include promotion 
of cell survival and inhibition of apoptosis (Vincent and Feldman, 2002). 
Stimulation of the IGF1R can promote cell proliferation and contact with the 
extracellular matrix (Vincent, 2002). Due to the high level of structural 
homology between these receptors, αβ hemireceptors can form in tissues 
which express both receptors. The physiological response induced by such 
hybrids is variable depending on the isoform of each subunit involved 
(LeRoith, 2003). 
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1.7 IIS pathway 
Insulin and IGF1 signalling is transduced by intracellular second messengers 
within the insulin/IGF-1 signalling (IIS) pathway. These include the 
phosphatidylinositol 3 kinase (PI3K), mammalian target of rapamycin 
(mTOR) and mitogen activated protein kinase (MAPK) pathways. 
 
1.8 PI3K pathway 
Following activation of the IR, the PI3K signalling pathway, an intracellular 
phosphorylation cascade, illustrated in Fig 1.1 below, is initiated: 
 
IRI
IRSI S
PI3KPI3K
PIP2
PIP2 PIP3
PIP3
PDK1P K1
PKBPKB
multiple substratesultiple substrates
Insulin receptor substrate
Phospoinositide biphosphate
Phosphoinositide
triphosphate
Phosphoinositide
dependent kinase 1
Protein kinase B
   
Fig 1.1: Schematic of the main insulin signalling cascade 
Binding of insulin to the insulin receptor results in recruitment of IRS proteins and PI3K. PI3K 
catalyses phosphorylation of phospholipids. This results in recruitment then activation of 
PDK1 and PKB. PKB, in turn, phosphorylates a variety of substrates mediating the 
pleiotropic action of insulin. 
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1.8.1 Insulin receptor substrate 
The activated IR phosphorylates specific tyrosine residues on insulin 
receptor substrates (IRS) that act as docking sites for additional signalling 
proteins (Lee and White, 2004; Taniguchi et al, 2006). The tyrosine 
phosphorylation sites interact with downstream substrates containing 
sarcoma (src) homology 2 (SH2) domains such as PI3K (Lee and White, 
2004; Taniguchi et al, 2006).  At least six insulin receptor substrate (IRS) 
proteins have been identified (Lee and White, 2004; Taniguchi et al, 2006). 
All IRS proteins have a pleckstrin homology (PH) domain and a 
phosphotyrosine binding (PTB) domain near the amino (NH2) terminal which 
interacts with the IR (Lee and White, 2004; Taniguchi et al, 2006). IRS1 and 
IRS2 are widely expressed, whilst IRS3 is a rodent specific IRS and IRS4 is 
found in thymus, brain and kidney cells of humans and mice (Lee and White, 
2004; Taniguchi et al, 2006). The functions and expression of IRS5 and IRS6 
are less well understood. The carboxy tail is of variable length, longest in 
IRS1 and IRS2, and contains tyrosine and serine phosphorylation sites (Lee 
and White, 2004). IRS1 deficient mice have been shown to display growth 
retardation and mild insulin resistance whereas IRS2 deficient mice display a 
more severe diabetic phenotype due to impaired β cell function (Withers et 
al, 1998). 
  
1.8.2 Phosphatidylinositol 3 kinase 
Phosphatidylinositol 3 kinase (PI3K) phosphorylates the 3’ hydroxyl (OH) 
group of the inositol ring of the inositol phospholipids, phosphatidylinositol 
(PI), phosphoinositide monophosphate (PIP) and phosphoinositide 
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biphosphate (PIP2) to produce PIP, PIP2 and phosphoinositide triphosphate 
(PIP3) respectively (Cantrell, 2001; Taniguchi et al, 2006). There are three 
classes of PI3K (Cantrell, 2001). Class I PI3Ks consist of a regulatory and a 
catalytic subunit, each of which occurs in several isoforms resulting in 
different combinations of PI3K due to various dimerizations of several 
regulatory and catalytic subunits (Cantrell, 2001; Taniguchi et al, 2006). 
These PI3Ks preferentially phosphorylate PIP2. Class II PI3Ks have a 
catalytic but no regulatory domain and preferentially phosphorylate PI and 
PIP (Cantrell, 2001). Class III PI3Ks, like class I, are heterodimeric but are 
involved in protein trafficking via vesicular transport (Abe et al, 2009) and 
only phosphorylate PI. Only class I PI3Ks respond to extracellular stimuli 
(Cantrell, 2001) such as insulin signalling (Taniguchi et al, 2006).   
Some selective or specific protein kinase inhibitors are available that inhibit 
PI3K. 2- (- 4- morpholinyl)- 8- phenyl- 4H- 1- benzoptran- 4- one (LY294002) 
has been proposed as PI3K selective (Davies et al, 2000) and LY294002 
and PI-103 to be selective for class I (Vlahos et al, 1994). 3- methyl adenine 
has been suggested to selectively inhibit class III (Egami and Araki, 2008). 
Wortmannin has been proposed to be PI3K specific (Davies et al, 2000) with 
selectivity for class I and II (Egami and Araki, 2008). 
 
1.8.3 Phosphatidylinositols and phosphoinositides 
Phosphatidylinositols (PIs) are components of the cytosolic surface of the 
cell membrane. They consist of a glycerol backbone, two fatty acid side 
chains, a phosphate group and an inositol group. The inositol group can be 
phosphorylated by PI3Ks on the 3’, 4’ and 5’ OH groups (Paolo and Camilli, 
 9 
2006).  The 1’ carbon is usually bound to the phosphate group and the 2’ and 
6’ OH groups are generally not phosphorylated due to steric hindrance 
(Mathews et al, 2005). Phosphorylated forms of PI are referred to as 
phosphoinositides. Activation of the IR leads to the recruitment of PI3K to the 
cell membrane where it can phosphorylate PIs, ultimately generating PIP3 
(Taniguchi, 2006). Proteins with PH domains such as phosphoinositide 
dependent kinase (PDK1) can bind to PIP3 and become localised to the cell 
membrane in the process (Taniguchi et al, 2006).  
 
1.8.4 Phosphoinositide dependent protein kinase 1 
Phosphoinositide dependent protein kinase 1 (PDK1) consists of a catalytic 
kinase domain and a PH domain (Alessi et al, 1997). The PH domain 
interacts with phosphoinositides (Biondi et al, 2000) and the kinase domain 
with various substrates including protein kinase B (PKB), phosphorylating 
and therefore activating it (Alessi et al, 1997). A hydrophobic pocket within 
the kinase domain of PDK1 interacts with a PDK1 interacting fragment (PIF) 
of PKB, acting as a docking site (Biondi et al, 2000) facilitating 
phosphorylation of PKB at Thr308 before being released into the cytoplasm 
in its active form (Alessi et al, 1997). 
  
1.8.5 Protein kinase B 
There are three isoforms of protein kinase B (PKB) – PKBα, β and γ. PKB 
consists of an N-terminal PH domain, a catalytic domain and a short C-
terminal tail (Alessi et al, 1996). In addition to interacting with a PDK1 
‘docking site’, the PH domain of PKBα can also interact with PIP3 and be 
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recruited to the cell membrane and undergo activation by PDK1 mediated 
phosphorylation of Thr 308 and Ser 473 (Shaw et al, 1998).     
There are various inhibitors for different isoforms of PKB. The commercially- 
available Akti, is a PKB inhibitor that has been found to abolish PKB activity 
in L6 myotubes which predominately express PKBα and γ (Green et al, 
2008). Akti 1/2 has been shown in vitro to only inhibit PKB α and β (Logie et 
al, 2007). Akti-1 inhibits only PKBα (Barnett et al, 2005) and Akti-2 only 
PKBβ (DeFeo-Jones et al, 2005). Isothiocyanates, a group of compounds 
found in various vegetables have been suggested to be inhibitors of PKBγ 
(Sharma et al, 2009).  PKB inhibitors can be used to determine whether this 
kinase mediates downstream cellular responses rather than other signalling 
pathways such as those regulated by mitogen activated protein kinase 
(MAPK) or mammalian target of rapamycin (mTOR). 
 
1.8.6 Mammalian target of rapamycin (mTOR) 
mTOR was originally identified as a target of the immunosuppressant drug 
rapamycin. It is regulated by various growth factors including insulin in a 
normal physiological setting (Chung et al, 1994). Activation of mTOR 
ultimately regulates protein translation, for example by inducing S6 protein 
phosphorylation (LaPlante and Sabatini, 2009).  
 
1.9 Forkhead box subtype O  
Forkhead box proteins are a group of proteins characterised by a conserved 
DNA binding domain, the Forkhead box, or Fox (Clark et al, 1993). The first 
of these proteins was identified in the fruit fly Drosophila melanogaster (Liu 
and Lehman, 2008) and named after the ectopic head structures which 
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developed as a consequence of mutation of the gene which encodes the 
protein (Jurgens and Weigel, 1988). This and subsequent Fox proteins which 
have been identified have been assigned to a subclass - A to O - and 
proteins within each subclass have been allocated a number i.e. FoxO1. 
Abbreviations for Fox contain all upper case letters for humans i.e. FOXO1 
but only the first letter is upper case for murine Foxo1 (Kaestner et al, 2000). 
FOXO proteins are transcription factors which are phosphorylated and as a 
consequence excluded from the nucleus and therefore inactivated, 
‘downstream’ of the insulin receptor or IGF-1 receptor. Here ‘downstream’ 
simply means that FOXO regulation occurs at the foot of the intracellular 
pathway triggered by insulin binding to its receptor. A FOXO homologue has 
been identified in Drosophila (dFOXO) and in C.elegans (dauer arrest 
phenotype 16 - DAF16) (Van Der Heide et al, 2004). The relevant pathways 
are highly conserved throughout animal evolution, as shown in Fig 1.2: 
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Fig 1.2: Analogous insulin signalling pathways in the nematode, fruit fly, mouse and 
human (Adapted from Woods et al, 2002). There is evolutionary conservation of proteins at 
each step in the pathway. 
 
 
1.9.1 Regulation of FOXO1 
FOXO1 has been shown to be regulated by phosphorylation (Biggs et al, 
1999) and nuclear/ cytosolic shuttling (van der Heide et al, 2004). 
 
1.9.1.1 Phosphorylation of FOXO1 
FOXO1 has been shown to be phosphorylated and inactivated by PKB in 
response to insulin or IGF1 at specific residues (see figure 1.3) which lie 
within Arg–Xaa–Arg–Xaa–Xaa–Ser/Thr motifs (Rena et al, 1999). This 
phosphorylation results in nuclear exclusion and therefore inactivation of the 
transcription factor (Rena et al, 2001).  
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It has been proposed that PKB mediated phosphorylation of Ser256 induces 
a conformational change in the protein which enables Thr24 and Ser319 
phosphorylation (Rena et al, 2001). Phosphorylation of Ser319 primes the 
molecule for Ser 322 followed by Ser 325 phosphorylation most likely 
catalysed by casein kinase 1 (CK1) (Rena, et al 2002). This hierarchal 
sequence of phosphorylation events is illustrated in Fig 1.3: 
 
 
Fig 1.3: Schematic of FOXO1a phosphorylation 
From left to right, the sequence of phosphorylation events which result in exclusion of 
FOXO1 from the nucleus and therefore result in inactivation of the transcription factor. 
 
1.9.1.2 FOXO1 inactivation by nuclear exclusion  
An intracellular ‘shuttling’ system exists which confines FOXO1 either to the 
cytoplasm, effectively inactivating it, or to the nucleus, which allows FOXO1 
to bind to specific DNA sequences and enables transcription of genes 
believed to be involved in glucose regulation such as PEPCK. Only proteins 
with a molecular mass of less than 50 kilodaltons (kDa) or a diameter of less 
than 9 nanometres (nm) diameter can passively diffuse through the nuclear 
pore. Larger molecules require active transport mechanisms. Several nuclear 
hormone receptors have been found to bind to FOXO1a, influencing its 
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nuclear exclusion and entry. These include estrogen, progesterone and 
androgen receptors as well as glucocorticoid and thyroid hormone receptors 
(Van der Heide et al, 2004). 
FOXO1 localisation in response to insulin is regulated by phosphorylation 
(Rena et al, 2001). Phosphorylation of Thr24 has been proposed to enhance 
nuclear exclusion of FOXO1 by binding to 14-3-3 proteins, probably by 
reducing the affinity for DNA binding (Van der Heide et al, 2004). A cluster of 
phosphorylated residues including Ser319, Ser322 and Ser325 is also critical 
for nuclear exclusion, as FOXO6, which lacks these residues but retains 
other regulatory features of FOXO1, is restricted to the nucleus (Jacob et al, 
2003). Mutation of these serines in FOXO1 retards but does not prevent 
nuclear exclusion (Rena, et al 2002) however, suggesting that the 
unphosphorylated motif supports a reduced rate of nuclear exclusion. Thus, 
phosphorylation of this cluster may reduce access to the nuclear localisation 
signal (NLS) or increase access to the nuclear exclusion sequence (NES) of 
the protein (Woods et al, 2002), or alter interaction with the nuclear hormone 
receptors described above.  
 
1.9.2 Functions of FOXO1 
Various studies have helped confirm the physiological roles of FOXO1 
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1.9.2.1 Development 
By embryonic day 9.5 (E9.5), Foxo1-/- mouse embryos have been found to 
be approximately half the size of their Foxo1+/+ and heterozygous littermates 
and to have cardiac, aorta and carotid abnormalities as well as poor vascular 
development of the yolk sac (Hosaka et al, 2004). All these mice died 
between E9.5 and E10.5 (Hosaka et al, 2004), suggesting a role for Foxo1 in 
vascular development. 
 
1.9.2.2 Aging 
It has been shown that the IIS pathway influences lifespan. C. elegans can 
respond to environmental stress such as food limitation by arresting 
maturation during an early alternative post-embryonic larval stage called 
dauer therefore these are longer lived than non dauer nematodes (Ogg et al, 
1997, Lin et al, 1997). C. elegans with impaired IIS function such as those 
carrying daf-2 mutations have been shown to be longer lived than wild type 
(WT) phenotypes (Ogg et al, 1997, Lin et al 1997). Equivalent studies on 
mammalian FOXOs are made difficult by the existence of multiple FOXO 
isoforms; however evidence that female Irs1-/- mice are long lived and Irs2-/- 
mice are short lived is consistent with a role for mammalian FOXOs in 
organismal longevity (Selman et al, 2008). It is important to remember 
however that reduced IIS in mammals ultimately risks diabetes and shorter 
longevity, which is the phenotype of Irs2-/- mice. 
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1.9.2.3 Metabolic functions of FOXO1a 
FoxO1 has been shown to be involved in both the development of adipose 
tissue and in the upregulation of gluconeogenesis (covered in more detail in 
the following section) (Gross et al, 2008). In the central nervous system 
(CNS), it has also been shown to mediate central actions of both insulin and 
leptin (an endogenous appetite suppressant) within the hypothalamus, 
influencing feeding behaviour. FoxO1 is also expressed in pancreatic β cells 
where it is thought to influence β cell proliferation (Glauser and Schlegel, 
2007).  
 
1.9.2.3.1 Regulation of gluconeogenesis by FOXO1a  
Gluconeogenesis is the production of new glucose from noncarbohydrate 
substrates such as amino acids, lactate and pyruvate (Devlin, 2011). 
Phosphoenolpyruvate carboxylase (PEPCK) has been shown to be a rate 
limiting enzyme in this pathway and as such has undergone extensive study. 
For example Scott et al, (1998) found repression of PEPCK to be glucose 
dependent but insulin independent, suggesting a negative feedback 
mechanism for glucose regulation not dependent on the insulin response.  
Another key enzyme, glucose 6-phosphatase (G6Pase) is involved in the 
final step of gluconeogenesis and catalyses the conversion of glucose-6-
phosphate to glucose (Sutherland et al, 2006). In a variety of experiments 
including genetic analyses, it has been suggested that increased expression 
of FOXO1 increases hepatic gluconeogenesis (Frescas et al, 2005; Nakae et 
al, 2002; Zhang et al, 2006). Nakae et al, for example, introduced a gene 
trap cassette into murine Foxo1 and demonstrated that the diabetic 
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phenotype resulting from Insr haploinsufficiency is partly rescued in Insr +/- 
Foxo1+/- heterozygotes through suppression of gluconeogenic gene 
expression (Nakae et al, 2002). Consistent with this, transgenic (TG) mice 
that express constitutively active hepatic FoxO1 have been noted to have 
elevated fasting glucose levels and impaired glucose tolerance in 
comparison to their WT counterparts (Zhang et al, 2006). It is important to 
note however that other factors besides FOXO1a also contribute to 
regulation of these genes (Barthel et al, 2001; Lochhead et al, 2001; Logie et 
al, 2007). Gluconeogenesis is illustrated schematically in Fig 1.4:  
 
 
Fig 1.4: Hepatic gluconeogenesis  
As described by Devlin, 2011 
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1.10 Regulation of ribosomal protein S6 
Phosphorylation and therefore activation of S6 by S6K is believed to be 
important in regulation of mRNA translation and therefore cell growth and 
proliferation (Laplante and Sabatini, 2009).  Treatment of cells with insulin 
induces S6 phosphorylation which is reduced in the presence of wortmannin, 
suggesting involvement of PI3K within the insulin signalling pathway (Pullen 
et al, 1998). Consistent with this, genetic modification of PDK1 demonstrated 
that this kinase is also active upstream of S6 phosphorylation (Collins et al, 
2003). The mechanism of PDK1/PKB dependent activation of S6K is 
complex, has only been resolved more recently (Laplante and Sabatini, 
2009) and is illustrated schematically in Fig 1.5: 
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Fig 1.5: Schematic representation of regulation of S6  
As described by Huang and Manning, 2008, resulting increased protein translation. The red 
cross denotes inhibition by PKB. Some steps are omitted for clarity. 
Rheb 
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1.10.1 Tuberous sclerosis complex (TSC). 
TSC 1 and TSC2  are tumour suppressor genes mutated in tuberous 
sclerosis complex syndrome (Huang and Manning, 2008), causing benign 
tumours to grow in the brain and other major organs such as the skin, 
kidneys, heart and lungs. This results in a combination of symtpoms 
including seizures, developmental delay, skin abnormalities and kidney 
disease (National Institutes of Health). TSC1/2 regulate mTOR indirectly 
through another protein, Rheb (Huang and Manning, 2008).  
 
1.11 Cell signalling responses to insulin sensitising agents  
Insulin sensitising agents such as metformin and thiazolidinediones do not 
act directly to induce IIS like insulin does. Pathways regulated by these 
agents are discussed below. 
 
1.11.1 Adenosine monophosphate activated protein kinase 
Adenosine monophosphate activated protein kinase (AMP activated protein 
kinase) has been described as a heterotrimeric enzyme consisting of a 
catalytic (α) and two regulatory subunits (β and γ) (Zhang et al, 2009). 
Isoforms containing the α2 subunit are more AMP sensitive than those 
containing the α1 (Winder and Hardie, 1999). AMPK is activated by cellular 
stresses that deplete ATP (Winder and Hardie,1999). It acts as an energy 
sensor within the cell and as a result of adenosine triphosphate (ATP) 
depletion, upregulates ATP producing pathways and downregulates ATP 
consuming pathways (Hawley et al, 2002) such as those regulated by acetyl 
CoA carboxylase (Abu-Elhelga et al, 2003). Conditions that increase 
intracellular AMP/ADP ratio therefore lead to AMPK activation (Zhang et al, 
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2008). The γ subunit of AMPK contains two pairs of cystathione β synthase 
(CBS) domains, each pair making up a Bateman domain. Binding of one 
AMP to one Bateman domain cooperatively increases binding affinity of the 
second (Adams et al, 2004). This causes a conformational change in the γ 
subunit which exposes the catalytic domain of the α subunit enabling 
phosphorylation by an upstream AMPKK (Hawley et al, 1996).   A simplified 
version of this pathway is illustrated in Fig 1.6: 
 
Fig 1.6: Schematic of AMPK signalling  
Activation of AMP activated protein kinase (AMPK) results in increased production of ATP 
through fatty acid oxidation (Abu-Elhelga et al, 2003).  
 
Various endogenous AMPK activators have been proposed. In addition to 
ACC, 3- OH- 3 methylglutaryl CoA reductase (HMGR), an enzyme involved 
in sterol production has also been proposed as a potential target of AMPK. In 
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adipose tissue, hormone sensitive lipase (HSL), involved in fatty acid 
synthesis, is an indirect substrate for AMPK as a consequence of 
phosphorylation of ACC (Winder and Hardie, 1999). AMPK has also been 
suggested to downregulate PEPCK and G6Pase (Lochhead et al, 2000). 
However, a later study by Foretz, et al 2010 suggested only AMP was 
necessary to inhibit hepatic glucose production, as ZMP inhibited cAMP 
mediated expression of G6Pase and PEPCK (Foretz et al, 2010).  
Exogenous AMPK activators include metformin, used clinically as an 
antihyperglycemic agent (Zhou, 2001), thiazolidinediones (Le Brasseur et al, 
2006) as do many natural products, including green tea catechins (Collins et 
al, 2007), and berberine, an alkaloid extracted from Rhizoma coptidis, a herb 
used in traditional Chinese medicine which inhibits mitochondrial activity and 
therefore increases AMP/ADP ratio (Yin et al, 2008).  
 AICAR monophosphate (ZMP), is a commercially available AMP analogue, 
therefore it can also bind to the Bateman domain, resulting in activation of 
AMPK. As an AMP analogue, this drug is likely to regulate other AMP-
sensitive proteins besides AMPK. Cannabinoids and ghrelin both have 
central and peripheral metabolic and cardiac effects via AMP-activated 
protein kinase (Kola et al, 2005) 
 
1.11.2 Acetyl CoA carboxylase    
Acetyl CoA carboxylase (ACC) carboxylates acetyl CoA to form malonyl 
CoA, a key molecule involved in the control of fatty acid synthesis and 
oxidation. Acetyl CoA is probably the best characterised substrate and 
downstream readout for AMPK activation (Hawley et al, 2010). ACC is 
inactivated by phosphorylation and activated by dephosphorylation on serine 
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residues 23, 25, 29, 76, 77, 95 and 1200 (Mabrouk et al, 1990). Glucagon, 
produced in response to hypoglycaemia, has been shown to induce 
phosphorylation of ACC, whereas insulin has the opposite effect. Two 
isoforms of ACC have been identified, ACC1 localised to the cytosol and 
ACC2 on the mitochondrial membrane. Malonyl CoA synthesised by ACC1 is 
thought to be involved in fatty acid synthesis and inhibition of this isoform 
results in decreased consumption of ATP for fatty acid synthesis. Malonyl 
CoA synthesised by ACC2 is thought to be involved in fatty acid oxidation 
and inhibition of this enzyme results in increased production of ATP through 
fatty acid oxidation (Abu-Elhelga et al, 2003). 
 
1.12 Factors leading to Diabetes 
Diabetes is a term use to describe a group of conditions characterised by 
hyperglycemia or elevated blood glucose levels. Type 1 and type 2 are the 
most commonly observed types of diabetes. Type 1 diabetes mellitus 
(T1DM) is a consequence of autoimmune destruction of pancreatic β cells so 
the patient does not produce insulin. In type 2 diabetes mellitus (T2DM) the 
patient produces insulin but liver, muscle and fat cells are unresponsive to it, 
resulting in hyperglycaemia.  
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1.12.1 Insulin resistance 
Various hypotheses have been proposed as to why obesity and T2DM 
should frequently exist comorbidly but the molecular basis of insulin 
insensitivity is most likely multifactorial.     
 
1.12.2 Free fatty acids 
Obesity and increased plasma free fatty acid (FFA) concentrations are 
associated with insulin resistance (Shulman, 2000). Randle and co-workers 
first showed that fatty acids competed with glucose for substrate oxidation, 
speculating that increased fat oxidation causes insulin resistance (Randle et 
al, 1963). Because of the close proximity of abdominal fat to the hepatic 
portal vein, fatty acids within these cells can drain directly into the portal 
venous system and thereafter into the general circulation. This, according to 
the lipid supply hypothesis of insulin resistance, could result in the impaired 
insulin mediated glucose uptake in insulin sensitive tissue that contributes to 
conditions such as metabolic syndrome and T2D (Greenfield and Campbell, 
2004). In a study by Roden et al, glucose and insulin levels of healthy human 
subjects were maintained under a hyperinsulinemic euglycemic clamp. A 
lipid infusion administered increase in circulating fatty acid concentration 
caused a reduction in insulin stimulated muscle glycogen synthesis (Roden 
et al, 1996). Attributed by Randle to direct inhibitory effects of FFAs on 
metabolic enzymes, these more recent studies emphasised the importance 
of FFAs on cell signalling mechanisms (Shulman, 2000). 
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1.12.3 Inflammation 
Increased levels of chronic inflammation are another possible factor 
underlying insulin resistance.  Much of this literature is focussed on the 
immunological cytokine- tumour necrosis factor α (TNFα), which is involved 
in systemic inflammation. Increased TNF α results in activation of inhibitory κ 
kinase (IKK), which consists of heterodimers of IKKα and IKKβ. Nuclear 
factor κ light chain enhancer of activated B cells (NF–κB) is a transcription 
factor excluded from the nucleus by inhibitory κβ (IkB). IKK phosphorylates 
and therefore degrades and inactivates IκB resulting in translocation of NF-
κB to the nucleus where it can initiate the synthesis of molecules involved in 
the immune response (Yinn et al, 1998). This sequence of events is 
illustrated diagramatically in fig 1.7: 
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High doses of sodium salicylate and related drugs have been known for 
many years to reduce glucosuria in some patients with diabetes (Williamson, 
1901). Much more recent data suggested that these antihyperglycaemic 
effects depend on the antiinflammatory effects of salicylate and 
acetylsalicyclic acid, mediated at least in part by inhibition of the kinase IKKβ 
(Yin et al,1998). The effects of salicylate pretreatment on fat induced insulin 
resistance were measured in hyperinsulinemic euglycemic clamped rats. 
Salicylate pretreatment prevented the lipid infusion induced reduction of PI3K 
activity observed in untreated animals. Also, IKKB(-/-)  mice did not exhibit 
decreased insulin stimulated glucose uptake in contrast to wild type, 
suggesting interaction between these pathways (Kim et al, 2001). Other pro-
inflammatory signalling pathways have been implicated in insulin resistance 
Fig 1.7:  Schematic of regulation of 
transcription factor NFκB  
     Inhibition relieved 
 
    Phosphorylation promotes degradation 
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and T2DM. For example, c-Jun N terminal kinases (JNKs) phosphorylate the 
transcription factor c-Jun in response to a variety of stimuli including 
inflammatory signals (Kynakis and Avrush, 2001). JNK is activated by 
cytokines, involved in defence and also by free fatty acids (Hotamsligil, 
2006). Activation of JNKs in insulin target cells results in phosphorylation and 
therefore inactivation of IRSs and they are also required for the accumulation 
of visceral fat (Solinas et al, 2007).  
In summary, activation of JNK or IKK can phosphorylate IRS, perhaps 
suppressing insulin responses directly. However, excess free fatty acids 
(FFA) can also induce an inflammatory type response that may contribute to 
insulin resistance. For example cytokines have been shown to be 
overexpressed in adipose tissue in obese mice and humans (Wellen and 
Hotsamligil, 2005). It is therefore possible that this type of response to 
excessive levels of FFAs and other nutrients can lead to inflammation which 
in turn leads to phosphorylation of IRS (Hotamsligil, 2006). A simplified 
version of these events is illustrated in Fig 1.8: 
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1.12.4 Genetic predisposition 
In the 1960s, the theory that a naturally selected ‘thrifty’ genotype which 
enabled efficient utilisation and storage of food and later conferred 
vulnerability to insulin insensitivity with the advent of a plentiful supply of food 
was proposed (Neel,1962). Later the ‘thrifty’ phenotype hypothesis emerged 
which suggested ante natal nutritional status to indicate the nutritional 
environment into which the fetus would be born and therefore influence later 
vulnerability to insulin sensitivity (Hales, 1997; Hales and Barker, 2001). 
 
1.13   Type 2 diabetes mellitus                           
This is a disorder of glucose metabolism characterised by insulin resistance 
of muscle, fat and liver cells. Before the onset of diabetes, insulin resistance 
may be overcome by increased insulin production and release by pancreatic 
β cells but this compensatory mechanism eventually breaks down and there 
is  destruction of these cells.  Type 2 diabetes mellitus (T2DM) has been 
described as an impending global epidemic (Mulder, 2010). The World 
Health Organisation (WHO) estimate that by the year 2030, 350 million 
excess nutrients 
        adipocytes      
           FFA 
           JNK 
             IRS 
Fig 1.8: A possible model of inflammation 
contributing to insulin resistance. 
Adapted from (Hotamsligil, 2006) 
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people will suffer from this condition worldwide and are seeking to improve 
current risk prediction models (Collins et al, 2011).  
 
1.14 Conditions associated with T2DM 
Various conditions have been associated with T2DM, including obesity (Li et 
al, 2011), cancer (Stocks et al, 2009), cardiovascular disease (Lebovitz, 
2006), and Alzheimer’s Disease (Han and Li, 2010). 
 
1.14.1  Cancer 
In 2009, a prospective study by Stocks et al showed a link between 
hyperglycemia and increased risk of cancer. It was proposed by the group 
that elevated blood glucose levels may contribute to this both directly and 
indirectly. Directly by providing an easily accessible energy substrate for 
tumour cells and indirectly by increasing IGF1 levels (Stocks et al, 2009). 
Metformin use has been associated with a reduced risk of cancer, possibly 
due to activation of AMPK (Libby et al, 2009). Activated AMPK activates the 
tumour suppressor gene p53 which can inhibit mTOR via activation of TSC1 
and TSC2 and therefore inhibit cell growth (Vousden and Ryan, 2009).  
 
1.14.2  Cardiovascular and vascular disease 
Both micro and macrovascular pathologies are associated with T2DM, 
including retinopathy (Creager and Luscher, 2003) and ischaemic heart 
disease (Despres et al, 1996), respectively. Many theories have been 
proposed to explain this, including that insulin may upregulate nitric oxide 
synthase (NOS) production in endothelial cells and that insulin resistance 
could therefore lead to reduced nitric oxide (NO) mediated vasodilation in 
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these cells (Campia et al, 2004). This could at least partly explain the 
hypertension and atherosclerosis which often appears to contribute to 
cardiovascular conditions in T2DM (Campia et al, 2004). Hyperglycemia has 
also been shown to raise diacylglycerol (DAG) levels. This activates PKC 
which subsequently inhibits PKB which can therefore no longer 
phosphorylate NOS (Creager and Luscher, 2003). 
 
1.14.3 Alzheimer’s Disease 
Epidemiological studies have suggested a link between T2DM and 
Alzheimer’s Disease (AD) (Cole et al, 2007). This is a neurodegenerative 
disorder characterised by global cognitive decline. The two most frequently 
documented pathological hallmarks of this condition are Aβ plaques resulting 
from the abnormal cleavage of the amyloid precursor protein (APP) and 
neurofibrillary tangles resulting from phosphorylation of the microtubular 
protein, tau. Potential molecular connections between T2DM and AD include 
glycogen synthase kinase 3 (GSK3), which is a kinase that lies downstream 
of the IR (Taniguchi et al, 2006). Following activation of the IR, GSK3 is 
phosphorylated and therefore inactivated by PKB, facilitating glycogen 
production and storage (Taniguchi et al, 2006). If not inactivated in this way it 
has also been shown, in vitro, to increase Aβ production and to 
phosphorylate tau, resulting in these characteristic plaques and tangles (Cole 
et al, 2007). 
 
 
 
 31 
1.15 Diagnosis and treatment of T2DM 
Accurate diagnosis and classification of diabetes is important with respect to 
clinical decisions made and lifestyle advice offered.  
 
1.15.1 Diagnosis 
Diagnostic tools available include measurement of blood glucose levels and 
consideration of medical and family history (SIGN guideline 116). Diagnosis 
is usually confirmed by hyperglycemia followed by a glucose tolerance test 
(SIGN guideline 116; Craig 2009). Age and severity of onset is usually later 
and milder than in T1DM and rate of onset of the condition and progression 
of symptoms is usually slower (Craig et al, 2009). However, classifying the 
type of diabetes could ideally be facilitated by measuring autoantibody 
markers (Craig et al, 2009). Measurement of C-peptide is a potential useful 
indicator of endogenously produced insulin levels for diagnosis of T2DM 
(Craig et al, 2009). Glycosylated haemoglobin (HbA1c) is used to monitor 
progression of diabetes, as a measure of average blood glucose level over 
the past 2-3 months (SIGN guideline 116). T2DM is often accompanied by 
obesity and acanthosis nigricans, a hyperpigmentation observed within skin 
folds. A family history of T2DM is often also present (Craig et al, 2009).   
 
1.15.2 Treatment 
Various pharmacological interventions are currently available for the 
treatment of T2DM (SIGN guideline 116). These consist mainly of oral 
antihyperglycemic agents and insulin.  
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1.15.2.1 Sulphonylureas 
Insulin secretagogues, such as sulphonylureas (SURs), increase insulin 
secretion from the pancreatic β cells but pose a risk of hypoglycaemia. Drugs 
in this class include glyburide and glipizide (Nyenwe et al, 2011). 
 
1.15.2.2 Thiazolidinediones 
Thiazolidinediones (TZDs) bind to peroxisome proliferator activated receptor 
(PPAR) transcription factors in the nucleus and therefore activate the 
transcription of various proteins (Smith, 2002).  These include increased 
expression of glucose transporters such as GLUT1 and 4, upregulation of 
IRS, decreased activity of PEPCK and increased levels of lipoprotein lipase, 
upregulating plasma triglyceride clearance (Smith, 2002). This results in 
increased insulin sensitivity and glucose utilisation and downregulation of 
gluconeogenesis (Smith, 2002). Endogenous activators of PPARs include 
some molecules involved in insulin signalling and glucose and energy 
homeostasis (Smith, 2002). These include fatty acids (Schoojans et al, 1996) 
and acyl CoA derivatives (Bronfman et al, 1986). However, some of these 
TZDs have been implicated in fluid retention, congestive cardiac failure and 
osteoporosis (Nyenwe et al, 2011). As a result, there is only one TZD, 
pioglitazone, still in clinical use in the UK. Other studies indicate that there 
are important PPAR gamma independent targets of TZDs, including AMPK, 
which is also a target of metformin (Fryer et al, 2002). 
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1.15.2.3 α-glucosidase inhibitors 
This group of compounds inhibit the action of α-glucosidase in the small 
intestine and reduce the absorption of glucose due to the reduction in 
breakdown of starch to glucose as α glucosidase in the small intestine would 
normally be involved in the catabolism of polysaccharides to 
monosaccharides (Nyenwe et al, 2011). This can, however, lead to excess 
glucose in the colon, which can cause problematic and often poorly tolerated 
gastrointestinal disturbances (Nyenwe et al, 2011). Hypoglycaemia as a 
consequence of poor glucose absorption can sometimes also be an issue 
and the dose and timing of drug application often requires to be considered 
on an individual basis (Nyenwe et al, 2011).  
 
1.15.2.4 Biguanides 
Biguanides such as metformin appear to act mainly by restoring suppression 
of hepatic gluconeogenesis which becomes abnormally elevated in T2D; 
however their mechanism of action remains a subject of ongoing 
investigation. Elevated muscle glucose uptake and decreased hepatic 
gluconeogenesis have been shown to contribute to the antihyperglycemic 
effects of metformin which have been proposed to be mediated via AMPK 
(Fryer et al, 2002) or possibly suppression of mTOR signalling (Kalendar, 
2010). Recent studies indicate that AMPK is not required for effects of 
metformin on S6 (Kalendar et al, 2010; Kickstein et al, 2010), suggesting that 
these two pathways can operate independently. Metformin has also been 
proposed to inhibit gluconeogenesis by inhibition of complex 1 of the 
mitochondrial respiratory chain (Owen et al, 2000). This increases the AMP/ 
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ATP ratio, which in turn activates AMPK (Foretz et al, 2010) Gastrointestinal 
side effects can be problematic (Nyenwe et al, 2011). 
 
1.15.2.5  GLP1 agonists 
Incretins increase post prandial insulin release from the pancreas. One such 
molecule is glucagon like peptide 1 (GLP1) (Drucker and Nauck, 2006). 
Exenatide and liraglutide are clinically available GLP1 agonists 
administerable subcutaneously (http://www.nice.org.uk/guidance/index). 
 
1.15.2.6 SGLT2 inhibitors 
Reabsorption of glucose occurs in the proximal tubule of the kidney by 
sodium coupled glucose transporters (SGLTs), predominately SGLT2 ( 
approximately 90%). Inhibition of SGLT2 results in increased levels of 
glucosuria and a corresponding reduction of blood glucose levels (Ghosh et 
al, 2012; Misra, 2012). Dapagliflozin is a selective SGLT2 inhibitor now 
licensed for use in the UK and is expected to be issued by June 2013. 
(http://www.nice.org.uk/guidance/index) 
 
1.16 Diet  
Before the discovery of exogenously administerable insulin in the early 
twentieth century by Banting and Best, low carbohydrate ‘starvation diets’ 
were prescribed to reduce glycosuria in diabetic patients. Although these 
delayed death by preventing hypoglycemic coma most patients ultimately 
died of starvation (Sawyer and Gale, 2009). Various diets have since been 
recommended for T1DM in conjunction with insulin therapy including high 
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carbohydrate, normal diet and high fibre diet (Sawyer and Gale, 2009). 
T2DM has been associated with obesity and therefore frequently with a 
calorie dense diet and a sedentary lifestyle (Torpy et al, 2009). Various diets 
have also been recommended from various sources to counteract the current 
obesity and T2DM epidemic including the pre insulin diets recycled and 
modified as the Atkins diet (Sawyer and Gale, 2009). Starvation diets 
recently attracted considerable new attention for treatment of T2DM but 
larger studies are required to determine what proportion of T2DM patients 
will be able to use this as a practical treatment (Lim et al, 2011).  
 
1.17 Searching for novel plant compounds with utility in T2DM 
As already discussed, metformin, salicylate and aspirin, all originally derived 
from plants, exhibit efficacy in treatment of T2DM in humans. Other plant 
compounds are under investigation. As T2DM is largely attributable to the 
overconsumption of energy rich food, if healthy, palatable medicinal foods 
could be formulated, it may be possible to reverse the current trend of 
increasing obesity and T2DM. T2DM is a particularly promising target for this 
type of approach because it often precedes many other health problems 
which might be prevented by more effective treatment of T2DM. Plant 
compounds under investigation include theaflavins, polyphenolic compounds 
found in black tea extract which have already been proposed as potential 
antihyperglycemic agents (Cameron et al, 2008). Polyphenols have also 
been proposed to be beneficial in other conditions that T2DM may precede 
including Alzheimer’s Disease (Pasinetti and Ho, 2010), cancer (He et al, 
2008) and cardiovascular disease (Mukamal, 2002).  
 36 
The ‘French paradox’ is the observation that French people suffer from a 
comparatively low incidence of cardiovascular pathology compared to the 
rest of Europe despite having a relatively high fat diet which would normally 
be believed to contribute to heart disease (Ferrieres, 2004). The mechanism 
and even existence of this effect has been contested but one possible and 
popular explanation has been that the French consume more red wine, 
containing phenolic compounds which may have antioxidant effects which 
could attenuate the oxidation of low density lipoproteins (LDL) and which 
have also been proposed to have anti-inflammatory properties which may be 
beneficial to the endothelium (Kappagoda et al, 2000). However flawed this 
simple connection may be, the link between intake of dietary phenolics 
(especially from fruit and vegetables) and health benefits has gathered 
momentum (Seeram, 2012). Therefore in this thesis, a variety of 
polyphenolic and other plant compounds have been investigated for 
therapeutic properties relevant to T2DM.  
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1.18 Aims and objectives 
The aims of this project were to: 
1. To extract polyphenolic compounds from grape seed, pine bark and 
berries using chromatographic techniques and to characterise these 
compounds using liquid chromatography/ mass spectrometry (LCMS). 
 
2. To exclude or confirm insulin-like or metformin-like properties of these 
compounds by application to cell culture models to assess effects on 
regulators of energy homeostasis by measuring phosphorylation of 
the transcription factor FOXO1a, AMPK and the ribosomal protein S6. 
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CHAPTER 2 – MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Lysis buffer  
This consisted of 50mM Tris acetate adjusted to pH 7.5 with acetic acid,  
0.27M sucrose (Fisher Scientific), 1mM ethylenediaminetetraacetic acid 
(EDTA, Fisher Scientific), 1 mM ethyleneglycoltetracetic acid (EGTA, Tocris 
Bioscience), 100 mM sodium orthovanadate (Sigma- Aldrich), 10 mM β-
glycerophosphate (Sigma), 50mM sodium fluoride, 5mM sodium 
pyrophosphate and  1% Triton X-100 (BDH; w/v 1.06g/ ml). 10µl β-
mercaptoethanol (Sigma,), 10µl phenylmethanesulphonylfluoride (PMSF, 
Sigma,) and 100µl 0.1M sodium orthovanadate were added to 10ml lysis 
buffer before use as their activity rapidly diminishes. Sucrose facilitates 
osmotic burst as when it is taken up by the cell, water osmotically follows. 
EDTA is a metal ion chelator and therefore acts as a metal ion dependent 
protease inhibitor. EGTA has a higher affinity for calcium ions than other ions 
and is used to inhibit calcium dependent phosphatases and protein kinases. 
Sodium orthovanadate inhibits protein tyrosine phosphatases which could 
otherwise remove phosphate groups from phosphorylated tyrosine residues 
on proteins. β- glycerophosphate and sodium fluoride are  serine/threonine 
phosphatase inhibitors and sodium pyrophosphate is a general phosphatase 
inhibitor. Triton X-100 is used to permeabilise the cell membrane. β-
mercaptoethanol was used to denature proteins to their secondary structure 
by cleaving disulphide bonds and stabilising the protein. The intermediate 
compound formed can then form a stable structure preventing further 
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reaction with the resultant free sulphydryl residues resulting in reformation of 
the bond.  PMSF is a serine protease inhibitor. 
 
2.1.2 Tris Buffered Saline X 10 
2 litres (L) Tris Buffered Saline (TBS) X10 consisted of 584.4 grams (g) 
sodium chloride (NaCl); (Aldrich) and 48.5g Tris (Fisher Bioreagents,) made 
up to 2L using distilled water and mixed using a magnetic stirrer. Tris can 
buffer at the normal mammalian physiological pH of 7.4. The pH of this 
solution was brought down to 7.4 using concentrated hydrochloric acid (HCl) 
and thereafter bottled and autoclaved. This buffer is used in Western blotting 
to maintain pH with a stringent (0.5M) salt wash to reduce non-specific 
interactions. For blotting, 1X TBS was used, with addition of 0.1 % tween 20 
(TBST). 
Tween 20 (Polysorbate 20) is a polysorbate surfactant which can be used as 
a washing agent in immunoassays such as Western blots to prevent non 
specific antibody binding. Blocking buffer consisted of TBST with 5% milk 
w/v, mixed using a magnetic stirrer. 
In western blotting, non-specific binding of proteins is prevented by placing 
the membrane in this dilute solution of milk. The proteins in the milk attach to 
the membrane in all places where the target proteins have not attached, 
termed ‘blocking’.  
 
2.1.3 Transfer buffer X10  
Transfer buffer is an electrolyte solution used to transfer proteins from a gel 
onto a nitrocellulose membrane. An electric current is passed through the 
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buffer which transfers the proteins from the gel onto the membrane. This 
buffer consisted of 288g glycine (Melford) and 60g Tris made up to 2L using 
distilled water, mixed using a magnetic stirrer and thereafter bottled and 
autoclaved. Before use, 300ml of this stock was added to 2400ml distilled 
water and 300ml methanol added. 
 
2.1.4 MOPS (morpholino propanesulfonic acid) buffer X1 
MOPS running buffer X 1 consisted of 950ml distilled water and 50ml X20 
MOPS buffer (83.7g MOPS; 13.6g sodium acetate trihydrate; 3.7g EDTA 
disodium dehydrate, 800ml nuclease free distilled water, adjusted to pH 7), 
made up to 1L. This buffer allows a current to flow through the gel, enabling 
electrophoretic movement of the proteins loaded on the gel. 500µl NuPage 
antioxidant was added to 200ml MOPS X1 to prevent reoxidation of reduced 
disulphide bonds within the proteins of interest. 
 
2.1.5  Loading buffer 
This consisted of 10g sodium dodecyl sulphate (SDS), 12.5 ml 0.5M Tris-HCl 
pH 6.8 and 50ml glycerol (Sigma- Aldrich) made up to 100ml with 25mg 
bromophenol blue (Sigma- Aldrich). Before use the loading buffer was 
heated twice for ten seconds or until no crystallisation was observed at full 
power in a microwave oven and 5% β-mercaptoethanol added.    
SDS is an anionic surfactant which disrupts non covalent bonds in the 
proteins, causing them to lose their secondary and tertiary conformation. 
SDS also confers a negative charge on the protein at a ratio of one SDS 
 41 
anion for every 2 amino acid residues, which is therefore proportional to the 
mass of the protein (Biological Industries, 2012).     
 
2.1.6  Grape seed and pine bark extracts 
Masquelier’s grape seed extract and pine bark extract were obtained 
separately from Berkem. They are commercially available as a grape seed 
and pine bark oligopranthocyanidin homeopathic mixture and sold to the 
public in tablet form. 
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2.1.7 Commonly used compounds. 
Commonly used compounds are listed in Table 2.1: 
Compound Supplier 
Tris base Fisher, Loughburgh, LE11 SRG 
Acetic acid VWR, Leicestershire, LE17 4XN 
EDTA Gibco, Paisley, PA4 9RF 
EGTA Tocris Bioscience, Bristol BS11 OQL 
Sodium orthovanadate Sigma- Aldrich, Dorset, England 
Β-glycerophosphate Sigma, Dorset, England 
Sodium fluoride Fischer Scientific, Loughburgh, LE11 SRG 
Sodium pyrophosphate BDH, Hull, HU1 1UY 
Triton-X Sigma, Dorset, England 
Β-mercaptoethanol Aldrich, Dorset, England 
PMSF Sigma, Dorset, England 
Sodium chloride Aldrich, Dorset, England 
Tween 20 Sigma, Dorset, England 
Glycine Sigma, Dorset, England 
Methanol Fisher chemical, Loughburgh, LE11 SRG 
SDS BDH, Hull, HU1 1UY 
Hydrochloric acid BDH, Hull, HU1 1UY 
Glycerol Sigma- Aldrich, Dorset, England 
Bromophenol blue Sigma- Aldrich, Dorset, England   
Dubelco’s Modified Eagle Medium Gibco, Paisley, PA4 9RF 
Fetal Bovine Serum Gibco, Paisley, PA4 9RF 
SeeBlue Plus2 Prestained standard Invitrogen, Paisley, PA4 9RF 
Trypsin Gibco, Paisley, PA4 9RF 
 
Table 2.1: Synopsis of commonly used chemicals 
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2.1.8  Primary and secondary antibodies. 
Some commonly used primary and secondary antibodies are shown in Table 
2.2 
Primary Supplier Secondary 
FoxO1a NG Rena, University of Dundee sheep 
pSer325 
FoxO1a 
NG Rena, University of Dundee sheep 
PKB Ser 473 Cell Signaling Technology, Hertfordshire, SG4 
OTY 
rabbit 
ACC Cell Signaling Technology, Hertfordshire, SG4 
OTY 
rabbit 
S6 Cell Signaling Technology, Hertfordshire, SG4 
OTY 
rabbit 
pACC Ser 79 Division of Signal Transduction Therapy, 
University of Dundee 
sheep 
pS6 Ser 
240/244 
Cell Signaling Technology, Hertfordshire, SG4 
OTY  
rabbit 
Actin Calbiochem, Irvine, KA12 8NB mouse 
 
Table 2.2: Some commonly used antibodies 
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2.1.9  Materials for extraction and analytical studies 
The suppliers for materials used for extraction and analysis of samples are 
shown in Table 2.3: 
Compound Supplier 
Bradford Reagent Sigma, Dorset, England 
Folin Ciocalteu Reagent Sigma, Dorset, England 
Sodium carbonate Fluka, Irvine, KA12 8NB 
Sodium acetate Fluka, Irvine, KA12 8NB 
Hydrochloric acid BDH, Hull, HU1 1UY 
Potassium chloride BDH, Hull, HU1 1UY 
Ferric ion BDH, Hull, HU1 1UY 
Tripyridyltriazine  Sigma, Dorset, England 
Methanol Fisher Chemical, 
Loughburgh, LE11 SRG 
Acetone Fisher Chemical 
Ethyl acetate BDH, Hull, HU1 1UY 
Trichloromethane BDH, Hull, HU1 1UY 
Ethanol Fisher Chemical 
Diethyl ether Sigma-Aldrich, Dorset, 
England 
Sephadex LH column GE Healthcare, 
Buckinghamshire, HP8 
4SP 
Supelco Discovery Polyamide DPA-6S cartidges Supelco, Dorset, 
England 
Synergi HPLC column 4µM Hydro- RP 80A RP C18 150 x 4.6mm Phenomenex, Cheshire, 
SK10 2BN 
Formic acid Fluka, Irvine, KA12 8NB 
HPLC grade acetonitrile Sigma-Aldrich Dorset, 
England 
HPLC grade dichloromethane Sigma-Aldrich, Dorset, 
England 
HPLC grade methanol Sigma-Aldrich, Dorset, 
England 
 
Table 2.3: Commonly used reagents for extraction and analysis of samples. 
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2.1.10  Benzoic acids and their analogues 
The suppliers of commonly used chemicals for benzoic acid studies are 
shown in Table 2.4: 
Compound Supplier 
Benzoic acid Sigma, Dorset, England 
2-hydroxybenzoic acid Sigma- Aldrich, Dorset, England 
3-hydroxybenzoic acid Aldrich, Dorset, England 
4-hydroxybenzoic acid Aldrich, Dorset, England 
2,3-dihydroxybenzoic acid Aldrich, Dorset, England 
2,4-dihydroxybenzoic acid Aldrich, Dorset, England 
2,5-dihydroxybenzoic acid Aldrich, Dorset, England 
2,6-dihydroxybenzoic acid Aldrich, Dorset, England 
3,4-dihydroxybenzoic acid Aldrich, Dorset, England 
3,5-dihydroxybenzoic acid Aldrich, Dorset, England 
3,4,5-trihydroxybenzoic acid Sigma, Dorset, England 
3,5-dimethoxy- 4- hydroxybenzoic acid  Aldrich, Dorset, England 
p-anisic acid Aldrich, Dorset, England 
2-methoxybenzoic acid Aldrich, Dorset, England 
4-ethylbenzoic acid Aldrich, Dorset, England 
3-hydroxy-4-methoxybenzoic acid Aldrich, Dorset, England 
4-hydroxy-3-methoxybenzoic acid Aldrich, Dorset, England 
4-hydroxybenzaldehyde Aldrich, Dorset, England 
 
Table 2.4: Some commonly used chemicals in benzoic acid studies.  
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2.1.11 Diguanide synthesis 
Suppliers of some commonly used chemicals for diguanide synthesis are 
shown in Table 2:5 
Compound Supplier 
Methylisourea Sigma- Aldrich, Dorset, England 
Potassium hydroxide BDH, Hull, HU1 1UY 
Cadaverine Sigma- Aldrich, Dorset, England 
Perichloric acid BDH, Hull, HU1 1UY 
1,7-diaminoheptane Sigma- Aldrich, Dorset, England 
1,8-diaminoheptane Sigma- Aldrich, Dorset, England 
Spermine Sigma- Aldrich, Dorset, England 
Spermidine Sigma- Aldrich, Dorset, England 
Arcaine Tocris Bioscience, Bristol BS11 OQL 
1,6- Bis(guanidine) hexane sulfate Santa Cruz, Middlesex, HA9 7YN 
1-Dodecyl-guanidiniumacetat  Fluka, Irvine, KA12 8NB 
 
Table 2.5: Sources of commonly used chemicals for diguanide synthesis 
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2.1.12 Gene expression reporter and WST-1 assay reagents 
The sources of some commonly used reagents for gene expression reporter 
assays and for WST-1 assays are shown in Table 2.6: 
Compound Supplier 
Dexamethasone Sigma, Dorset, England 
Cyclic adenosine monophosphate (cAMP) Calbiochem, Irvine, KA12 8NB 
Insulin Novo Nordisk, West Sussex, RH11 9RT 
Metformin Calbiochem, Irvine, KA12 8NB,  
Luciferase assay reagent Promega, Southampton, SO16 7NS 
Luciferase assay lysis buffer Promega, Southampton, SO16 7NS 
WST-1 assay Millipore, Dundee DD2 1SW 
 
Table 2.6: Sources for commonly used reagents for gene expression and WST-1 assays 
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2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Maintenance 
Cell culture is a technique whereby cells are grown under controlled 
conditions. All cell culture techniques were carried out under aseptic 
conditions and all media was heated to 37oC before use. Cells were cultured 
at 37oC in 75cm3 flasks (Corning) in a 5% carbon dioxide (CO2) water 
saturated incubator. 
 
2.2.1.2 Human Embryonic kidney 293 cells 
 Human embryonic kidney (HEK) 293 cells were used as they express a high 
and therefore detectable level of FOXO1a. These cells were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM, GIBCO) containing 1g/l 
glucose, L-glutamate and pyruvate supplemented with 10% (v/v) foetal 
bovine serum (FBS, GIBCO). The cells were passaged three times a week 
(1:4). Passage of cells was achieved by aspirating the cell culture medium 
and washing twice with 5ml sterile DMEM before the cells were dissociated 
from the flask by the addition of 5ml 0.25% trypsin. The cells were allowed to 
detach for one minute at 37oC in a 5% CO2 water saturated incubator before 
inactivation of trypsin by the addition of 50ml DMEM supplemented with 10% 
FBS. 10ml of this culture was transferred to a new sterile 80cm2 flask to 
maintain stocks and the remainder divided between ten 6cm2 dishes for 
further experimentation. 
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2.2.1.3 H4IIE cells 
This cell line was used to detect phosphorylated ACC (pACC), 
phosphorylated AMPK (pAMPK) and phosphorylated S6 (pS6). They are rat 
hepatocytes where gluconeogenesis is regulated by insulin in a similar way 
to human liver cells. Cells were maintained as above except 5% FBS was 
used and a 1:4 passage was carried out twice weekly. The cell line was a 
generous gift from Dr Calum Sutherland. 
 
2.2.2 Cell stimulation and lysis 
Four days after passage, DMEM with FBS was renewed 24 hours before 
experimentation and prior to incubation with stimuli, the cells were serum 
starved for 30 minutes by rinsing the cells once in 4ml DMEM, which was 
replaced by 2ml DMEM. Each plate was then treated and labelled as 
required and incubated at 37oC in a 5% CO2 water saturated atmosphere for 
one hour. The DMEM was removed from the plates which were then placed 
on ice and lysis buffer added, the cells scraped into the buffer and the 
buffer/protein mixture placed into correspondingly labelled eppendorf tubes 
which were centrifuged at 13,000 rpm for five minutes at 4oC. 150µl 
supernatant was removed then placed into labelled eppendorf tubes and the 
tubes containing the pellets were stored at -80oC. Loading buffer was then 
heated 2X10 seconds at full power in a microwave oven or until no SDS 
crystallisation was observed and 5% β-mercaptoethanol added. 38µl loading 
buffer was then added to each of the tubes containing 150µl supernatant 
which were then vortexed and stored at -20oC. 
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2.2.3 Cell reporter assay   
G6Pase expression was measured using a luciferase cell reporter assay. 
Luciferase and luciferin are endogenous to the firefly. Luciferin reacts with 
oxygen, ATP and luciferase to produce light. LLHG (Lisa Logie human 
G6Pase) cells are H4IIE cells transfected with a G6Pase/ luciferase DNA 
construct. In this construct, luciferase expression is under the control of the 
human G6Pase promoter, so luciferase expression monitors the activity of 
the promoter. G6Pase expression is induced by glucocorticoids such as 
dexamethasone and by glucagon via cAMP. Therefore combined 
dexamethasone (100µM) and cAMP (500nM) was used as a positive control 
to induce G6Pase expression and the negative control involved suppression 
by treatment with 10nM insulin.    
 
2.2.4 WST1 assay 
A WST1 assay is a colorometric measurement of cell viability. It is based on 
the cleavage of the tetrazoium salt WST1 to formazin by succinate 
tetrazolium reductase, a mitochondrial dehydrogenase resulting in a colour 
change from a pale to a darker yellow, depending on the number of viable 
cells present. Water soluble tetrazolium salts were developed by introducing 
positive or negative charges and hydroxyl groups to the phenyl ring of the 
tetrazolium salt. The bioreduction of WST1 is thought to depend on glycolytic 
NADPH production and therefore reports the presence of viable cells.  
H4IIE cells were seeded on a 96 well plate, starved and treated with the 
appropriate samples. WST1 mixture was added to each well, mixed and 
 51 
incubated for two hours. The absorbance of each sample was measured 
using a spectrophotometer at a wavelength of 250nm.  
 
2.2.5 Western blotting 
Western blotting is an analytical technique used to detect specific proteins in 
a sample after separation of the proteins by SDS-PAGE. 
 
2.2.5.1 SDS-PAGE (Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis)   
Samples in loading buffer were removed from -20oC storage, thawed and 
heated at 95oC for 5 minutes on a heating block to denature the proteins. 
The proteins in each sample were separated by SDS-PAGE on NuPage 4-
12% Bis-Tris gels (Invitrogen). The reservoirs of the electrophoresis 
apparatus were filled with 1X MOPS running buffer and the central reservoir 
also contained a 1/400 v/v concentration of NuPage antioxidant (Invitrogen). 
The wells of the gels were then rinsed with running buffer and loaded with 
1µl SeeBlue Plus2 Prestained Standard (Invitrogen) or 15µl sample as 
required. The gels were then run for 50 minutes at 200V when probing for 
FOXO proteins and 2hrs at 90V when probing for ACC, AMPK and S6 
proteins, as this allowed better resolution of ACC. The remainder of each 
sample was stored at -20oC.  
 
2.2.5.2 Protein Transfer 
Once the proteins had been separated, they were electroblotted to transfer 
them onto nitrocellulose membranes. The gel was placed into a transfer 
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cassette as follows. A blotting pad was placed into the transfer cassette 
followed by two pieces of blotting paper and a nitrocellulose membrane 
(Whatman) then the gel was placed on top followed by another two pieces of 
blotting paper and a blotting pad. After ensuring no air bubbles remained 
within the cassette, the cassette was closed and loaded into transfer 
apparatus which was then filled with transfer buffer and run overnight at 
0.12A, over two days at 0.1A, three days at 0.07A or four days at 0.05A 
current. Once the proteins had transferred, the nitrocellulose membranes 
were removed from the cassette and were stained with Ponceau (Invitrogen) 
to confirm that the protein content of each of the samples was equivalent. 
The membranes were then rinsed briefly three times with TBST to rinse off 
the Ponceau stain, renewing the TBST after each rinse. 
 
2.2.5.3 Immunoblotting and exposure    
The membranes were then blocked with TBST + 5% milk and placed on a 
platform rocker for one hour. Then the blot was treated with the specific 
primary antibodies in 10ml TBST with 5% milk and incubated overnight at 
4oC. The membranes were then quickly rinsed in TBST three times then 
rocked in TBST for ten minutes followed by two five minute periods with fresh 
TBST after each rinse or wash. The blots were then incubated with the 
secondary antibody specific to the primary antibody host for 1 hour in 10ml 
TBST + 5% milk The secondary antibody was coupled to horse radish 
peroxidase (HRP) to enable detection by chemiluminscence. After incubation 
in secondary antibody, the blots were quickly rinsed in TBST three times and 
rocked with TBST for ten minutes, rinsed and rocked with TBST again for a 
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further two five minute periods. The blots had excess buffer removed, were 
placed in a clean dish and 2ml of enhanced chemoluminescence (ECL) 
reagent (Amersham Biosciences) was added for one minute. The blots were 
removed, the excess reagent removed and the blot transferred to a film 
cassette lined with cling film. In the dark room, typically one, five fifteen 
minute and overnight exposures were captured on X-ray film (Fuji), carried 
out under a safe light.   
 
2.2.6 Bradford assay 
This method measures the concentration of protein in a sample (Bradford, 
1976). When proteins bind to Coomassie Brilliant Blue G-250 (Bradford 
reagent, Sigma), the dye changes from red to blue causing a change in 
absorption from 465nm to 595nm. A standard curve was generated using 
incrementally increasing concentrations of protein standard and the protein 
concentration of each sample was determined using this curve. 
y = mx + c 
x = y – c/m where: 
x = protein concentration 
y = absorbance at 595nm 
m = gradient 
c = y intercept 
 
2.2.7 Total phenols assay 
All assays were carried out in triplicate to determine the phenolic content of 
each sample. Samples were diluted to 1% in distilled water. 250µl half 
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strength Folin Ciocalteu Reagent (Sigma F295 with distilled water) was 
added to 250µl of each sample. After three minutes, 500µl of saturated 
sodium carbonate solution was added and one hour later, the absorbance of 
the sample at 750 nm was measured using an Ultrospec 2100 pro 
spectrophotometer. Reduction of molybdenum in the Folin Ciocalteu 
Reagent results in a colour change from yellow to blue under the basic 
conditions provided by sodium carbonate. Five incrementally-increasing 
concentrations of phloroglucinol were used to generate a standard curve. 
The values obtained were then analysed on an Excel programme using the 
following equation:  
y = mx + c; therefore:  x = y/m – c; c = 0 therefore: x =y/m where: 
y = phenolic concentration in diluted sample (µg); 
x = absorbance of sample at λ 750nm 
m = gradient 
The result obtained was then multiplied by 100 to give the phenolic 
concentration of 100% sample.     
 
2.2.8 Total anthocyanin assay 
The total anthocyanin assays were performed using a pH differential method. 
At pH1, anthocyanins exist predominately in the form of the red flavylium 
cation and increasing the pH to 4.5 leads to a decrease in the concentration 
of the flavylium cation and therefore a decrease in colour intensity. 
Anthocyanins absorb well at 510 nm at pH 1 and poorly at pH 4.5. The 
measurements at 700 nm pick up compounds that are brown at these pHs 
and interfere with the measurement at 510 nm. The absorbance correlates 
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with the concentration of anthocyanins in samples according to the follows 
the Beer Lambert law. 
 
(A510 – A700) pH1 – (A510 – A700 ) pH4.5 
 
Samples were diluted to 2% final concentration (20µl sample/ 980µl distilled 
water) in both 0.2M HCl/ KCl pH1 and 0.1M sodium acetate pH 4.5 (2 
repeats per sample). A blank of 0.2M HCl /KCl pH1 was used.  After a 15 
minute incubation, the absorbance of each sample was measured on a 
spectrophotometer at wavelengths of 510 and 700 nm.  
The values obtained were then entered into an Excel programme using the 
above equation. All assays were carried out in duplicate and the average 
values used to estimate the anthocyanin content of each sample. 
 
2.2.9 Ferric reducing antioxidant power (FRAP) Assay 
Each sample was diluted to 1% in distilled water. A ferric complex was made 
from ferric ion (Fe3+) and tripyndylthiazine (TPTZ) and the degree to which 
samples reduced this to the ferrous form (Fe2+), changing its colour to blue, 
was measured at a wavelength of 593nm over 4 minutes. A standard curve 
is generated using known concentrations of ferrous ion using ferrous 
sulphate. The values obtained were entered into an Excel programme using 
the following equation:  
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y = mx + c; therefore:  x = y/m – c; c = 0 therefore: x =y/m where: 
x = FRAP 
y = absorbance of sample at λ593nm 
m = gradient 
 
2.2.10 Chromatography 
This is a technique whereby compounds within a mixture are separated 
according to their physical and/ or chemical properties. Preparative 
chromatography involves purification of a sample and analytical 
chromatography involves measuring the relative proportions of analytes in a 
sample. 
Chromatographic techniques can be classified according to the state of 
either the mobile or the stationary phase, by the separation mechanism 
involved, by the comparative polarities of the mobile and stationary phases 
or by size. 
In gas chromatography the mobile phase is a gas and the stationary phase is 
a liquid set within a glass or metal column. In liquid chromatography the 
mobile phase is a liquid and the stationary phase is a solid. 
In column chromatography the stationary phase is a solid support set within 
a tube and the mobile phase is liquid. In size exclusion chromatography 
molecules are separated according to size. Smaller molecules are able to 
enter pores within the stationary phase and remain there whereas larger 
molecules are excluded and eluted. 
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In normal phase chromatography, the stationary phase is more polar than 
the mobile phase. In reverse phase chromatography, the mobile phase is 
more polar than the stationary phase. 
 
2.2.11 Extraction of phenols from berries 
100g berries were liquidised in 400ml of a 50/ 50 methanol/ acetone mix and 
placed in 50ml centrifuge tubes. Ultrasound assisted extraction (5 X 2 mins) 
was then applied to aid extraction by breaking down the plant cell wall and 
tubes were centrifuged at 3000 rpm for 4 minutes and supernatant collected. 
The pellets were redissolved in 30ml of the acetone/methanol solvent and re-
extracted. A further extraction of the pellet was carried out using 20 ml 
solvent before all 3 extracts were combined. A total phenol assay was then 
carried out to determine the phenol content of the sample.   
 
2.2.12 Solvent/ solvent fractionation 
This method was adapted from that described by Saucier et al, (2001), which 
involved fractionation based on the relative solubility of proanthocyanidins 
(PACs) of different sizes in different solvents. A flow diagram is shown in 
Figure 2.1. 
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Whole sample 
Separate components into water 
and ethyl acetate fractions (See 
step 1) 
Evaporate 
Redissolve water fraction 
in methanol (See step2) 
Add chloroform to 
50% and centrifuge 
Precipitate = F1 
Add chloroform to 
60% and centrifuge Precipitate = F2 
Add chloroform to 
70% and centrifuge Precipitate = F3 
Add chloroform to 
80% and centrifuge 
Precipitate = F4 
Evaporate supernatant 
and resuspend in 50% 
methanol 
F5 
Treat supernatant from F5 
water fraction (See step 3) 
Solid phase extraction 
Ether 
Fraction 6E 
Methanol 
Fraction 6M 
Fig 2.1 Flow diagram 
illustrating the solvent/ 
solvent fractionation used. 
(Adapted from Saucier, 
2001) Steps 1- 3 are 
discussed in the text. 
Water 
fraction Ethyl acetate 
fraction 
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Step 1. Extraction of PACs in ethyl acetate 
0.5g whole sample (GSE or PBE) was dissolved in 50ml distilled water and 
20ml placed in a separating funnel. 20ml of ethyl acetate was added then the 
water and ethyl acetate fractions were separated into round bottomed flasks 
and dried on a rotatory evaporator. 
Step 2. Treatment of ethyl acetate fraction 
 The water fraction was redissolved in 5ml methanol and 5ml chloroform 
added to raise the chloroform concentration to 50% (v/v). After mixing, the 
solution was centrifuged at 3000rpm for 10mins at 5oC. The supernatant was 
removed and placed in a new tube and the pellet resuspended in 1ml 
methanol to generate Fraction 1 (F1). 2.5ml chloroform was then added to 
raise the chloroform concentration to 60% (v/v) and the sample was treated 
as before. The supernatant was removed and the pellet was resuspended in 
1ml methanol to generate F2. 4.2ml chloroform was added to the 
supernatant to raise the chloroform concentration to 70% (v/v) and after 
centrifugation, the pellet was resuspended in 1ml methanol to form F3. 8.3ml 
chloroform was then added to the supernatant to raise the chloroform 
concentration to 80% (v/v). Again the pellet was resuspended in 1ml 
methanol to form F4 and the supernatant was labelled F5. Fractions 1- 4 
were dried in the centrifugal evaporator and F5 in the rotatory evaporator. 
Step 3. Solid phase extraction 
The ethyl acetate fraction was then resuspended in 50% ethanol and a C18 
SPE column (Thermo Scientific) was then prepared by filtering 35ml diethyl 
ether followed by 35ml methanol through the column. The sample was added 
and the run-through, including a 20ml distilled water wash, discarded. 50ml 
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diethyl ether was then added and an ether subfraction (F6) was collected. 
50ml methanol was then added and a methanol subfraction of F6 was 
collected. 35ml distilled water was then added and a water subfraction of F6 
was collected. These subfractions were then dried in the rotatory evaporator.   
 
2.2.13 Column chromatography 
2.2.13.1 Sephadex LH20 gel filtration column 
0.5g (GSE or PBE) of sample was dissolved in 50ml 50% ethanol. A lipohilic 
Sephadex LH20 column (GE Healthcare) was then used to separate each 
sample into fractions largely according to hydrophobicity. The column was 
prepared according to the manufacturer’s instructions and 5ml distilled water 
was passed through the column and discarded. The sample (total volume 5 
ml) was applied to the column. The column was eluted with 50% ethanol and 
unbound sample collected. Bound components were eluted using 50% 
acetone. After this, 80% acetone was added and a final acetone wash 
sample collected. Then 20ml 50% ethanol was passed through the column 
and a final ethanol wash sample collected. Each fraction was assayed for 
total phenols and the following equation used to produce 250µg GAE 
aliquots: 
250/ phenolic concentration in µg/ml) X 1000 = volume in no µl required to 
give 250µg GAE of sample 
These samples were then dried in a centrifugal evaporator under vacuum.  
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2.2.13.2 Solid phase extraction on Discovery polyamide columns 
This solid phase extraction (SPE) technique was adapted from a method 
described by Hellstrom et al (2007). SPE uses the affinity of molecules within 
a sample for a solid matrix through which the sample passes.  
Supelco Discovery DPA-6S polyamide cartridges (Supelco) adsorb polar 
compounds such as proanthocyanidins through hydrogen bonding between 
amide groups on the column and hydroxyl groups on the proanthocyanidins  
were used. These units were set up on a SPE vacuum manifold. The column 
was first conditioned with 10ml 100% methanol and then 10ml distilled water. 
The sample (10ml) was placed on top of the bed and 10ml unbound wash 
(sample) was collected. Then 10ml distilled water was added and 10ml 
unbound wash collected. Elution with 10ml 20% methanol was used to elute 
the unbound components. After this, the bound components were eluted 
using 80% acetone. Finally, 10ml 100% methanol was added and a 10ml 
methanol wash collected and 10ml distilled water was added and 10ml water 
sample collected. Each fraction generated was aliquoted according to its 
phenol content and evaporated as previously described. 
 
2.2.13.3 Liquid chromatography/ Mass spectrometry 
Mass spectrometry (MS) is an analytical technique used to determine the 
molecular composition of a sample. The components of each sample and 
fraction generated were determined by liquid chromatography/mass 
spectrometry (LCMS) using an LCQ-Deca system which consisted of a 
surveyor autosampler, a chromatography column, a pump, a photodiode 
array (PDA) detector and a Thermofinnigan mass spectrometer. The 
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autosampler injects the sample onto the column and the pump creates a 
gradient of an aqueous /organic solvent mix through the column enabling 
separation of different components. The column is referred to as the 
stationary phase and the solvents as the mobile phase. The PDA detector 
detects the absorption of eluted components at different wavelengths. The 
mass spectrometer consists of an ion source, an electrospray ionisation 
(ESI) interface which ionized the samples (usually to a monovalent charge), 
a mass analyzer where the mass/ charge (m/z) ratio of components was 
detected. Mass fragmentation (MS2) can then be used to further identify the 
ions through characteristic fragmentation of the parent ions. 
Samples were prepared by dissolving 250µg phenol equivalents in 250µl 
solvent and vortexing. After centrifugation, the samples were pipetted into 
100 µl inserts in autosampler vials. A hole was placed on top of each sample 
vial and the samples were loaded into the autosampler. The column was 
equilibrated prior to use in solvents A and B then pre-equilibrated at the 
starting %s. 
 
2.2.13.4 Reverse phase high performance liquid chromatography 
Reverse phase chromatography uses a non polar stationary phase and a 
polar mobile phase so the most polar molecules elute from the column first.  
A Synergi 4µm Hydro-RP 80A reversed phase C18 column, size 150mm X 
4.6mm (Phenomenex), was initially used as this column has proved effective 
in separation of polyphenol components. The term C18 describes the 
hydrophobic alkyl chain length of the stationary phase. 4µm describes the 
particle size of the solid support, RP indicates reverse phase and 80A 
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indicates the average pore size within each particle. Ultra pure water (UPW) 
with 0.2% formic acid (FA) was used as the aqueous solvent A and 90% 
HPLC grade acetonitrile (ACN) containing 0.1 % FA as the organic solvent B. 
FA was used to improve peak resolution. A gradient of 5 – 40% solvent B 
was used over a 30 min run to separate components. 
 
2.2.13.5 Normal phase HPLC 
This was method adapted from Hellstrom et al (2007). Normal phase HPLC 
uses a polar stationary phase and a non polar mobile phase to separate 
components. The method used a Silica Luna 5µm 100A column. 
Dichloromethane:methanol:water (5:44:1) was used as the aqueous solvent 
and dichloromethane:methanol:water (42:7:1) as the organic solvent. The 
analytes have varying affinities for the stationary phase by non polar 
interactions so the order of elution differs from reversed phase HPLC.  
 
2.2.14 Purity analysis 
Purity was assessed using the peak area detection facility in XCalibur 
software. The area of the peak of interest was divided by the total area of 
peaks in the separation zone. The result was then multiplied by 100 to 
calculate the percentage purity value. 
 
2.2.15 Diguanide synthesis 
Diguanides were synthesised using a method adapted from Tricot, 1990 
using 1 mole of a diamine and 2 moles of methylisourea. The methylisourea 
was added to ice cold UPW and the pH increased to 10 using 5M KOH. The 
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diamine was added and this was incubated for three hours, performing 15 
minute checks to ensure that the pH was maintained at 10. The 
guanidinylated products are insoluble at pH 10 and precipitates formed were 
collected by centrifugation and washed twice with 10ml ice cold UPW by 
recentrifugation. The final precipitates collected were frozen at -20oC and 
freeze dried. The purity of the products was assessed by direct injection MS 
analysis and MS2 fragmentation was used (with 45% energy collision factor) 
to obtain further information on the products.  More detailed information is 
included in chapter 6. 
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CHAPTER 3 – GRAPE SEED AND PINE BARK EXTRACTS 
3.1 Introduction 
Phenolic compounds consist of a hydroxyl group bound to a benzene ring. 
The simplest of these, phenol is illustrated in Fig 3.1: 
 
OH
    
Polyphenols are compounds which contain many phenolic rings. 
 
3.1.1 Flavonoids and proanthocyanidins 
The flavonoids are a diverse sub-group of polyphenolic compounds based on 
a phenolic ring system. The basic flavonoid skeleton and associated 
numbering and lettering systems are illustrated in Fig 3.2: 
O
 
 
 
Proanthocyanidins are polymerised flavonoids found in a wide variety of 
plant foods. They can exist as dimers up to polymers, with or without 
modification such as galloylation. 
 
Fig 3.1: Structure of phenol 
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Fig 3.2 The basic flavonoid structure 
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3’ 
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3.1.2 Benzoic acids 
These consist of a benzene ring with an acid group. The simplest of these, 
benzoic acid, is illustrated in Fig 3.3: 
O OH
 
 
3.1.3 Gallic acid and galloyl moiety 
Gallic acid (3,4,5 trihydroxybenzoic acid) is a hydroxylated benzoic acid with 
an atomic mass of 170 atomic mass units (amu). Its structure is illustrated in 
Fig 3.4: 
 
O OH
HO
OH
OH
 
 
Galloylation is a condensation reaction between the carboxylic acid group of 
gallic acid and a hydroxyl group of the PAC which results in the loss of a 
water molecule. This is illustrated in Fig 3.5:  
 
 
 
Fig 3.3: Benzoic acid. 
2 
3 
4 
5 
6 
Fig 3.4: Gallic acid  
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Fig 3.5: Reaction scheme of galloylation 
A galloylated phenolic molecule is 152 amu heavier than its ungalloylated form i.e. 170 amu 
(gallic acid) – 18 amu (water) = 152 amu. 
 
3.1.4 Grape seed and pine bark extracts 
These are industrial products of grape seed and pine bark which have been 
shown to be rich in phenolic compounds (Weber et al, 2007). Plant 
compounds have provided a number of clinical and experimental therapies 
+ 
+ 
H2O 
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for T2D and existing literature suggests polyphenols have a number of 
potential health benefits as described in Chapter 1. To search for insulin-like 
and metformin-like cellular responses to polyphenolic compounds, it was 
decided to fractionate grape seed and pine bark extracts and apply the 
fractions to cells. The purpose of this was to deduce chemical structural 
motifs or identify specific structures underlying any effects that were 
observed  
 
3.2 Results 
3.2.1 Insulin-like effects of grape seed and pine bark extracts   
HEK293 cells were stimulated with incrementally increasing concentrations 
of grape seed extract (GSE) and pine bark extract (PBE) using no treatment 
(vehicle only) as a negative control and 50µg/ ml black tea extract (BTE) as a 
positive control. Western blotting confirmed that treatment with 100µg/ml 
GSE induced phosphorylation of FOXO1a. Similar but less pronounced 
induction was found for PBE. This is illustrated in Fig 3.6:  
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 -  +  -  -  -  -  -  -  positive control  
 -  -  +  -  -  -  -  -  50µg/ ml GSE 
 -  -  -  +  -  -  -  -  100µg/ ml GSE  
 -  -  -  -  +  -  -  -  200µg/ ml GSE 
 -  -  -  -  -  +  -  -  50µg/ ml PBE 
 -  -  -  -  -  -  +  -  100µg/ ml PBE 
 -  -  -  -  -  -  -  +  200µg/ ml PBE 
                                                
 
 
 
 
 
 
3.2.2 Effect of GSE and PBE on AMPK and S6 phosphorylation 
H4IIE cells were treated with incrementally increasing concentrations of GSE 
and PBE and 2 mM metformin was used as a positive control. Western 
blotting suggested that GSE was more effective than PBE in inducing 
phosphorylation. These results are shown in Fig 3.7: 
 
 
 
 
 
 
Fig 3.6: Effect of GSE and PBE on FOXO1a phosphorylation. Serum starved HEK293 cells 
were treated with incrementally increasing concentrations of GSE and PBE for one hour, 
followed by lysis and SDS-PAGE as described in the methods. Immunoblotting was carried out 
using an antibody that detects FOXO1a only if it is phosphorylated on Ser 325 (pSer325 
FOXO1a) and a second antibody that detects FOXO1a regardless of phosphorylation state 
(FOXO1a). Negative control was DMEM only and positive control was 50µg/ ml Black Tea 
Extract (BTE) 
 
pSer325 FOXO1a 
FOXO1a 
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-  +  -  -  -  -  -  -  50µg/ ml GSE 
-  -  +  -  -  -  -  -  100µg/ ml GSE 
-  -  -  +  -  -  -  -  200µg/ ml GSE 
-  -  -  -  +  -  -  -  50µg/ ml PBE 
-  -  -  -  -  +  -  -  100µg/ ml PBE 
-  -  -  -  -  -  +  -  200µg/ ml PBE 
-  -  -  -  -  -  -  +  positive control 
Fig 3.7: Effect of GSE and PBE on AMPK and S6 phosphorylation.  
Serum starved H4IIE cells were treated with incrementally increasing concentrations of GSE 
and PBE for three hours, followed by lysis and SDS-PAGE as described in the methods. 
Immunoblotting was carried out using an antibody that detects AMPK only if it is 
phosphorylated on Thr172 (pThr172 AMPK), an antibody that detects Ser 240/244 S6 
phosphorylation (pSer240/244 S6) and an actin antibody. The negative control was DMEM 
only and the positive control 2mM metformin. 
 
 
Similar to the differences in FOXO1a responses to GSE & PBE (Fig. 3.6), 
these results indicate that GSE was more effective than PBE at inducing 
AMPK phosphorylation (Fig. 3.7) and repressing S6 phosphorylation (Fig. 
3.7). At low concentrations however, both GSE and PBE appeared to elevate 
S6 phosphorylation (Fig. 3.7).   
 
3.2.3 Phenolic content of GSE and PBE. 
A total phenols assay showed that GSE contained a higher concentration of 
phenolic compounds than PBE (Table 3.1).    
pThr172 AMPK 
pSer240/244 S6 
actin 
S6 
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Sample Phenols (mg/ml) SEM 
GSE 6.3 0.1 
PBE 4.7 0.1 
 
Table 3.1: Total Phenol content of GSE and PBE 
 
Although the total phenol assays suggested a higher content of phenolic 
compounds in GSE than PBE, all subsequent cell culture based assays were 
carried out using equivalent phenol contents.  
 
3.2.4  Analysis of phenolic compositon of GSE and PBE by LC-MS 
The composition of the GSE and PBE samples was analysed by LCMS. The 
components did not separate well using RP-HPLC and there was substantial 
overlap of peaks, particularly between 25- 40 mins (see Figs 3.8 and 3.9 A). 
Therefore the MS spectra obtained across the elution of the bound 
components (5-60 mins) was also used to indicate their phenolic composition 
(see Figs. 3.8 and 3.9 B). The MS data fitted with data from previous studies 
(Saucier et al, 2001; Hellstrom et al, 2008) on proanthocyanidin-rich extracts 
from GSE and PBE.  
One obvious difference between the extracts was the presence of signals 
characteristic of galloylated PACs in GSE. This is highlighted in Fig 3.8 B, 
where peaks representing galloylated molecules that are 152 amu heavier 
than their ungalloylated counterparts are present in the GSE sample 
whereas they are absent in the PBE sample (Fig 3.9 B).  
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Retention time (mins) Atomic weight (amu) Putative ID 
10.9 169.1 gallic acid 
21.6 577.1 dimer 
24.5 289.1 monomer 
27.1 577.1 dimer 
28.8 289.1 monomer 
32.4 729.1 galloylated dimer 
33- 35 1153.1 
1305.0 
1441.0 
tetramer 
galloylated tetramer 
pentamer 
36.6 577.1 dimer 
37.8 1017.0 galloylated trimer 
38- 55 1305.0 
1593.0 
galloylated tetramer 
galloylated pentamer 
 
Fig 3.8: GSE chromatogram and MS. Highlighted peaks on GSE chromatogram scanned 
at λ280nm represent galloylated and ungalloylated PACs as detected by corresponding MS 
and listed in the table shown, beside putative IDs from Passos, 2007. Gallic acid is not well 
represented on the MS scan due to poor ionisation 
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Retention time (mins) m/z [M-H] Putative ID 
10.8 169.1 gallic acid 
19.9 371.1 caffeic acid derivative 
21.4 577.1 dimer 
22.5 495.1 lignan derivative 
23.2 577.1 dimer 
24.4 865.1 trimer 
24.9 865.1 trimer 
29.4 865.1 trimer 
34.0 865.1 trimer 
34.4 465.1 lignan derivative 
36.1 1153.1 tetramer* 
30-55 1153.1 
1441.1 
1730.0 
tetramer* 
pentamer* 
hexamer* 
Fig 3.9: Chromatogram and MS spectra from PBE. A= HPLC chromatograph at 280 nm; B = MS 
spectrum from 5-60 mins. The table gives putative peak identifications based on Karonen et al., 2004. 
The figures in the top right corner represent the FSD of the detectors. * - These PAC signals are in the 
unresolved “hump” of material.  
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It was also noted from this data that GSE contains a higher concentration of 
gallic acid (GA; RT = 10.9) than PBE and that PBE contained a substantial 
amount of non-PAC components including lignans. Therefore, although PBE 
and GSE were applied at the same concentration of total phenols, PBE 
contained less proanthocyanidins. 
 
3.2.5 Fractionation of extracts by solvent to solvent partitioning 
Fractionation of these samples was then carried out using the solvent to 
solvent partition method described in chapter 2, which has been used to 
produce fractions that differ in molecular weight. Briefly, fractionation was 
carried out on the following basis (Saucier et al, 2001).  
Molecules of low degree of polymerisation (DP) should partition from a PAC 
sample dissolved in UPW into the ethyl acetate fraction, whilst those of 
higher DP should remain in the water fraction. Further fractionation of the 
ethyl acetate sample using methanol and diethyl ether may  separate this 
fraction into molecules of larger (6E) and smaller (6M) DP. The water 
fraction, which should contain the higher molecular weight molecules, can be 
sequentially fractionated by their relative solubility in increasing 
concentrations of chloroform (i.e. fractions F1 to F4). 
 The chromatograms for each fraction are shown in Fig 3.10 and MS data in 
Fig 3.11. For identifications, we refer back to the Tables in Figs. 3.8 and 3.9. 
The corresponding PBE chromatography is shown in Fig 3.12 and the mass 
spectra in Fig 3.13. 
 
 75 
 
Fig 3.10: LC traces of GSE fractions obtained by solvent-to-solvent fractionation. 
Traces at 280 nm are shown. FSDs are shown in the top right corners of each trace. 
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Fig 3.11: MS spectra of GSE fractions obtained by solvent-to-solvent fractionation.   
The FSD are shown in the top right hand corner of each panel. 
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The solvent-solvent partition of GSE largely followed the predicted pattern. 
The initial ethyl acetate fraction (which gives rise to fractions F6M and 6E) 
was enriched in low MW components including gallic acid (RT = 10.9), 
monomers (RTs 24.3 and 28.6), dimers (RTs 21.4 & 26.9) and some 
galloylated PACs (RTs = 32.2 & 37.6). There was some further fractionation 
of these peaks between fractions 6E and 6M. This generally fits with the MS 
spectra for fractions 6E and 6M (Fig. 3.11). In the water fraction (which 
ultimately yielded fraction F1- 4) there was a relative enrichment in higher 
MW PACs as judged by the PAC-rich hump (Fig. 3.10). There was also a 
relative enrichment of peaks at RT = 21.5 and 26.9 (dimers) in fractions F1 
and F4, which accounts for their high intensity of m/z 577 signals (Fig. 3.11). 
Overall, there was a trend to enrichment in higher MW PACs through 
fractions F1 to F4 which was evidenced by the increasing relative intensity of 
m/z 1153 signals and the corresponding reduction in the intensity of the m/z 
577 signal. 
 
There was a similar pattern for the fractions obtained from the partition of 
PBE (Fig. 3.12 and 3.13). Initial fractionation with ethyl acetate (which 
yielded fractions 6M and 6E) enriched specific peaks (RTs = 23.2 and 24.3 = 
PAC dimer and trimer respectively.) This was supported by the higher 
intensity of signals at m/z 577 and 865 in their MS spectra (Fig. 3.13). There 
was a corresponding enrichment in certain peaks in the water fractions 
derived samples (F1, F3 and F4). Most notably the non PAC peaks at RT = 
19.8 (m/z 371, caffeic acid derivative) and 22.5 min (m/z 495, lignan 
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derivative) were enriched (Karonen et al., 2004). These signals were also 
enriched in the MS spectra of F1 and F3 (Fig. 3.13). 
The water derived fractions (F1, F3 and F4) yielded progressively more 
higher MW PACs as judged by the PAC-rich “hump” between 25-50 mins 
(Fig. 3.12). This trend is also apparent in the MS spectra (Fig. 3.13) more 
obviously by the relative increase in the signal at m/z 1153 (but also possibly 
m/z 1441) from fraction F1- F4. 
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Fig 3.12: LC traces of PBE fractions obtained by solvent-to-solvent fractionation. 
 Traces at 280 nm are shown. FSDs are shown in the top right corners of each trace. 
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Fig 3.13: MS spectra of PBE fractions obtained by solvent-to-solvent fractionation. 
FSDs are shown in the top right corners of each trace. 
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Cell culture and western blotting suggested that all fractions tested were 
active with respect to phosphorylation of FOXO1a. This is shown in Fig 3.14.   
 
 
 
-  +  -  -  -  -  -  -    +  
-  -  +  -  -  -  -  -    100µg/ ml GSE 
-  -  -  +  -  -  -  -    100µg/ ml GSE F1  
-  -  -  -  +  -  -  -    100µg/ ml GSE F4 
-  -  -  -  -  +  -  -    100µg/ ml GSE F6M 
-  -  -  -  -  -  +  -    100µg/ ml PBE F4 
-  -  -  -  -  -  -  +    100µg/ ml PBE F6M 
 
Fig 3.14: Effect of GSE and PBE fractions on FOXO1a phosphorylation 
Serum starved HEK293 cells were treated as above for one hour followed by lysis and SDS- 
PAGE as described in chapter 2. Immunoblotting was carried out using an antibody that 
detects FOXO1a only if it is phosphorylated on Ser 325 (pSer325 FOXO1a) and a second 
antibody that detects FOXO1a regardless of phosphorylation state. ‘F’ followed by a number 
denotes fraction number. ‘M’ denotes methanol.  
 
3.2.6 Fractionation on Sephadex LH-20 
Fractionation of the GSE and PBE samples was then carried out using a 
Sephadex LH20 column (as described in Chapter 2). 
The fractionation of GSE on Sephadex LH20 is illustrated in Figs. 3.15 and 
3.16.  The unbound fractions were enriched in PAC dimers (m/z = 577; RT = 
22.3 and 23.9) and the monomer (m/z = 289; RT = 25.1). Certain non-PAC 
derivatives were fractionated in the unbound samples including gallic acid 
(m/z = 169; RT = 10.9) and some unidentified peaks (e.g. RT = 35.1) which 
were concentrated during the fractionation. The MS spectra (Fig. 3.16) tend 
to over-report on PAC components as they ionize efficiently in negative 
FOXO1a 
pSer325FOXO1a 
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mode and they show the concentration in signals ascribed to monomer and 
dimers (m/z = 577 and 865 respectively). The unbound 2 sample also shows 
the presence of trimers (m/z 865). 
The bound fractions were enriched in higher molecular weight PACs. This is 
illustrated by the relative increase in the peaks at RT = 28.3 and 30.2 (m/z 
1153 and 865 resp) and the hump of unresolved PACs between RT 20-50 
mins. The MS spectra (Fig. 3.16) also show the trend to higher molecular 
weight PACs with relative increases in signals at m/z 1153, 1441 and 1729 
apparent. It was very notable that the bound samples did not contain any 
signals from galloylated PACs and it appears that the galloylated molecules 
were not recovered from the Sephadex by these treatments. 
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Fig 3.15: LC traces of fractions obtained by Sephadex LH20 fractionation of GSE 
Traces at 280 nm are shown. FSDs are shown in the top right corners of each trace. 
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Fig 3.16 MS spectra of fraction obtained from GSE by Sephadex LH20 fractionation. 
FSDs are shown in the top right corners of each trace. 
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The fractionation of PBE on Sephadex LH20 is illustrated in Figs. 3.17 and 
3.18. The LCMS run was changed to 30 min separation rather than 60 min 
so the traces are different from Fig. 3.9. The unbound samples were 
enriched in certain PACs including the PAC dimers (m/z 577; RT = 21.5 and 
23.4) and a PAC trimer (also in RT 23.4). They also contained non-PAC 
components including the lignan derivatives (m/z 496; RT = 22.5 and m/z 
465; RT = 28.7). Gallic acid was present (m/z 169; RT = 17.9) and preceding 
peaks (RT = 16.8 and 17.4) appear to contain the caffeic acid derivatives 
noted previously (Fig. 3.9). The MS spectra largely support these findings. 
The bound 1 sample contained many of the peaks found in the unbound 
samples but also contained the characteristic hump of unresolved PAC 
peaks from RT 20-30 mins. The bound 2 sample was similar but appeared to 
contain more PACs. The MS spectra (Fig. 3.18) also illustrate the trend to 
higher MW PACs in the bound samples, especially in the amounts of signal 
at m/z 1153. 
Fractions were prepared as aliquots of 250 µg GAE phenol content for cell 
culture work.   
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Fig 3.17: LC traces of fractions obtained from PBE by Sephadex LH20 fractionation. 
Traces at 280nm are shown. FSDs are shown in the top right corners of each trace. 
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Fig 3.18: MS spectra of fractions obtained from PBE by Sephadex LH20 separation. 
FSDs are shown in the top right corners of each trace 
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The fractions from the Sephadex LH20 fractionation were applied to cells to 
determine the effect on FOXO1a phosphorylation. These experiments are 
shown in Fig 3.19 and Fig 3.20. 
                                           
                              
  -   +   -   -   -   -   100µg/ ml GSE  
  -   -   +   -   -   -   100µg/ ml GSE Unbound 1 
  -   -   -   +   -   -   100µg/ ml GSE Unbound 2  
  -   -   -   -   +   -   100µg/ ml GSE Bound 1 
  -   -   -   -   -   +   100µg/ ml GSE Bound 2 
 
Fig 3.19: Effect of bound and unbound GSE fractions on FOXO1a phosphorylation. 
Serum starved HEK293 cells were treated as above for one hour followed by lysis and SDS- 
PAGE as described in chapter 2. Immunoblotting was carried out using an antibody that 
detects FOXO1a only if it is phosphorylated and Ser325 (pSer325 FOXO1a) and a second 
antibody that detects FOXO1a regardless of phosphorylation state (FOXO1a).  
 
It is clear that all fractions could induce phosphorylation of FOXO1a to some 
extent. However, the bound fractions (and especially the bound 2 fraction) 
were most effective. This suggests that the higher molecular weight PACs 
are particularly potent as removing them (as in the unbound fractions) 
reduced effectiveness and retaining them recovered effectiveness. 
 
 
 
 
 
 
 
 
 
 
 
 
pSer325 FOXO1a 
FOXO1a  
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-   +   -   -   -   -   100µg/ ml PBE  
-   -   +   -   -   -   100µg/ ml PBE Unbound 1 
-   -   -   +   -   -   100µg/ ml PBE Unbound 2  
-   -   -   -   +   -   100µg/ ml PBE Bound 1 
-   -   -   -   -   +   100µg/ ml PBE Bound 2 
 
Fig 3.20: Effect of bound and unbound PBE fractions on FOXO1a phosphorylation. 
Serum starved HEK293 cells were treated as above for one hour followed by lysis and SDS- 
PAGE  as described in chapter 2. Immunoblotting was carried out using an antibody that 
detects FOXO1a only if it is phosphorylated and Ser325 (pSer325 FOXO1a) and a second 
antibody that detects FOXO1a regardless of phosphorylation state (FOXO1a).  
 
The pattern was similar for the PBE fractions (Fig. 3.20). In this case, the 
unbound fractions were less effective although the unbound 1fraction had 
some effect. The bound samples were the most effective and this strongly 
suggests that the higher MW PACs recovered in these fractions are most 
effective in inducing phosphorylation of FOXO1a. 
 
3.2.7 Fractionation on polyamide columns 
Another fractionation technique was then employed using a Discovery 
polyamide column (described in Chapter 2). Briefly, polyamide is known to 
adsorb highly hydroxylated molecules such as PACs under certain 
conditions. The unbound component of the sample was eluted from the 
column using 20% methanol and the bound component using 80% acetone.  
The fractionation of GSE by the polyamide SPE method is illustrated in Figs. 
3.21 and 3.22. The unbound fractions were enriched in gallic acid (m/z 169; 
RT = 8.7) and the monomers (m/z 289; RT = 16.3 and 18.5). There was also 
pSer325 FOXO1a 
FOXO1a 
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a concentration of the peak at RT = 13.4 (m/z 153) which may be due to 
dihydroxybenzoic acid. The MS spectra show the dominance of the m/z 
signals at 289 due to the enrichment of the monomers (Fig. 3.22). The signal 
at m/z 579 is also due to the presence of the monomers and results from a 
half-charged version of the monomers which gives a doubled m/z ratio. 
The bound samples differed in their composition (Fig. 3.21). The bound 1 
fraction was greatly enriched in the monomer peaks (RT = 16.3 and 18.4) but 
was relatively depleted in gallic acid (RT = 8.7) compared with the unbound 
samples. The bound 1 fraction also had appreciable amounts of the dimers 
(m/z 577; RT = 14.3 and 17.2). This is consistent with the first application of 
acetone removing the last of the unbound monomers but also enriching in 
some dimers. On the other hand, the bound 2 fraction was composed of a 
unresolved hump of PACs (RT 13-25 mins). The MS spectra (Fig. 3.22) 
showed these differences and confirmed that the bound 2 fraction was 
enriched in higher MW PACs including signals characteristic of galloylated 
forms which exceeded those identified in the original GSE (e.g. signals at 
m/z = 1593 and 1881 are indicative of galloylated pentamers and hexamers).  
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Fig 3.21: LC traces of fractions obtained from GSE from polyamide column. 
Traces at 280 nm are shown. FSDs are shown in the top right corners of each trace. 
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Fig 3.22: MS spectra of fractions of GSE from the polyamide column. 
FSDs are shown in the top right corners of each panel. 
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The fractionation of polyphenol components from PBE on polyamide SPE is 
illustrated in Fig. 3.23 and 3.24. The original PBE sample was not run for 
direct comparison but the peaks can be compared with Fig. 3.9. The 
unbound samples were enriched in PAC components (dimers m/z 577; RT 
14.0 and 15.1), a PAC trimer (m/z 865; RT = 15.5) and a monomer (m/z 289; 
RT = 16.1). The unbound fractions also contained non-PAC components 
including the lignan derivatives (m/z 495; RT = 14.0 and m/z 465; RT = 21.2). 
Gallic acid was also present (m/z 169; RT = 8.5). The MS spectra (Fig. 3.24) 
show the enrichment in dimer signals (m/z 577) but also pick up some trimer 
signals (m/z 865). 
The bound fractions were enriched in higher molecular weight PACs. This 
was illustrated by the increase in the abundance of the peak at RT = 17.1 
(m/z 1153) but also the unresolved hump of PACs between 15 and 30 mins. 
The MS spectra (Fig. 3.24) illustrate the trend towards higher molecular 
weight PACs with signals at m/z 1153 and 1441 becoming more dominant. 
The fractions from the polyamide fractionation were applied to cells to 
determine the effect on FOXO1a phosphorylation. These experiments are 
shown in Fig 3.25. 
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Fig 3.23: LC traces of fractions obtained from PBE on polyamide column. Traces at 
280nm are shown. FSDs are shown in the top right corner of each trace. 
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Fig 3.24: MS spectra of fractions of PBE from polyamide column.  
FSDs are shown in the top right corners of each panel. 
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- + - - - - - - - -  100µg/ ml GSE  
- - + - - - - - - -  100µg/ ml GSE Unbound 1 
- - - + - - - - - -  100µg/ ml GSE Unbound 2  
- - - - + - - - - -  100µg/ ml GSE Bound 1 
- - - - - + - - - -   100µg/ ml GSE Bound 2 
- - - - - - + - - -  100µg/ ml PBE Unbound 1 
- - - - - - - + - -  100µg/ ml PBE Unbound 2 
- - - - - - - - + -  100µg/ ml PBE Bound 1 
- - - - - - - - - +  100µg/ ml PBE Bound 2 
Fig 3.25: Effects on cell responses of bound and unbound fractions separated on 
polyamide columns. 
Following fractionation on polyamide column, fractions were freeze dried, reconstituted and 
applied to serum starved HEK293 cells as above for one hour followed by lysis and SDS- 
PAGE. Immunoblotting was carried out using an antibody specific for FOXO1a only if it is 
phosphorylated on Ser325 (pSer325 FOXO1a) and a second antibody that detects FOXO1a 
regardless of phosphorylation state (FOXO1a). This again suggested the bound fractions 
phosphorylated FOXO1a. 
 
Only the bound 2 fraction from the GSE polyamide fractionation was effective 
in inducing phosphorylation of FOXO1a (Fig 3.25). Little or no 
phosphorylation was observed in cells treated with the unbound 1 or 2 
fractions.  
The pattern was subtly different with the fractions obtained from PBE. But in 
essence only the bound fractions displayed appreciable ability to induce 
FOXO1a phosphorylation. This suggests that the higher molecular weight 
PACs are most effective but interestingly there seems little difference in 
effectiveness between the effectiveness of the non-galloylated PACs from 
PBE and the mixture of galloylated and non galloylated PACs from GSE. 
pSer325 FOXO1a 
FOXO1a 
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3.2.8 Purification of PACs by normal phase HPLC 
 
Although these fractionation methods provided evidence that PACs were 
important for the induction of the phosphorylation events, they do not provide 
particularly stringent separation of PACs as all were usually mixtures of sizes 
and types. Therefore, attempts to purify the PACs from GSE and PBE were 
made using HPLC techniques.  Due to the poor quality of chromatography 
achieved using reverse phase HPLC, further analysis of these samples was 
carried out using normal phase HPLC, which has been reported to achieve 
baseline separation of PACs (Hellstrom, 2008). The aqueous/ organic 
solvent gradient of the normal phase method was altered and fine-tuned to 
increase separation of the peaks of interest. After some adaptations of the 
method, the polyamide bound fraction 1 of GSE gave some separation of 
peaks (Fig 3.26) but separation of peaks in the bound fraction 2 from PBE 
was less successful (Fig. 3.27). The peaks were tentatively identified by their 
MS properties (Table 3.2). 
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Fig 3.26: Separation of GSE by normal phase method 
The sample was polyamide bound fraction 2. The trace at 280 nm is shown in panel A. The 
MS spectrum across the separation zone (5-60 mins) is shown in panel B. FSDs are shown 
in the top right corners of each panel.  
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Fig 3.27: Separation of PBE by normal phase method 
The sample was the polyamide bound fraction 1. The trace at 280 nm is shown in panel A. 
The MS spectrum across the separation zone (5-60 mins) is shown in panel B. FSDs are 
shown in the top right corners of each panel. 
 
 
 
 100 
GSE bound 
RT (mins) m/ z (M- H) Putative ID 
14.2 503.0 Not identified 
15.7 614.9 Not identified 
17.6 578.6 dimer 
25.0 882.8 A-type trimer 
30.2 577.0 dimer 
31.1, 31.9 579.1 dimer 
32.0 577.0. 729.1 dimer, galloylated dimer 
33.5 729.0 galloylated dimer 
34.5 729.0, 865.0, 1055.1 galloylated gimer, trimer, not 
identified 
35.4 729.0 galloylated dimer 
35.8, 37.0, 
37.4 
865.1 trimer 
38.5, 39.5 1017.1 galloylated trimer 
40- 60 575.0, 729.0, 865.1, 
1017.0 
 1153.1, 1151.1,1169.0, 
1305.0 
dimer, galloylated dimer, trimer, 
galloylated trimer 
tetramer, not identified, galloylated 
tetramer  
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PBE bound 
RT (mins) m/ z (M- H) Putative ID 
16.0 203.4 Not identified 
17- 27 1908.4 Not identified 
27.6 920.9 Not identified 
28.2 970.2 Not identified 
29.4 577.0 dimer 
30.6 412.4, 579.0 Not identified, dimer 
31.3 579.1, 865.1 dimer, trimer 
32.0 577.0, 711.1, 729.0, 
865.1, 879.1 
dimer, not identified, galloylated 
dimer, trimer, not identified 
33.2, 33.6, 
34.8 
865.1 trimer 
36- 37 865.1, 1452.6 trimer, not identified 
37.5 1153.0 tetramer 
38.2 328.7 Not identified 
39- 60 577.0, 633.1, 863.1, 
1153.1, 1441.0 
dimer, not identified, trimer, tetramer, 
pentamer 
 
Table 3.2: Putative identification of compounds in bound fractions prepared on the 
new normal phase gradient  
Chromatograms and MS data are shown in Figs 3.26 and 3.27 respectively.  
 
However, the ionisation in the mixture of solvents used for the normal phase 
method was not very reliable and the MS data was not convincing. 
Therefore, individual peaks were collected as they eluted from the UV 
detector, dried to remove the solvents and re-analysed using direct-infusion 
into the MS detector (Figs. 3. 28 and 3.29). Their putative identities are noted 
in Table 3.3. 
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Fig 3.28: MS spectra of peaks purified from GSE using normal phase HPLC 
Peaks were dried, resuspended then subjected to ESI-MS. The FSDs are given in each 
panel 
 
 
8.7E4 
3.22E5 
3.65E6 
1.77E6 
1.57E6 
1.55E6 
4.98E5 
 103 
 
 
Fig 3.29:  MS spectra of purified PBE peaks. 
FSDs are  shown in the top right corners of each panel. 
 
 
2.31E5 
1.81E5 
2.18E5 
3.95E3 
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GSE bound 
Peak 
no 
RT 
(mins) 
m/ z (M- H) Putative ID 
1 25.0 289.4, 441.6, 577.5, 
729.1, 865.1, 1017.5, 
1153.1, 1305.4, 1441.3, 
1729.0 
monomer, galloylated monomer, dimer, 
galloylated dimer, trimer, galloylated trimer, 
tetramer, galloylated tetramer, pentamer, 
galloylated pentamer 
2 30.3 289.3 monomer 
3 32.4 441.3 galloylated monomer 
4 33.5 577.4 dimer 
5 35.4 577.4, 729.4 dimer, galloylated dimer 
6 37.0 577.4, 729.4, 865.4 dimer, galloylated dimer, trimer 
7 40.8 289.4, 577.5, 729.5, 
865.5, 1017.4, 1153.3 
monomer, dimer, galloylated dimer, trimer 
 galloylated trimer, tetramer 
 
PBE bound 
Peak 
no 
RT 
(mins) 
m/ z (M- H) Putative ID 
1 22.75 303.4 Not identified 
2  29.4 297.8 Not identified 
3 30.7 289.4. 311.6, 577.4, 865.4, 
969.6, 1167.5, 1267.4 
monomer, not identified, dimer, trimer, not 
identified, not identified, not identified 
4 34.8 289.4, 577.5, 865.5, 
1153.4, 1455.3 
monomer, dimer, trimer, tetramer 
Not identified 
 
Table 3.3: Putative identification of compounds in purified peaks prepared on the new 
normal phase gradient  
MS data is in Figs 3.28 and 3.29 for GSE and PBE respectively. The compounds found in 
each fraction were identified from Passos, 2007. 
In some cases, e.g. GSE peaks 2, 3 and 4, the separation appears to yield 
relatively pure components whereas other peaks contain mixtures of higher 
MW PAC components. The PBE separation was less effective.  
 
Cell culture and western blotting suggested none of these purified GSE 
samples strongly induced the phosphorylation of FOXO1a (Fig 3.30). Similar 
results were obtained with PBE (data not shown). 
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- + - - - - - - - -   Positive control  
- - + - - - - - - -   100µg/ ml GSE Bound 2  
- - - + - - - - - -   100µg/ ml GSE Bound 2 P1  
- - - - + - - - - -   100µg/ ml GSE Bound 2 P2 
- - - - - + - - - -   100µg/ ml GSE Bound 2 P3 
- - - - - - + - - -   100µg/ ml GSE Bound 2 P4 
- - - - - - - + - -   100µg/ ml GSE Bound 2 P5 
- - - - - - - - + -   100µg/ ml GSE Bound 2 P6 
- - - - - - - - - +   100µg/ ml GSE Bound 2 P7 
Fig 3.30: Effect of peaks purified from GSEon phosphorylation of FOXO1a. 
Samples from each peak were collected directly from the mass spectrometer, dried and 
reconstituted. Serum starved HEK293 cells were treated as above followed by lysis and 
SDS-PAGE. Immunoblottting was carried out using an antibody that detects FOXO1a only if 
it is phosphorylated on Ser325 (pSer325 FOXO1a) and a second one detects FOXO1a 
regardless of phosphorylation state.  
 
 
However, when these purified samples were re-analysed by LCMS, it was 
found they had deteriorated significantly (Fig. 3.31).  
 
pSer325 FOXO1a 
FOXO1a 
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Fig 3.31: Purified samples after one week in storage. Purified samples appear to be 
unstable compared to unpurified samples. 
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No P5 sample was available for this analysis. Few of the original MS signals 
were present and the signal MS intensity has been greatly reduced. This 
may be because the PAC components are less stable when isolated than 
when in a complex mixture.  
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3.2.9 Antioxidant activity of PAC fractions 
FRAP assays (as described in Chapter 2) were carried out to assess the 
antioxidant capacity of the various fractions harvested from the polyamide 
columns. Although the active samples that induced phosphorylation of 
FOXO1a and AMPK had considerable antioxidant capacity so did many of 
the fractions that were not active. This is illustrated graphically in Fig 3.32. 
The samples found to be active are marked with an asterisk and those found 
to be inactive with a cross. Active and inactive fractions both have 
considerable antioxidant capacity, suggesting that if antioxidant capacity 
does play a part in FOXO1a and AMPK phosphorylation, it is unlikely to be 
the only mechanism involved. 
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This theory is supported by the fact that GSE, which was more effective than 
PBE in inducing FOXO1a phosphorylation, has similar FRAP levels to PBE. 
 
 
Fig 3.32: Antioxidant capacity of GSE and PBE fractions.  
 
* = active fractions; X = inactive fractions 
* * 
* 
* 
X 
X 
X 
X 
X 
X 
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3.2.10 Metals enhance effects of proanthocyanidins on AMPK and FOXO1a 
phosphorylation 
Previous results found that insulin-like properties of tea polyphenols may be 
potentiated by zinc (Cameron, 2010). Therefore the effect of GSE was 
reanalysed in the presence and absence of zinc (Fig 3.33). 
 
 
  
  
 - + - - - - - -     50µg/ ml GSE  
 - - + - - - - -   100µg/ ml GSE 
 - - - + - - - -    200µg/ ml GSE   
 - - - - + - - -   50µM Zn 
 - - - - - + - -     50µg/ ml GSE + 50µM Zn 
 - - - - - - + -     100µg/ ml GSE + 50µM Zn 
 - - - - - - - +     200µg/ ml GSE + 50µM Zn 
Fig 3.33: Western blot showing effects of zinc on the activity of GSE 
Serum starved HEK293 cells were treated as above with GSE in the presence and absence 
of zinc followed by lysis and SDS- PAGE. Immunoblotting was carried out using an antibody 
that detects FOXO1a only if it is phosphorylated on Ser325 (pSer325 FOXO1a) and a 
second one that detects FOXO1a regardless of phosphorylation state (FOXO1a).  
 
 
These results suggest that the presence of zinc enhanced the GSE induced 
phosphorylation of FOXO1a.  
  
 
 
 
 
pSer325FOXO1a 
FOXO1a 
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3.3 Discussion 
3.3.1 What structural components are important for the ability to induce 
phosphorylation of FOXO1a 
GSE was more effective than PBE in inducing phosphorylation of FOXO1a 
and AMPK. The initial LCMS analysis showed that GSE contained a higher 
proportion of proanthocyanidins (PACs) than PBE, which also contained non-
PAC components such as lignans and caffeic acid derivatives. This 
suggested that the PACs were important for effectiveness. Indeed, the most 
effective fractions after fractionation using Sephadex LH20 and polyamide 
SPE were those enriched in PACs, which strongly suggests that these were 
active agents.  
The higher proportion of GA and galloylated molecules in GSE than in PBE 
could be a contributory factor to the greater effectiveness of GSE. However, 
it is unlikely to be the only factor that controls the induction of FOXO1a and 
AMPK phosphorylation as galloylated molecules were found in some inactive 
fractions and some of the active fractions contained only a low concentration 
of GA and galloylated molecules. For example, fractionation of GSE on 
Sephadex LH20 produced a bound fraction that lacked galloylated PACs 
(Fig. 3.15 and 3.16), probably because the galloylated PACs had remained 
attached to the Sephadex. This fraction was effective in inducing 
phosphorylation of FOXO1a at 100 µg/ml. The GSE bound 2 fraction 
obtained after polyamide SPE was particularly enriched in galloylated PACs 
and contained high MW forms that were not apparent in the original GSE. 
This fraction was also effective in inducing phosphorylation of FOXO1a at 
100 µg/ml. The solvent to solvent fractionation also produced fractions that 
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were relatively enriched in galloylated PACs but these were no more 
effective than other fractions at the levels tested. However, in this case, the 
fractions always contained a wide mix of components and lacked stringency. 
If time had allowed, a more detailed comparison of the different PAC-rich 
fractions at a range of concentrations may have suggested more detailed 
structural requirements for activity. However, the approach taken was to 
separate and purify PACs and then directly compare their effectiveness. 
Unfortunately, although the normal phase method did achieve some 
separation, this approach took much longer than expected to successfully 
separate the PACs. The instability of the purified PACs was unexpected. 
Oxidative degradation of polyphenols is well known but seemed to be 
accelerated possibly because they were both pure and at low concentration. 
 
It was also noted that galloylated molecules eluted from the C18 HPLC 
columns close to the end of the run and are probably more hydrophobic than 
their ungalloylated forms. Hydrophobicity may increase their uptake through 
the plasma membrane and make them more effective in inducing intracellular 
insulin-like phosphorylation events than their ungalloylated counterparts. 
Indeed, some galloylated tea components such as EGCG are predicted (e.g. 
by Molinspiration software) to be more hydrophobic than their ungalloylated 
forms (EGC). Whilst this thesis was in preparation, another group reported 
that GSE PACs induced IR autophosphorylation. The downstream 
phosphorylation pattern was different compared with insulin, with more 
sustained MAPK activation than insulin is capable of (Montagut, 2010). More 
research is needed to confirm therefore how the intracellular effects 
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observed are mediated and whether or not more than one agent in the 
extract is involved. For example, it would be interesting to track if these 
PACs enter the cell or act at the cell surface perhaps through interactions 
with membrane-sited receptors or the plasma membrane itself (Fraga et al., 
2010). 
Because the affinity of tannins for proteins and potentially for receptors has 
been proposed to increase with an increasing degree of polymerisation (DP) 
in vitro due to a corresponding increase in ability to interact due to hydrogen 
bonding or crosslinking (Bate-Smith, 1973), fractionation based on size, 
using the method developed by Saucier et al, 2001, was attempted. This led 
to the conclusion that degree of polymerisation was not a major factor as 
fractions containing PACs of all sizes were equally able to induce the 
phosphorylation of FOXO1a at 100 µg/ml phenol content, It should be noted 
that the LCMS methods used can only detect molecules of m/z < 2000 and 
some of these fractions may contain PACs of much greater molecular weight 
(Hellstrom et al, 2008). 
 
3.3.2 Antioxidant activity may be contributory factor to insulin-like effects 
Although the active bound samples possessed significant antioxidant activity 
so did many of the inactive ones. Therefore it seems that antioxidant activity 
is unlikely to be the sole or major mechanism by which these compounds 
induce phosphorylation of FOXO1a and AMPK but that it may be important 
but insufficient for the effect. A future approach would be to rank the 
antioxidant potential of PAC-rich samples with established varying levels of 
effectiveness. 
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3.3.3 Zinc enhances the activity of these compounds by an unknown 
mechanism. 
The presence of zinc was found to enhance the FOXO1a phosphorylating 
effects of these samples but a mechanism of action was not determined. 
Previous work in this area has suggested the site of action to be at or 
upstream of PI3K (Cameron et al, 2008) and that a tropolone like structure 
was necessary for this effect (Cameron et al, 2010). 
This study found for salicylate on its own to phosphorylate ACC and AMPK 
and to dephosphorylate S6 a free 2-OH group was required. Further work 
investigating this and other structures with a tropolone or tropolone like motif 
may therefore be of potential benefit. 
This study also found antioxidant activity may play a part in some of the 
effects observed therefore it is also possible that the presence of a divalent 
cation my facilitate reducing and therefore antioxidant potential. Further 
screening in this area in the future may also be potentially beneficial. 
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CHAPTER 4 – BENZOIC ACIDS 
4.1 Introduction 
4.1.1. Antihyperglycaemic properties of hydroxybenzoic acids 
The difficulties that were encountered in chapter 3 in purifying individual 
compounds to homogeneity encouraged an alternative approach to the study 
of compounds regulating the signalling pathways of interest. This chapter 
took a candidate-based approach, starting with the observation that gallic 
acid (GA, 3,4,5-trihydroxybenzoic acid), a component of both extracts 
studied in the previous chapter, induced effects similar to those of metformin 
on AMPK, ACC and S6 phosphorylation status.  
Amongst the other hydroxybenzoic acids, salicylic acid (SAL) and its 
acetylated form, aspirin, have been known for many years to exhibit anti-
hyperglycaemic effects at high concentrations (Williamson, 1901; Yuan et al, 
2001). The mechanism of action is unclear. One study linked the anti-
hyperglycaemic properties of salicylate to suppression of hepatic 
gluconeogenesis, suggested to be a result of mitochondrial inhibition (Woods 
et al, 1974) as SAL is a known inhibitor of mitochondrial energy production 
(Brody and Fouts, 1956). SAL inhibits the mitochondria in a similar manner to 
the uncoupling agent 2,4-dinitrophenol (DNP), by abolishing ATP production 
but not oxygen consumption. However the two agents differ in that millimolar 
concentrations of SAL are required to generate effects similar to micromolar 
amounts of DNP (Brody and Fouts, 1956). In the last twelve years however, 
inflammatory signalling mechanisms, particularly SAL-dependent inhibition of 
TNF-alpha-induced NFkB signalling have become an increasingly prominent 
explanation for anti-hyperglycaemic properties of SAL (Yin et al, 1998). Other 
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workers have found that TNF-alpha itself suppresses gluconeogenesis, 
indicating that it will be hard to reconcile anti-inflammatory mechanisms with 
those that depend on inhibition of gluconeogenesis (Grempler et al, 2004). 
Comparative investigation of a panel of hydroxybenzoic acids offers the 
possibility of differentiating between these two mechanisms as, for example, 
the related 2, 5-dihydroxybenzoic acid (as sodium gentisate) exhibits anti- 
inflammatory properties (Meyer and Ragan, 1948) similar to SAL but does 
not exhibit anti-hyperglycaemic properties (Smith and Meade, 1952). The 
mechanism or target(s) underlying these differences is unclear at present. To 
investigate this further, commercially-available pure samples of gallic acid 
(GA) and related analogues were investigated for effects on AMPK, ACC and 
S6 phosphorylation status. A panel of other benzoic acids and related 
analogues which have been shown to be metabolites produced following the 
ingestion of proanthocyanidin-rich extracts and their subsequent breakdown 
by gut microflora in rats (Gonthier et al, 2003) and in humans (Appeldoorn et 
al, 2009),was also tested.  
 
4.1.2 Benzoic acids 
Benzoic acids (BA) consist of a benzene ring with an acid group as 
described in Chapter 3. Some hydroxylated BAs are shown in Fig 4.1: 
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3, 5 Di-OH-BA  
Benzoic acid 
Fig 4.1:  Some hydroxybenzoic acids studied in this chapter 
3, 4, 5 Tri-OH-BA  
Benzoic acid 
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4.1.3 Gallic acid 
 In addition to the samples mentioned in Chapter 3, gallic acid is also found 
in: some oak species (Mammela et al, 2000); Caesalpinia mimosoides, a 
plant native to Thailand where it is used as a vegetable (Chanwitheesuk et 
al, 2007); Drosera capesis or Sundew, a carnivorous plant (Kovacik et al, 
2012) sometimes used to treat respiratory disease (Hirsikopi et al, 2002); 
Rhodeala rosea or golden root (Ming et al, 2005) which has been proposed 
to increase lifespan in D. melanogaster (Jafari et al, 2007); Toona sinensis 
(Chinese mahogany) which has been proposed as an anti-cancer agent with 
gallic acid suggested to be the active component (Chen et al, 2009); 
Arctostaphylos. uvi- ursi (bearberry) which has been reported to be beneficial 
in diseases of the urinary tract (Pegg et al, 2008); Blackberry (Hager et al, 
2002); Threobroma cocao (cocoa) (Osman et al, 2004) whose seeds are 
used to make chocolate; Juglans regia (walnut) (Muir et al, 2011). Mango 
(Elzaawely and Tawata, 2010) which has been proposed to have antidiabetic 
properties (Gupta and Gupta, 2011); Emblica officianalis (Indian gooseberry) 
(Sawant et al, 2010) which has been reported to have effects that could be 
beneficial in a variety of human diseases (Khan, 2009) and Syzgium 
aromaticum (clove) (Cai and Wu, 1996). 
 
4.1.4 Fate in the body 
A study in rats by Booth et al, (1959) suggested that gallic acid underwent 
methylation in vivo as the major urinary metabolite produced following a diet 
containing 0.5% gallic acid was 4-O-methyl benzoic acid. It was proposed 
that the source of methyl groups was from choline and a later study 
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suggested a retarded growth rate observed in young chicks reared on a diet 
relatively high in tannins could be alleviated by supplementing the diet with 
choline and methionine (Potter and Fuller, 1968).  It was also noted by Booth 
(1959) that when rats were given 100 mg gallic acid by intraperitoneal 
injection, an additional metabolite, pyrogallol, was produced presumably due 
to decarboxylation of gallic acid. 
 
4.2 Results 
4.2.1 Investigation of effects of HBAs on ACC, AMPK and S6 
phosphorylation. 
Gallic acid was tested for its effects on the induction of phosphorylation of 
FOXO1a and AMPK. To test this H4IIE cells were treated with 10 mM GA 
and a variety of related benzoic acids. The results of one such experiment 
are shown in Fig 4.2. 
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pACC 
ACC 
  pThr172AMPK 
  pSer240/244S6  
  S6  
  actin  
 - + - - - - - - - - - - GA (3, 4, 5-trihydroxy BA) 
 - - + - - - - - - - - - Benzoic acid (BA) 
 - - - + - - - - - - - - 2-hydroxy BA (salicylate, SAL) 
 - - - - + - - - - - - - 3-hydroxy BA  
 - - - - - + - - - - - - 4-hydroxy BA 
 - - - - - - + - - - - - 2, 3-dihydroxy BA 
 - - - - - - - + - - - - 2, 4-dihydroxy BA 
 - - - - - - - - + - - - 2, 5-dihydroxy BA (gentisate) 
 - - - - - - - - - + - - 2, 6-dihydroxy BA 
 - - - - - - - - - - + - 3, 4-dihydroxy BA 
   - - - - - - - - - - - + 3, 5-dihydroxy BA 
 
Fig 4.2: Effect of HBAs on AMPK, ACC and S6 phosphorylation 
H4IIE cells were serum starved for 2 hours then treated with the HBAs shown above for 3hrs 
followed by lysis and SDS- PAGE. Immunoblotting was carried out using 2 ACC antibodies- 
one which detects total ACC (ACC) and one which detects phosphorylated ACC (pACC), an 
antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK), 2 S6 
antibodies- one which detects total S6 (S6) and one which detects Ser240/244 S6 
phosphorylation (pSer240/244 S6) and an actin antibody.  
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This result indicated that only GA and SAL induced phosphorylation of 
AMPK. GA and SAL also reduced S6 phosphorylation. Partial effects on S6 
were also observed with other HBAs, 2,5 di-OH-BA and 2,6-di-OH-BA.  
 
4.2.2 Dose response of GA on AMPK, ACC and S6 phosphorylation 
The two most active HBAs, GA and SAL, were characterised in more detail. 
To test the ability of GA to affect AMPK, ACC and S6 phosphorylation, a 
dose response experiment was carried out. This experiment found that GA 
induced phosphorylation of AMPK and ACC at concentrations above 1 mM. 
A similar dose response was observed for inhibition of S6 phosphorylation in 
that phosphorylation of ACC and AMPK and dephosphorylation of S6 
increased with GA concentration applied (Fig. 4.3).  
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- + - - - - - 10mM SAL 
- - + - - - - 10mM GA 
- - - + - - - 1mM GA   
- - - - + - - 314µM GA  
- - - - - + - 100µM GA  
- - - - - - + 31.4µM GA  
 
Fig 4.3: GA dose response on AMPK, ACC and S6 phosphorylation in H4IIE cells  
H4IIE cells were serum starved for 2 hours, then treated with differing doses of GA for 3hrs 
followed by lysis and SDS-PAGE. Immunoblotting was carried out using two ACC 
antibodies- one which detects total ACC (ACC) and one which detects phosphorylated ACC 
(pACC), an antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 
AMPK), two S6 antibodies- one which detects total S6 (S6) and one which detects 
Ser240/244 S6 phosphorylation (pSer240/244 S6) and an actin antibody.10mM SAL is 
presented for comparison. 
pACC 
ACC 
pThr172 AMPK 
pSer240/244 S6 
S6 
actin 
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4.2.3 Time course of GA-dependent effects on AMPK, ACC and S6 
phosphorylation 
To determine the time course of GA-dependent effects on AMPK and S6 
phosphorylation an experiment was carried out using western blot analysis 
(Fig 4.4).  
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- + - - - - 10mM SAL- 2hrs 
- - + - - - 10mM GA- 0.5h 
- - - + - - 10mM GA- 1h   
- - - - + - 10mM GA- 2h  
- - - - - + 10mM GA- 4h  
 
Fig 4.4: Time course of GA-dependent effects on AMPK and S6 phosphorylation in 
H4IIE cells 
H4IIE cells were serum starved for 2 hours, then treated with 10mM GA in a time-course 
followed by lysis and SDS-PAGE. H4IIE cells were placed in serum-free medium for 2h, then 
treated with 10mM GA for 3hrs followed by lysis and SDS- PAGE. Immunoblotting was 
carried out using an antibody which detects AMPK only if it is phosphorylated on Thr172 
(pThr172 AMPK), two S6 antibodies- one which detects total S6 (S6) and one which detects 
Ser240/244 S6 phosphorylation (pSer240/244 S6) and an actin antibody. 10mM SAL is 
presented for comparison. 
 
The effect of GA on phosphorylation of AMPK was maximal at the shortest 
time point (0.5 h) but required two hours to exert its maximal effect on S6 
pThr172 AMPK 
pSer240/244 S6 
S6 
actin 
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dephosphorylation and these effects were sustained throughout the time 
course. 
4.2.4 Effects of SAL: Dose response and time course. 
To investigate the response of SAL more thoroughly, time course and dose-
response experiments were carried out. The effect of SAL continued to 
increase up to 10mM, the highest dose that was tested. This is shown in Fig 
4.5. For phosphorylation of ACC, AMPK and dephosphorylation of S6, 
effects were first noticeable between 2 and 5mM. 
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-  +  -  -  -  -    0.5mM SAL  
-  -  +  -  -  -     1mM SAL  
-  -  -  +  -  -     2mM SAL   
-  -  -  -  +  -     5mM SAL  
-  -  -  -  -  +     10mM  SAL 
 
Fig 4.5: SAL dose response on AMPK, ACC and S6 phosphorylation in H4IIE cells 
H4IIE cells were serum starved for 2 hours, then treated with differing doses of SAL for 3hrs 
followed by lysis and SDS-PAGE. Immunoblotting was carried out using two ACC 
antibodies- one which detects total ACC (ACC) and one which detects phosphorylated ACC 
(pACC), an antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 
AMPK), two S6 antibodies- one which detects total S6 (S6) and one which detects 
Ser240/244 S6 phosphorylation (pSer240/244 S6) and an actin antibody.  
 
The maximal effect on phosphorylation of AMPK appeared not to occur until 
two hours had passed and maximal dephosphorylation of S6 took one hour 
(Fig. 4.6). 
 
 
pACC 
ACC 
pThr172 AMPK 
pSer240/244 S6 
S6 
actin 
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-   +   -   -   -  5mM SAL 0.5h  
-   -   +   -   -  5mM SAL 1h  
-   -   -   +   -  5mM SAL 2h   
-   -   -   -   +  5mM SAL 4h  
 
Fig 4.6: Time course of SAL-dependent effects on AMPK, ACC and S6 
phosphorylation in H4IIE cells 
H4IIE cells were serum starved for 2 hours, then treated with 5mM SAL for the times shown, 
followed by lysis and SDS-PAGE followed by lysis and SDS- PAGE. Immunoblotting was 
carried out using an antibody which detects AMPK only if it is phosphorylated on Thr172 
(pThr172 AMPK), two S6 antibodies- one which detects total S6 (S6) and one which detects 
Ser240/244 S6 phosphorylation (pSer240/244 S6) and an actin antibody.  
 
4.2.5 Comparison of SAL and acetyl salicylate  
It was then decided to compare the effects of salicylate, which is not used 
clinically, with those of acetyl salicylate (aspirin), which is used clinically for 
its anti-inflammatory, analgesic, antipyretic and anti-thrombitic effects. These 
two structures are illustrated in Fig 4.7:  
 
pThr172 AMPK 
S6 
actin 
pSer240/244 S6 
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Fig 4.7: Structures of salicylate and aspirin 
 
Western blotting experiments found that salicylate was much more effective 
than acetyl salicylate. This is shown in Fig 4.8: 
 
 
 
 - + - - - - - - -  1mM ASP 
 - - + - - - - - -  2mM ASP 
 - - - + - - - - -  5mM ASP 
 - - - - + - - - -  10mM ASP 
 - - - - - + - - -  1mM SAL 
 - - - - - - + - -  2mM SAL  
 - - - - - - - + -  5mM SAL 
 - - - - - - - - +  10mM SAL  
 
 
Fig 4.8: Comparison of SAL with aspirin 
H4IIE cells were serum starved for 2 hours, then treated with differing doses of SAL and 
ASP for 3hrs followed by lysis and SDS- PAGE. Immunoblotting was carried out using an 
antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK), 2 S6 
antibodies- one which detects total S6 (S6) and one which detects Ser240/244 S6 
phosphorylation (pSer240/244 S6).  
pThr172 AMPK 
pSer240/244 S6 
S6 
Salicylate Acetyl salicylate 
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4.2.6. Comparison of SAL with 2-methoxybenzoic acid 
2-methoxybenzoic acid is an ester of methanol and salicylic acid. This is 
shown in Fig 4.9: 
O
O OH
CH3
 
Cell culture and western blotting comparing these two compounds suggested 
that SAL was much more effective than 2-methoxybenzoic acid. We were 
unable to obtain a response to this latter compound that was any more than 
marginally different to basal levels of phosphorylation. This is shown in Fig 
4.10: 
 
 
 
 
 
 
 
 
 
     Fig 4.9: 2-methoxybenzoic acid  
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- + - - - - - - - -     1mM SAL 
- - + - - - - - - -     2mM SAL 
- - - + - - - - - -     5mM SAL 
- - - - + - - - - -    10mM SAL 
- - - - - - + - - -     1mM 2-methoxybenzoic acid  
- - - - - - - + - -     2mM 2-methoxybenzoic acid 
- - - - - - - - + -     5mM 2-methoxybenzoic acid 
- - - - - - - - - +    10mM 2-methoxybenzoic acid 
Fig 4.10: Comparison of SAL with 2-methoxybenzoic acid 
H4IIE cells were serum starved for 2 hours, then treated with differing doses of SAL and 
methyl ASP for for 3hrs followed by lysis and SDS-PAGE. Immunoblotting was carried out 
using two S6 antibodies- one which detects total S6 (S6) and one which detects Ser240/244 
S6 phosphorylation (pSer240/244 S6) and an actin antibody.  
 
4.2.7 Screening of further HBA analogues for effects on AMPK, S6 and ACC 
phosphorylation 
To further probe structure activity relationships, further screening was carried 
out, using additional HBA analogues that were mostly already available in 
the laboratory. The structures illustrated in fig 4.11 were screened. 
pACC 
ACC 
pS6 
S6 
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                                         Fig 4.11: Further HBA analogues 
4 –OH-3-methoxy BA 
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The subsequent screen indicated that only 4–OH-benzaldehyde induced 
effects on AMPK, ACC and S6 that are comparable with GA, which was used 
as a positive control. This is shown in Fig 4.12. 
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+ - - - - - - - GA (positive control) 
- - + - - - - - 4-methoxy-BA 
- - - + - - - - 3, 5 dimethoxy- 4-OH-BA (syringic acid) 
- - - - + - - - 3-OH-4-methoxy-BA (isovanillic acid) 
- - - - - + - - 4-ethyl-BA 
- - - - - - + - 4-OH-benzaldehyde 
- - - - - - - + 4-OH-3-methoxy-BA 
 
Fig 4.12: Investigation of further benzoic acid analogues 
H4IIE cells were serum starved for 2 hours then treated with 5mM of the benzoic acid 
analogues shown above for 3hrs followed by lysis and SDS-PAGE. Immunoblotting was 
carried out using two ACC antibodies- one which detects total ACC (ACC) and one which 
detects phosphorylated ACC (pACC), an antibody which detects AMPK only if it is 
phosphorylated on Thr172 (pThr172 AMPK), two S6 antibodies- one which detects total S6 
(S6) and one which detects Ser240/244 S6 phosphorylation (pSer240/244 S6) and an actin 
antibody.  
 
 
pThr172 AMPK 
pACC 
pSer240/244 S6 
actin 
ACC 
S6 
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4.2.8 Dose response effects of 4–OH–benzaldehyde on AMPK, ACC and S6 
phosphorylation  
A concentration assay experiment found that 4–OH–benzaldehyde reached 
its maximum effect at around 3-5 mM with respect to ACC and AMPK 
phosphorylation but S6 phosphorylation was undetectable at 2 mM. (Fig 
4.13). 
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- + - - - - - - - - - - 5mM SAL (positive control) 
- - + - - - - - - - - - 300µM 4-OH-Be 
- - - + - - - - - - - - 400µM 4-OH-Be 
- - - - + - - - - - - - 500µM 4-OH-Be 
- - - - - + - - - - - - 1mM 4-OH-Be 
- - - - - - + - - - - - 2mM 4-OH-Be 
- - - - - - - + - - - - 3mM 4-OH-Be 
- - - - - - - - + - - - 4mM 4-OH-Be      
- - - - - - - - - + - - 5mM 4-OH-Be 
- - - - - - - - - - + - 10 mM 4-OH-Be 
Fig 4.13 Dose response of 4-OH benzaldehyde dependent effects on AMPK, ACC and 
S6 phosphorylation in H4IIE cells 
H4IIE cells were serum starved for 2 hours then treated with differing doses of 4-OH 
benzaldehyde shown above for 3hrs followed by lysis and SDS-PAGE. Immunoblotting was 
carried out using one ACC antibody that detects phosphorylated ACC (pACC), an antibody 
which detects AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK) two S6 
antibodies- one which detects total S6 (S6) and one which detects Ser240/244 S6 
phosphorylation (pSer240/244 S6) and an actin antibody.  
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pThr172 AMPK 
pSer240/244 S6 
S6 
actin 
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4.2.9 Time course of AMPK and S6 phosphorylation in response to 4–OH–
benzaldehyde 
In a time-course at 5 mM, it appears that with respect to phosphorylation of 
ACC and AMPK, 4-OH-benzaldehyde induced phosphorylation within 30 
minutes but this seemed to diminish at later time points. However complete 
dephosphorylation of S6 took two hours. This is shown in Fig 4.14. It was 
also noted earlier that 4-OH-BA was ineffective suggesting the benzaldehyde 
moiety is necessary for this effect.  
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- + - - - - - Positive control 
- - + - - - - 5mM 4-OH-BA (2h) 
- - - + - - - 5mM 4-OH-Be (0.5h) 
- - - - + - - 5mM 4-OH-Be (1h) 
- - - - - + - 5mM 4-OH-Be (2h) 
- - - - - - + 5mM 4-OH-Be (4h) 
Fig 4.14: Time course of 4-OH benzaldehyde dependent effects on AMPK, ACC and S6 
phosphorylation in H4IIE cells 
Serum starved H4IIE cells were treated as above for 3hrs followed by lysis and SDS-PAGE. 
Immunoblotting was carried out using two ACC antibodies- one which detects total ACC 
(ACC) and one which detects phosphorylated ACC (pACC), an antibody which detects 
AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK) two S6 antibodies- one which 
detects total S6 (S6) and one which detects Ser240/244 S6 phosphorylation (pSer240/244 
S6) and an actin antibody.  
 
 
pACC 
ACC 
pThr172AMPK 
pSer240/244S6 
S6 
actin 
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4.2.10 Investigation of the role of the Fenton reaction in effects of benzoic 
acids on AMPK, ACC & S6 phosphorylation. 
Some phenolic compounds are unstable in the presence of oxygen and 
metal ions because of the Fenton reaction (Long et al, 2000). This may be 
significant in cell culture because cells are cultured in pro-oxidant conditions 
and ferric nitrate is present in the cell culture medium at 0.248 µM. Ferric iron 
can reduce molecular oxygen to produce superoxide: 
 
Fe2+ + O2    Fe
3+ +O-2 
 
Superoxide reacts with groups on the polyphenol to generate hydrogen 
peroxide and oxygen radicals which reduce molecular oxygen and initiate a 
series of redox reactions: 
 
O-2 + 2OH             H2O2 + O2       
 
The hydrogen peroxide produced in vivo would be limited due to high levels 
of catalase in the liver but under cell culture conditons in the absence of 
catalase it could influence biochemical pathways necessary for emergency 
responses. Whether or not such responses were physiologically relevant 
would require further investigation. We had noted that the addition of gallic 
acid to the cell culture medium caused the medium to darken. This is likely to 
be due to complexation with iron in the medium, as iron is known to bind 
gallic acid to form deeply coloured complexes (Miller, 1996). This is 
illustrated in Fig 4.15 where the colour difference between DMEM and 10mM 
GA DMEM can be compared. 
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Fig 4.15: The change in colour of DMEM caused by GA  
To investigate any potential interaction of BAs with metals more 
quantitatively, the absorbance spectra from wavelengths of 300-800 nm were 
obtained from samples containing 40µM BA and 40µM metal ion. These 
results are shown in Table 4.1, presented alongside data on AMPK 
regulation (this thesis) and data on uncoupling from a previous study. 
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Compound used  
0
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A
 
4
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0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Fe 
2+ 
0 0 0 0 0 0.739 0 2.760 0.393 0.056* 0 0.331 +3 
Fe
3+ 
0 0 0 0 0 0.707 0 2.764 0.386 0101* 0 0.323 0 
Transition 
metal 
used 
Cu
2+ 
0 0 +3 0 0 0.309 0 2.740 0.361 0 0 0.391 +3 
AMPK activation (this thesis)  
- - + - - - - - - - - + + 
Uncoupling properties of compound, (Brody, 1956)  
0 0 98 ND ND 55 9 7 10 ND ND ND ND 
 
 
Table 4.1: Measurement of metal-binding of HBAs and related compounds.  
This data shows absorbance measured in absorbance units (AU). All absorbance maxima 
detected were at 340 nm apart from those highlighted by an asterisk* which were detected 
at 567 nm. Values >3 are highlighted in red. However, the samples were dissolved in UPW 
for this experiment to facilitate spectrophotometry and the pH of this was found to be 5.23, 
compared to a pH of 7.4 in the case of DMEM, therefore it is unclear to what extent pH 
influences metal binding and ionisation compared to physiological events in this case.  For 
comparison, the ability of each compound to activate AMPK phosphorylation and uncouple 
mitochondria are shown where this data was available, presented as % uncoupling of control 
(Brody, 1956). Each value is the mean absorbance of three different readings. 
 
 
In summary, no relationship was confirmed between iron binding and activity 
as salicylate, which did induce phosphorylation of ACC and AMPK and 
dephosphorylation of S6, did not bind iron. 
Oxidation state would appear to have limited effect on these results as there 
was very little differences in results between Fe2+ and Fe3+ apart from in the 
case of 4-OH-benzaldehyde. 
It was also noted that although copper-binding was a common property 
amongst the compounds activating ACC, AMPK and dephosphorylation of 
S6, it cannot be sufficient because some inactive compounds were also 
found to bind copper. 
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To test the role of the extracellular Fenton reaction in mediating the effects of 
GA, SAL and other hydroxybenzoic acids, the medium was substituted for 
normal saline which does not contain any iron. These results are shown in 
Fig 4.16. In comparison with earlier experiments carried out in the presence 
of DMEM, the results indicate that GA and SAL do not require extracellular 
iron to mediate their effects on AMPK, ACC and S6.  
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- + - - - - - - - - - - 2-hydroxy BA (salicylate) 
- - + - - - - - - - - - 3, 4, 5-trihydroxy BA (gallic acid) 
- - - + - - - - - - - - BA 
- - - - + - - - - - - - 3-hydroxy BA  
- - - - - + - - - - - - 4-hydroxy BA 
- - - - - - + - - - - - 2, 3-dihydroxy BA 
- - - - - - - + - - - - 2, 4-dihydroxy BA 
- - - - - - - - + - - - 2,5-dihydroxy BA (gentisate) 
- - - - - - - - - + - - 2, 6-dihydroxy BA 
- - - - - - - - - - + - 3, 4-dihydroxy BA 
  - - - - - - - - - - - + 3, 5-dihydroxy BA 
 
Fig 4.16: Effect of benzoic acids on AMPK and ACC phosphorylation in H4IIE cells: 
incubation in normal saline 
 H4IIE cells were incubated in normal saline followed by treatment with 10mM of the benzoic 
acids shown for 3hrs followed by lysis and SDS-PAGE. Immunoblotting was carried out 
using two ACC antibodies- one which detects total ACC (ACC) and one which detects 
phosphorylated ACC (pACC), an antibody which detects AMPK only if it is phosphorylated 
on Thr172 (pThr172 AMPK), and an actin antibody.  
 
 
 
 
pACC 
ACC 
pThr172AMPK 
actin 
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4.3 Discussion 
4.3.1 Structural requirements for effects of benzoic acids and related 
compounds on AMPK, ACC and S6.  
Of all the benzoic acids screened, only GA and SAL induced ACC and 
AMPK phosphorylation and inhibited S6 dephosphorylation, although other 
HBAs induced partial effects on S6 alone. Both GA and SAL possess 
hydroxyl groups and a comparison of SAL with either 2-methoxybenzoic acid 
or acetyl salicylate showed SAL to be active but these analogues to be 
inactive, confirming that the presence of a free 2-OH group was required for 
the effect. This correlation is not upset by the anti-hyperglycaemic properties 
of aspirin observed in vivo, as these are thought to depend on the drug’s 
conversion to SAL, which does not occur in cell culture (Hawley, 2012). 
However, differing hydroxylation positioning of the two molecules suggests 
that it might be unlikely that they interact with a single target. Equally, there 
were many hydroxybenzoic acids that were inactive at the concentrations 
tested, suggesting that hydroxylation by itself might be necessary but is not 
sufficient to trigger effects on AMPK and S6 phosphorylation. The third active 
compound in the screen was 4-OH-benzaldehyde. A comparison of 4-OH-BA 
and 4-OH-benzaldehyde confirmed that while 4-OH-benzaldehyde was 
active, 4-OH-BA was not, indicating that the acid moiety is dispensible. In 
addition, the hydroxyl groups in the three active compounds (SAL, GA and 4-
OH-benzaldehyde) were in different locations on the ring. Thus the 
relationship between structure and function does not yet appear to be 
straightforward. It is important to bear in mind therefore that the molecules 
under investigation are so simple that there may be more than one target 
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(and therefore more than one chemical motif) mediating the effects. This will 
obviously make structure/function studies more difficult to interpret. 
Effects on S6 were usually but not always accompanied by effects on AMPK 
and ACC. We did not establish whether or not effects of drugs on S6 in the 
absence of AMPK depend on kinase inhibition or phosphatase activation, or 
both, but clarification of this would possibly begin to unravel the mechanism 
underlying these effects. 
 
4.3.2 Functional requirements: Compounds that regulate AMPK, ACC and 
S6 inhibit intracellular ATP production  
As discussed in the introduction, two competing mechanisms for the 
antihyperglycaemic effects of HBAs have emerged, focussed mostly on 
studies of SAL. These mechanisms are inhibition of gluconeogenesis, 
through inhibition of mitochondrial ATP production and anti-inflammatory 
effects of the drugs. The data from our panel of HBAs suggests that it may 
be possible to differentiate between these two competing models. This is 
because SAL, 2,5 di-OH-BA and 2,6 di-OH-BA have each been reported to 
possess anti-inflammatory properties (Meyer, 1948) but amongst these only 
SAL is anti-hyperglycaemic and induces AMPK activation (Smith, 1952, 
Mahler 1960, Hawley, 2012), suggesting that AMPK activation rather than 
anti-inflammatory effects of HBAs is a better reporter of antihyperglycaemic 
effects of HBAs.  
The effects of the HBAs on AMPK can probably be directly attributed to their 
uncoupling properties, as both SAL and GA but not other HBAs are effective 
uncouplers at the concentrations used (Nakagawa et al, 1995; Brody and 
Fouts 1956; Meade, 1954; Whitehouse and Dean 1965). While this thesis 
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was in preparation, direct effects of SAL on AMPK were also reported 
(Hawley et al 2012) but this paper also ruled out a role for AMPK in anti-
hyperglycaemic effects of SAL. Taken together with the data in this thesis, a 
possible model emerges of AMPK-independent direct effects of 
mitochondrial inhibition on hepatic glucose production (still to be measured), 
with the anti-inflammatory effects of the HBAs insufficient to support by 
themselves these antihyperglycaemic responses. Further work will be 
required to substantiate this analysis and to understand more clearly the 
activity of GA and 4-OH-benzaldehyde, whose effects on cells have been 
studied less extensively than the other compounds discussed. 
 
4.3.3 Role of metal-binding  
Many BAs are known to bind to metals and a preliminary investigation was 
carried out to assess whether or not this is likely to be important in the 
properties of these drugs, as earlier studies on metformin analogues 
suggested that binding of this drug to copper ions correlated closely with 
cellular responses (Logie et al, 2012). Spectrophotometric analysis in this 
thesis suggested that activity of BAs correlated more closely with copper 
binding than iron; however, some BAs that bind either of these metals had no 
significant effects on the cellular responses under investigation. In additional 
experiments, we excluded any role of iron in the DMEM. Preliminary studies 
were also carried out using specific copper and iron-sequestering drugs 
including triethylaminetetramine to bind copper and desferoxamine to bind 
iron. The aim of these experiments was to determine more directly whether 
or not the cellular effects we were studying depend on metal-binding of BAs 
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but it was impossible to draw firm conclusions on the data available. Further 
work will be required to establish whether or not metal binding is necessary 
for the action of these drugs on AMPK but even if metal-binding is required, 
the results so far indicate that it is not sufficient. 
Whether any involvement of metals is due to inhibition of specific 
metalloenzymes would also require further study. The possibility of induction 
of intracellular ROS through the Fenton type reaction described earlier 
remains. However, it seems unlikely that the HBA derivatives studied here 
would differ significantly in their susceptibility to this reaction. Further study to 
determine the stability of each of these compounds in vivo may help to clarify 
as to whether this is a possibility. 
 
4.3.4. Physiological relevance 
The concentrations of SAL that inhibit the mitochondria are 
pharmacologically-relevant but whether or not the effects of GA are relevant 
to dietary levels will require further study. Our work with hepatocytes found 
that these cells certainly respond to GA but GSE also contains a large 
amount of galloylated PACs that may be more active because hydrophobic 
alkyl esters of GA, which are more hydrophobic than GA itself, are also more 
potent inhibitors of ATP production (Nakagawa et al, 1995). However, a 
study by Cacetta et al (2000) showed that 2-4 hours after ingesting 5ml/kg 
body weight red wine containing 9.5mg/ml GA plasma levels were 1.8µM 
(Cacetta et al, 2000). In this study concentrations over 1mM were required to 
cause the physiological response observed therefore further in vitro study 
including lower concentrations over a longer time period may be of benefit. 
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CHAPTER 5- CELLULAR RESPONSES TO LINGONBERRY AND 
CRANBERRY EXTRACTS 
 
5.1 Introduction 
Besides grape seed and pine bark, PACs are also found in berries such as 
Vaccinium oxycoccus (cranberry) and V.vitis-idaea (lingonberry).  
A-type and B-type PACs have characteristically different structures (Fraga et 
al, 2010) and have different three dimensional shapes (Porter, 1993) which 
may affect their ability to interact or bind with receptors e.g. on the plasma 
membrane. Berry polyphenols including PACs have been shown to inhibit 
pancreatic amylase (Grussu et al, 2011) and PACs have been implicated in 
the inhibition of pancreatic lipase (McDougall et al., 2009; Kimura et al, 
2011). Inihbition of amylase could influence starch digestion and therefore 
has been proposed as a potential prophylactic measure with respect to post 
prandial hyperglycemia (Grussu et al, 2011). It has been suggested that the 
presence of larger PACs (Kimura, 2011) and procyanidins (Sugiyama et al, 
2007) are associated with increased lipase inhibition in vitro (Kimura et al, 
2011) and in vivo (Sugiyama et al, 2007) but also that A type PACs inhibit 
pancreatic lipase more effectively than B type (Kimura, 2011) 
 
5.1.1 Cranberry 
V.oxycoccus has been divided into various subspecies. American cranberry 
(V. macrocarpon) is the most extensively commercially exploited of these. 
Cranberry is native to North America and found in Newfoundland, Minnesota, 
Illinois, Ohio, Indiana, Tennessee and Carolina. It grows in bogs and 
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swamps in acidic soil (Vander Kloet, 1988). In the 1820s cranberries were 
shipped to Europe (Cape Cod Cranberry Growers’ Association) and by 1923 
were observed growing wild in Ireland (Stelfox, 1923). 
Cranberry has been suggested to be beneficial in the treatment of urinary 
tract infections (Avorn et al, 1994), type 2 diabetes (Kotiokari et al, 2002) and 
cancer (Yan et al, 2002). A study by Avorn et al in 1994 suggested cranberry 
juice to have bacteriostatic properties, possibly contributed to by adhesion 
inhibition. It was also noted that the beneficial effects of cranberry juice were 
observed after one to two months, perhaps compatible with the time frame 
required for modification of gut bacteria. Bacterial cell adhesion has been 
shown to be inhibited by cranberry juice in vitro, by inhibiting attachment of 
bacterial fimbriae to cells expressing oligosaccharide receptors similar to 
those on uroepithelial cells (Foo et al, 2000). Therefore it has been 
suggested that the apparent prevention and treatment of urinary tract 
infections by cranberry juice may be due to its modification of gut flora and 
anti-adhesive properties respectively.  
Cranberry has also been suggested to elevate high density lipoprotein- 
cholesterol levels in a patient based study using 31 healthy sedentary adult 
males, showing an 8% increase (Ruel et al, 2006) compared to a 10% 
increase noted by fibrates in a previous meta-analysis (Birjmohun et al, 
2005). Flavan-3-ols and procyanidins have been proposed as potential 
antihypertensive agents by inhibition of angiotensin converting enzyme 
(ACE) (Actis-Goretta et al, 2003).  
Cranberry has also been found to improve the lipid profile of patients with 
T2D (Lee et al, 2008). In one study on rats fed a high fructose diet, metabolic 
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abnormalities appeared to be ameliorated when the diet was supplemented 
with 3% cranberry pomace. The animals on the supplemented diet had lower 
fasting plasma insulin, cholesterol and triacylglycerol levels as well as 
decreased insulin resistance (Khanal et al, 2010).  
Cranberry has also been proposed to have antiproliferative effects in lung 
H460), cervical (ME180), prostate (PC3), breast (MCF- 7), colon (HT- 29) 
and leukaemia (K562) cell lines (Yan, 2002). Another study found that 
antiproliferative effects in oral (KB; CAL27), colon (HT- 29; HCT116; SW480; 
SW620) and prostate (RWPE- 1; RWPE- 2; 22Rv1) cancer cell lines are 
enhanced when polyphenolic rich extracts were used (Seeram, 2004). 
Hydroxycinnamates have been suggested to be the active agents with 
respect to breast, cervical and prostate cell lines (Murphy et al, 2003). 
 
5.1.2 Lingonberry 
One subspecies of V.vitis-idaea exists - V.vitis-idaeaminus which differs from 
the main species only in length of the leaves and size of the berries (United 
States Department of Agriculture). Both are suitable for commercial use. Like 
cranberry, lingonberry is also native to North America and found in 
Greenland, Connecticut and the Aleutian Islands. It is also found in 
Scandinavia and Russia (Ek et al, 2006). It grows in raised bogs, lichen 
woodlands, heaths, high moors, tundra, cliffs and mountain summits (Vander 
Kloet, 1988) 
Lingonberry has been suggested to be effective in the treatment of 
cardiovascular disease (Kivomaki et al, 2011) and urinary tract infection 
(Kotiokari et al, 2002). Lingonberry juice has been shown to increase 
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endothelial dependent vasodilation in hypertensive rats (Kivimaki et al, 2011) 
and has been proposed as a potential treatment (Tapiainen et al, 2012) and 
preventative measure (Kotiokari et al, 2002) for urinary tract infections. It has 
been found to reduce proliferation in colon and breast cancer cell lines. This 
effect correlated with vitamin C levels in the sample but was not observed in 
the presence of ascorbate alone, suggesting a possible synergistic effect 
between vitamin C and other components of the sample (Olsson et al, 2004). 
 
5.1.3 Molecular basis for cellular effects. 
The molecular targets underlying responses to polyphenols are not well 
understood. Various attributes of polyphenols have been proposed to 
contribute to their apparent medicinal effects, including antioxidant capacity 
(Zheng et al, 2003; Shyur et al, 2005), when measured in plants used for 
medicinal effect. Prevention of ischaemia- reperfusion injury by inhibition of 
nitric oxide synthase has also been observed (Brouet and Ohshima, 1995). 
Cell culture studies have shown cranberry anthocyanins to reduce hydrogen 
peroxide damage, to inhibit oxidation of cell membrane lipids and to 
upregulate inflammatory mediators interleukin- 8 (IL8), monocyte 
chemotactic protein- 1 (MCP-1) and intracellular adhesion molecule (ICAM-
1), as these  molecules are involved in the recruitment of leucocytes to areas 
of endothelial damage. These studies were performed using human 
microvascular endothelial cells (Youdim et al, 2002). 
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5.1.4 Geographical distribution 
The geographical distribution of these plants in the USA is shown in Fig 5.1. 
Green indicates the presence of the relevant plant. Images are from the 
United States Dept of Agriculture Plants database. 
 
                      Cranberry                                   Lingonberry 
Fig 5.1: Geographic distribution of cranberry and lingonberry 
This data suggests cranberry to grow in wet areas and lingonberry in cold, dry areas 
(Images from United States Dept of Agriculture)  
 
 
5.1.5 Proanthocyanidins 
Proanthocyanidins, also called condensed tannins (Hagerman, 2011), are 
widespread in nature and are reported to be the most ingested class of 
polyphenol as they are found at reasonable levels in a wide range of 
foodstuffs as shown in Table 5.1: 
 
 
 
 
 
 152 
Food PAC  With peel No peel White Rose Red Black Baking Dark Milk 
Beer 2          
Wine    1 2 62     
Apple juice 12          
Apples  43-136 17-99        
Apricots  11.32         
Babyfood 0-54          
Chocolate        1636 234 152 
Bananas 3          
Barley 99          
Beans 0-767          
Berries  24-664         
Cherries  19         
Cocoa powder 1373          
Coffee 0.1-3.7          
Cranberry juice 22          
Currants      5 158    
Dates 11          
Grape juice 49          
Grape seeds 373          
Grape skins 48          
Grapes 62-83          
Kiwi fruit 3-14          
Mango 13          
Nectarines 22-29          
Nuts 0-501          
Peaches  30-72         
Peanuts 16          
Pears 32-42          
Plums 28-247          
Pomegranate 1          
Spices 742-8137          
 
Table 5.1: PAC concentration of various foodstuffs. Units are mg/ 100g (US Dept of 
Agriculture, 2004).  
 
PACs can be found as dimers to polymers (DP or degree of polymerisation 
from 2) upwards of flavan-3-ol units, such as epicatechin, which can be 
joined by two type of linkage. A type PACs contain at least one doubly linked 
unit with C4-C8 and C2–O7 bonds and B type PACs are singly linked 
through a C4–C8 bond. The additional bond in A type PACs causes the loss 
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of 2 hydrogen atoms, reducing the molecular weight by 2. These structures 
are illustrated in Fig 5.2: 
O
O
O
                         
O
O
 
 
 
Fig 5.2: Schematic Illustration of Different Types of PACs 
Examples of A-type and B-type proanthocyanidins (PACs). A-types have doubly linked units 
and B-types are singly linked. 
 
 
5.1.6 Anthocyanidins 
Proanthocyanidins yield anthocyanidins upon oxidative cleavage as shown in 
Fig 5.3: (Hagerman, 2011): This has been used as a diagnostic test for PACs 
(Porter, 1993) and is the reason behind their name. 
 
 
 
 
 
 
 
Type A Type B 
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Fig 5.3: Hydrolysis of proanthocyanidins 
Hydrolysis of this PAC dimer yields one anthocyanidin and one catechin whereas a PAC 
trimer would yield 2 anthocyanidins and one catechin and so on (Hagerman, 2011).  
 
5.1.7 Anthocyanins 
Anthocyanins are glycosylated anthocyanidins. The basic structure is shown 
in Fig 5.4 (Vermerris and Nicholson, 2006): 
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Fig 5.4: Structure of pelargonidin-3-glucoside, one of the anthocyanins  
Anthocyanins are glycosylated anthocyanidins. R= glycosyl group 
 
Anthocyanins are the compounds which give berries their red or blue colour 
and these have been suggested to have anti-inflammatory, antioxidant and 
vasoprotective effects (Wada and Ou, 2002). In addition, a study by Tsuda et 
al, (2003) suggested anthocyanins ameliorated weight gain and 
hyperglycemia caused by a high fat diet. This conclusion is undermined 
because the high fat and anthocyanin treated mice were fed 11g/ kg 
anthocyanin in place of 11g/ kg sucrose in the high fat diet only mice, which 
could well have contributed to the difference. Also, it was noted that food 
intake was lower in these mice compared to the control group.  
 
5.1.8 Purpose of investigation 
The chapter begins with identification of effects of lingonberry and cranberry 
extracts on FOXO1a phosphorylation. These extracts were fractionated 
using the experience that had been gained studying grape seed and pine 
bark extracts. The aim, as in chapter 3, was to learn more about the 
individual molecules or groups of molecules involved in mediating the cellular 
effects. By changing the extract under investigation it was hoped that this 
might become more tractable.  
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5.2 Results 
Lingonberry (LB) and cranberry (CB) extracts samples were prepared as 
described in chapter 2. Solid phase extraction on Supelco SPE columns was 
used to fractionate the samples into unbound and bound fractions. Total 
phenol assays showed that the majority of phenolic compounds were 
recovered in the bound fractions (Table 5.2): 
 
 
Sample % of total recovery  Sample % of total recovery 
 
L UB1 5.5 C U1 7.1 
L UB2 2.6   
L B1 63.8 C B1 92.1 
L B2 11.0   
 
 
 
 
 
 
 
 
 
 
 
5.2.1 Comparison of the effectiveness of lingonberry and cranberry extracts 
in inducing FOXO1a phosphorylation 
The lingonberry extract (LB) was more effective than the cranberry extract 
(CB) in inducing FOXO1 phosphorylation (Fig 5.5): 
 
 
Table 5.2: Recovery of phenols in lingonberry and cranberry 
fractions after SPE 
A total phenols assay was carried out to determine the phenolic 
content of each fraction.  
 
L UB1- lingonberry unbound 1 
L UB2- lingonberry unbound 2 
L B1- lingonberry bound 1  
L B2- lingonberry bound 2 
CU1 – cranberry unbound 1 
CB1 – cranberry bound 1 
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+ - - - - - - - - -  100µg/ ml BTE 
- - + - - - - - - -  100µg/ ml LB 
- - - + - - - - - -  100µg/ ml LB U1 
- - - - + - - - - -  100µg/ ml L UB2 
- - - - - + - - - -  100µg/ ml LB1  
- - - - - - + - - -  100µg/ ml LB2 
- - - - - - - + - -  100µg/ ml CB 
- - - - - - - - + -  100µg/ ml CU1 
- - - - - - - - - +  100µg/ ml CB1 
 
Fig 5.5: Effect of LB and CB and their fractions on FOXO1a phosphorylation 
HEK 293 cells were cultured as described in the methods, followed by withdrawal of serum 
for 30 min. Cells were then stimulated for 30 minutes as above with 100µg/ml of the LB and 
CB whole extract or unbound/bound fractions. BTE was used as the positive control and 
vehicle only (DMEM) as the negative control.  Cells were lysed and prepared for SDS-PAGE 
as described in the methods, followed by immunoblotting with an antibody that detects 
FOXO1a only when it is phosphorylated on the insulin-sensitive residue pSer 325 
pFOXO1a) as well as a second antibody that detects FOXO1a regardless of phosphorylation 
state (FOXO1a).  
 
After SPE fractionation, the activity was recovered in the second bound 
fraction of the LB whereas the LB unbound fractions showed no activity at 
this dose. This suggests that the most active components were recovered in 
this bound fraction. In the case of cranberry, although the original extract was 
effective, phosphorylation-stimulating activity was not recovered in the 
unbound or bound fractions. This suggests that either the active components 
were destroyed or did not elute from the SPE matrix under these conditions. 
pSer325FOXO1a 
FOXO1a 
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5.2.2 Anthocyanin content of SPE fractions  
The SPE fractionation of CB was repeated with certain changes. Firstly, the 
SPE units were washed more thoroughly. Secondly, a vacuum pump was not 
used which ensured that the sample had longer to bind to the SPE matrix.  
As before, the majority of the phenolic material eluted in the bound fractions 
(Table 5.4). The fractions from this attempt were applied to cells and the blot 
repeated but using a higher concentration (200µg GAE/ml). It was apparent 
that the active components were recovered in the first bound sample and 
these were sufficient to induce phosphorylation of FOXO1a (Fig 5.6). At this 
higher dose, some activity was also seen in the later unbound washes.  
 
Sample % recovery total phenols 
Unbound1 6.4 
Unbound2 9.8 
Unbound3 9.9 
Unbound4 10.3 
Unbound5 12.4 
Unbound6 4.6 
Bound1 15.5 
Bound2 4.8 
 
Table 5.3: The distribution of phenolic compounds after SPE of CB. 
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- + - - - - - - - -  100µg/ ml BTE (positive control 
- - + - - - - - - -  200µg/ ml C U1 
- - - + - - - - - -  200µg/ ml C U2 
- - - - + - - - - -  200µg/ ml C U3 
- - - - - + - - - -  200µg/ ml C U4  
- - - - - - + - - -  200µg/ ml C U5 
- - - - - - - + - -  200µg/ ml C U6 
- - - - - - - - + -  200µg/ ml C B1 
- - - - - - - - - +  200µg/ ml C B2 
 
Fig 5.6: Effect of CB fractions on FOXO1a phosphorylation 
HEK 293 cells were cultured as described in the methods, followed by withdrawal of serum 
for 30 min. Cells were then stimulated for 30 minutes as above with 200µg/ml of the CB 
whole extract or unbound/bound fractions. 100µg/ ml BTE was used as the positive control 
and vehicle only (DMEM) as the negative control.  Cells were lysed and prepared for SDS-
PAGE as described in the methods, followed by immunoblotting with an antibody that 
detects FOXO1a only when it is phosphorylated on the insulin-sensitive residue pSer 325 
pFOXO1a) as well as a second antibody that detects FOXO1a regardless of phosphorylation 
state (FOXO1a).  
 
5.3 Identification of active components in the cranberry extracts using LCMS 
LCMS analysis was used to characterise the polyphenol composition of the 
CB and LB extracts and their unbound and bound fractions. The composition 
of the cranberry extracts is summarised in Table 5.5 and Figure 5.7. The MS 
data is shown in Fig 5.8. 
 
pSer325FOXO1a 
FOXO1a 
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Peak 
no 
Retention time 
(mins) 
PDA max. M/Z MS
2
 Putative ID 
1 8.0 280 779 389 Unknown 
2 8.5 300 575 341  PAC dimer (A) 
3 9.1 280 ND ND Not identified 
4 12.0 295 387 341, 179 Caffeoyl hexose 
5 13.1 285 315 153 dihydroxy benzoic acid 
hexose 
6 15.3 290 353 191 Chlorogenic acid 
7 15.6 315 341 179 caffeoyl hexose 
8 16.6 515, 285 447 285 Cyanidin hexose 
9 17.4 315 341 179 caffeoyl hexose 
10 17.7 515, 325, 
285 
353 191 Chlorogenic acid/ 
Anthocyanin 
11 18.2 315 461 415, 293, 
191 
HCA derivative 
12 19.2 275 329 283, 121 Benzoic acid hexose 
13 20.4 275 513, 401, 
289 
401, 289 PAC derivative 
14 20.8 280 863 711, 289 PAC trimer (A) 
15 21.6 355 479, 317 317 Myricetin hexose 
16 23.7 350 463, 301 301 Quercetin hexose 
17 25.0 285 1151 
 575 
ND 
ND 
Proanthocyanidin tetramer  
(A) 
Proanthocyanidin dimer (A) 
18 25.7 350 433, 301 301 Quercetin pentose 
19 25.9 355 447 301 Quercetin rhamnose 
20 29.1 350 317 ND Myricetin 
21 29.8 275 609 
121 
463, 301 
No MS 
Quercetin coumaroylhexose 
Benzoic acid 
22 32.3 350 567, 301 301 Quercetin benzoyl hexose 
23 33.8 350 310 ND Quercetin 
 
Table 5.4: Identification of phenolic compounds in cranberry extracts 
Putative IDs for compounds in CB were collated from data in Antolovitch, 2004; McDougall, 
2008; McDougall, 2010; Passos, 2007 and Weaver, 2009. PDA represents the maximal 
wavelength of absorption, m/z the mass to charge ratio and MS
2
, the breakdown products 
generated with a collision factor of 45% normalised energy. The peak numbering refers to 
Fig. 5.7. 
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Fig 5.7: UV traces of CB fractions obtained by solid phase extraction 
CB extract was fractionated by SPE as detailed in the methods. The figures in the top right 
corner denote the full scale deflection of the detector at 280 nm. Three fractions were 
subjected to LCMS as detailed in the methods. Some compounds were concentrated in the 
fractions that were too dilute to observe in the original sample. These are highlighted in red. 
PACs denotes an area rich in unresolved PACs. Numbering denotes peaks discussed in 
Table 5.5.   
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Fig 5.8: MS spectra of CB fractions obtained by solid phase extraction. 
The figures in the top right corner denote the full scale deflection of the MS detector.  
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The original cranberry extract contained a mixture of polyphenol 
components, mainly hydroxycinnamic and hydroxybenzoic acid derivatives, 
flavonols, proanthocyanidins and some anthocyanins. The overall 
composition was similar to previous reports (Prior et al, 2001). Fig. 5.7 
illustrates the fractionation of phenolic components on the Supelco columns. 
The components displayed differential affinity for the column matrix and the 
unbound sample was enriched in anthocyanins, hydroxycinnamic acid and 
hydroxybenzoic acid derivatives. In addition, certain components that were 
hidden in the original extract became apparent in the unbound sample, 
including some hydroxycinnamic acid derivatives that are characteristic of 
cranberry. For example, there are a cluster of peaks that were obscured by 
the abundance of peak 16 (quercetin hexose) in the original extract that have 
LC-MS properties that identify them as caviunin hexose derivatives (m/z 535 
and 537; Iswaldi, 2012). Also, the presence of benzoic acid in peak 21 was 
more apparent in the unbound sample. 
 
As outlined in the original method paper (Hellstrom, 2007), elution with 
aqueous acetone released the bound components and proanthocyanidins 
and flavonols were enriched in this fraction. The CB bound 1 fraction  was 
enriched in some flavonols including peak 16 (quercetin hexose) and peaks 
20 and 23 (myricetin and quercetin resp.). Certain PAC peaks were clearly 
eniched (peak 17; PAC tetramer). However, enrichment in PACs can be 
more readily displayed by comparing the MS spectra of the bound, unbound 
and original samples (Fig. 5.8) because these components do not separate 
well on RP-HPLC. It can be clearly noted that the MS spectra of the bound 
fraction is enriched in signals characteristic of a range of PACs and signals 
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from flavonols. It was also noted that the PAC concentrations in CB were low 
in comparison to other samples. It is possible that the PACs were removed 
when this commercially available juice was being processed. 
 
5.4 Identification of active components in the lingonberry extracts using LC-
MS 
The LCMS data for lingonberry samples are shown in Table 5.6 and Figs 5.9 
and 5.10. 
 
Peak no Retention time (mins) PDA M/ Z MS2 Putative ID 
1 9.9 280 865.1 Multiple PAC trimer (B) 
2 14.0 280 577.0 407.1, 289.1 PAC dimer (B) 
3 14.4 280, 515 447.0 285.1 Cyanidin hexose 
4 15.1 280 577.0 425.0, 289.0 PAC dimer (B) 
5 15.7 280 865.1 693.0, 577.1 PAC trimer (B) 
6 16.0 280 865.1 695.1, 575.1 PAC trimer (B) 
7 17.0 275 461.0 414.9 Not identified 
8 18.1 275 863.0 711.0 PAC trimer (A) 
9 18.6 280 865.1 Multiple PAC trimer (B) 
10 21.0 280 575.1 377.0, 449.1 PAC dimer (A) 
11 21.1 280 355.1, 193.0 193.0 Feruloyl hexose 
12 22.2 355 463.0 301.0 Quercetin hexose 
13 22.7 285 861.1 700.0, 573.0 PAC derivative 
14 24.3 350 433.0 323.0 Quercetin pentose 
15 24.6 265, 350 447.0 301.0 Quercetin rhamnose 
16 27.8 350 591.1 447.0, 489.1 Quercetin-HMG rhamnose 
17 28.5 275 121.1 ND Benzoic acid 
18 29.1 290, 325 193.1 193.1, 161.0 Ferulic acid 
19 30.2 350 575.1, 285.2 445, 285 Kaempferol-HMG rhamnose 
20 30.9 345 567.1, 301.1 447.1, 301.1 Quercetin benzoyl hexose 
21 31.7 345 567.1, 301.1 447.1, 301.1 Quercetin benzoyl hexose 
22 32.1 365 301.1 165.0 Quercetin 
 
Table 5.5: Identification of phenolic compounds in lingonberry extracts 
Putative IDs for compounds in LB were collated from data in Antolovitch, 2004; McDougall, 
2008; McDougall, 2010;Passos, 2007 and Weaver, 2009. PDA represents the maximal 
wavelength of absorption, m/z the mass to charge ratio and MS
2
, the breakdown products 
generated with a collision factor of 45% normalised energy. The peak numbering refers to 
Fig. 5.9. 
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Fig 5.9: Chromatograms of LB fractionated by solid phase extraction 
LB extract was fractionated by SPE as detailed in the methods. Five fractions were 
subjected to LCMS as detailed in the methods. The figures in the top right corner denote the 
full scale deflection of the detector at 280 nm. Some more concentrated compounds were 
observed in the fractions produced that were too dilute to observe in the original sample. 
These m/z values are highlighted in red. Numbering follows format discussed in Table 5.6.   
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Fig 5.10: MS of LB obtained by solid phase extraction 
Fractions were subjected to mass spectrometry as detailed in the methods. The figures in 
the top right corner denote the full scale deflection of the MS detector. 
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The polyphenol composition of the lingonberry extract matched previous 
reports (Prior et al, 2001; Ek et al, 2006; McDougall et al, 2008A) and 
contained a diverse mixture of anthocyanins, hydroxycinnamic acid 
derivatives, flavonols and proanthocyanidins. It also contained substantial 
amounts of both ferulic acid and benzoic acid, which is characteristic of 
lingonberry (McDougall et al, 2008B; Visti et al, 2003). After fractionation on 
SPE, the unbound sample was enriched in anthocyanins, hydroxycinnamic 
acid derivatives, hydroxybenzoic acid derivatives and benzoic acid. Some 
peaks become more apparent in the unbound sample following the removal 
of other peaks, e.g. a second feruloyl hexose appears (see asterisk, Fig 5. 
9). Once again, the bound fractions were relatively enriched in certain 
flavonols and PACs. For example, peak 16 was identified as quercetin 
hydroxymethylglutaroyl (HMG) rhamnose and peaks 5 and 8 as PAC trimers. 
The enrichment in PACs in LB bound 2 was also apparent in the hump of 
unresolved peaks between 8-25 mins. The enrichment in PACs and flavonols 
was mirrored in the MS spectra (Fig. 5.10). 
 
5.5 Comparison of the spectra of active fractions 
Cell-based studies had also shown that the most active LB bound fraction 
was substantially more effective than the most active CB bound fraction. 
Comparing these PAC-rich fractions further, it is clear that the most-active LB 
bound fraction (LB bound 2) contained a higher proportion of predominately 
B-type PACs than the less active CB bound 1 fraction (see Figs. 5.8 and 
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5.10). In addition, the LB bound 2 fraction appeared to contain a larger 
proportion of higher molecular weight PACs.  
 
The data also suggested that LB bound fraction 2 was considerably more 
effective than LB bound 1 in inducing phosphorylation of FOXO1a (Fig 5.5). 
The LC-MS runs and MS spectra data (Figs 5.9 and 5.10) show that both 
bound fractions were enriched in PACs and certain flavonols. The bound 
fraction 1 contained a greater proportion of smaller PACs (trimers and below) 
and probably contained a greater proportion of flavonols. The bound fraction 
2 was more enriched in PACs as it only contained substantial amounts of 
one flavonol (peak 16, quercetin-hydroxymethylglutaroyl rhamnose). Also, 
the PACs present appeared to be of generally higher DP (trimers and 
above). Overall, this suggests that PACs may be more effective than 
flavonols in inducing phosphorylation of FOXO1a and that PACs of higher 
molecular weight  may also be more effective. 
 
5.6 Dose-response effect of the most active LB fraction on FOXO1a 
phosphorylation 
Dose response experiments were carried out to assess how effective the LB 
bound 2 was at lower concentrations. Phosphorylation of FOXO1a was 
apparent at 25 µg /ml (Fig 5.11) and did not increase greatly at 100 µg/ml of 
LB bound 2 fraction. 
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+ - - - - - - -   100µg/ ml BTE 
- - + - - - - -   25µg/ ml L U2 
- - - + - - - -   50µg/ ml L U2 
- - - - + - - -   100µg/ ml L U2 
- - - - - + - -   25µg/ ml L B2  
- - - - - - + -   50µg/ ml L B2  
- - - - - - - +   100µg/ ml L B2  
 
Fig 5.11: Effect of different doses of LB bound 2 fraction on FOXO1a phosphorylation  
HEK 293 cells were cultured as described in the methods, followed by withdrawal of serum 
for 30 min. Cells were then stimulated for 30 minutes as above with 100µg/ml of the LB and 
CB whole extract or unbound/bound fractions. 100µg/ ml BTE was used as the positive 
control.  Cells were lysed and prepared for SDS-PAGE as described in the methods, 
followed by immunoblotting with an antibody that detects FOXO1a only when it is 
phosphorylated on the insulin-sensitive residue pSer 325 pFOXO1a) as well as a second 
antibody that detects FOXO1a regardless of phosphorylation state (FOXO1a).  
 
 
5.7  Fate of lingonberry components during incubation with cells 
 HEK293 cells were treated with 100 µg/ml LB for 0, 15, 30, 45, 60 and 75 
mins and the media subjected to LCMS to track the fate of the phenolic 
components. Over time, the larger PACs disappeared from the LCMS trace 
of the media beginning at between 15 mins and were completely absent by 
60mins. There was a suggestion that flavonol components (e.g. peak I and 
pSer325FOXO1a 
FOXO1a 
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peak D) survived for longer but this could not be determined with confidence. 
This was mainly because the media contained components that interfered 
with detection of peaks (e.g. the resilience of peak 4 is mainly due to the 
presence of the pH indicator dye in the media) or ions with similar m/z that 
overwhelmed the phenolic components. 
The larger PACs may have bound to other components of the media (Porter, 
1993).  It is also possible that the larger PACs were being transported into 
the cell or were bound to or sequestered into the plasma membrane perhaps 
due to their lipophilic nature or simply that degradation occurred in the 
extracellular medium. Further work could examine for the uptake of these 
components or the presence of their metabolites inside the cells. This data is 
shown in Fig 5.12 and 5.13 and table 5.6:  
Peak m/z ID 0 15 30 45 60 
A 865.1 PAC trimer (B) 865.1     
B 863.0 PAC trimer (A) 863.0     
C 865.1 PAC trimer (B) 865.1 865.1 865.1   
D 463.0 Quercetin hexose 463.0 463.0 463.0 463.0  
E 433.0 
575.1 
863.0 
Quercetin pentose 
PAC dimer (A) 
PAC trimer (A) 
433.0 
575.1 
863.0 
433.0 
575.1 
863.0 
433.0 
575.1 
863.0 
 
 
863.0 
 
F 433.0 
575.1 
865.1 
1153.1 
Quercetin pentose 
PAC dimer (A) 
PAC trimer (B) 
PAC tetramer (B) 
433.0 
575.1 
865.1 
1153.1 
433.0 
575.1 
 
1153.1 
433.0 
575.1 
 
575.1 
 
G 575.1 
863.0 
1153.1 
 
PAC dimer (A) 
PAC trimer (A) 
PAC tetramer (A) 
575.1 
863.0 
1153.1 
    
H 575.1 
863.1 
1151.1 
PAC dimer (A) 
PAC trimer (A) 
PAC tetramer (B) 
575.1 
863.1 
1151.1 
    
I 591.1 Quercetin HMG rhamnose 591.1 591.1 591.1 591.1  
 
Table 5.6 Time course study of PAC presence in DMEM. HEK293 cells were treated with 
100 µg/ml LB for 0, 15, 30, 45, 60 and 75 mins and the media subjected to LCMS at 45
o
C. 
The presence of characteristic MS signals was assessed over 60 mins. 
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Fig 5.12: Comparison of chromatograms of LB exposed to cells and DMEM 
over a time course. 
HEK293 cells were placed in serum free medium and LB added. At the different time 
points shown, DMEM was taken for analysis by LCMS. The figures in the top right 
corners represent the full scale deflection of the detector at 280 nm. Peaks A-I are 
from the LB extract and are discussed in the text and in Table 5.6. 
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Fig 5.13: MS data from LB media recovery experiment. 
HEK293 cells were placed in serum free medium and LB added. At the different time points 
shown, DMEM was taken for analysis by LCMS. T=75mins not included because it was 
identical to t=60mins. The figures in the top right corners represent the full scale deflection. 
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Discussion 
5.8  LB is more effective than CB in inducing FOXO1a phosphorylation 
Cell culture and western blot analysis confirmed that LB was more effective 
at inducing phosphorylation of FOXO1a than CB. The induction of FOXO1a 
phosphoylation by phenolic rich extracts of  CB and LB confirm previous 
results obtained with black tea theaflavins (Cameron et al, 2008). It proved 
impossible to identify individual structures mediating the cellular effects of LB 
and CB and therefore no further characterisation of such agents could be 
carried out. Despite this, LCMS analysis of the extracts suggested that the 
most effective fractions contained:  
1. a higher level of PACs 
2. the presence of larger PACs in active compared to inactive fractions  
3. more B type PACs in LB compared to CB 
 
5.9 Role of linkage type and degree of polymerisation in effects of PACs on 
other model systems 
LCMS analysis suggested that the most active fraction of LB contained a 
higher proportion of larger molecules than in the inactive samples. Other 
studies also suggested that the levels of the PACs began to decline in the 
extracellular media within 15 minutes of treatment and they were 
undetectable by 60 minutes. This may be due to the breakdown of PACs to 
monomers which can be predicted to be taken up into the cell and thereby 
exert their effects on FOXO1a. Indeed, PAC monomers and dimers are 
known to be taken up by epithelial cells (Deprez et al, 2001).  Initial work to 
identify which phenolic compounds entered the cells was unsuccessful, 
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probably because the levels were below detection levels of the MS 
techniques employed. Further work using labelled compounds may be 
required to determine if monomers or indeed PACs can be detected within 
the cells 
It was noted that LB, which was more effective with respect to inducing 
phosphorylation of FOXO1a, contained more B type PACs than CB, which 
contained predominately A type PACs. and in view of the results presented 
here, further study into the differential effects of A type versus B type may be 
of interest.  
 
5.10 Effects of flavonols compared to PACs 
The data presented here shows that samples more enriched in PACs than 
flavonols were more effective at inducing phosphorylation of FOXO1a than 
those with more substantial levels of flavonols. This suggests PACs may be 
more effective than flavonols. 
 
In conclusion, this chapter investigated the ability of lingonberry and 
cranberry extracts to regulate the phosphorylation of the transcription factor 
FOXO1a. As in chapter 3, it was not possible to identify individual active 
structures for detailed characterisation. The analysis of the composition of 
active fractions that has been carried out may facilitate this in the future.  
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CHAPTER 6- BIGUANIDES AND DIGUANIDES 
6.1 Introduction 
Guanidines were originally extracted from French lilac (G. officinalis) 
(Witters, 2001) and were found to have blood glucose lowering effects in 
rabbits. While guanidine itself proved too toxic for clinical use, for example in 
one study 12 out of 21 rabbits died (Watanabe, 1918), galegine, synthalin 
and biguanides proved less toxic (Bailey and Day, 2004). Several of these 
agents have been used clinically since but only one, the biguanide 
metformin, remains in clinical use today (Witters, 2001). The basic guanidine 
structure is shown in Fig 6.1: 
 
H2N NH2
NH  
 
 
 
6.1.1 Galegine 
Galegine (isoamylene guanidine) was briefly used as an antidiabetic agent in 
the 1920s. This molecule is illustrated in Fig 6.2: 
 
H2N N
H
NH
CH3
CH3
 
 
 
 
 
 
Fig 6.1: The basic guanidine structure.  
Various modified forms of this structure are found in French lilac.  
Fig 6.2: Structure of galegine  
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6.1.2 Biguanides 
Biguanides are synthesised from 2 moles of guanidine with the elimination of 
one mole of ammonia (Kurzer and Pitchfork 1968) as shown in Fig 6.3: 
 
NHH2N
NH
H H NH NH2
NH  
 
 
H
NH2N
NH
NH2
NH                                    
H
N
H
H  
 
Fig 6.3: Synthesis of biguanide 
  
6.1.2.1 Buformin 
Buformin was used as an antihyperglycemic agent in the 1960s but was 
withdrawn in the 1970s due to an unacceptably high number of incidents of 
lactic acidosis and cardiac mortality (Witters, 2001). Lactic acidosis is a 
metabolic condition characterised by low tissue pH caused by elevated 
lactate levels. Lactate is a substrate for hepatic gluconeogenesis but 
metabolism of lactate in this way is inhibited by biguanides, probably due to 
inhibition of electron transport (Owen et al, 2000; El-Mir et al, 2000; Foretz et 
al, 2010), which will also promote anaerobic respiration, and accelerate 
lactate formation. The buformin structure is shown in Fig 6.4: 
 
 
+ 
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NH2 NH NH
NH NH
CH3 
 
 
6.1.2.2 Phenformin 
Phenformin started to be used as an antihyperglycemic agent in the 1950s 
(McKendry et al, 1959) but was withdrawn in the 1970s due to a high risk of 
lactic acidosis (Bailey, 1992) which was later associated with older age 
(Fimognari et al, 2008).  The structure of phenformin is shown in Fig 6.5: 
 
N
H
N
H
H2N
NH NH
 
 
 
 
6.1.2.3 Metformin 
Metformin has been in use since 1957 and is only contraindicated in patients 
with renal failure as it is eliminated by the kidney (Bailey, 1992). Unlike 
phenformin, metformin does not induce lactic acidosis, probably because it is 
a less potent inhibitor of electron transport (Owen et al, 2000). The metformin 
structure is shown in Fig 6.6: 
 
N N
H
NH2
H3C
CH3
NH NH
 
 
Fig 6.4: Structure of Buformin (butylbiguanide)  
Fig 6.5: Structure of Phenformin (phenethylbiguanide). 
Fig 6.6: Structure of Metformin (dimethylbiguanide)  
 178 
6.1.3 Diguanides 
Diguanides are 2 guanidine molecules joined together by a hydrocarbon 
chain of variable length. The general diguanide structure is shown in Fig 6.7 
 
NH2NH
(CH2)n
NHNH2
NHNH  
 
 
 
 
6.1.4 Diguanides and related compounds that are commercially available  
At the time of these experiments, there were three diguanides commercially 
available. Diguanide 4 (DG4) has been proposed as an N-Methyl-D-aspartic 
acid (NMDA) antagonist (Daeffler et al, 1999). It is illustrated in Fig 6.8: 
 
H2N
H
N
NH
N
H
NH2
NH
 
 
 
 
The structures of other diguanides, DG6 and DG10 are shown in Fig 6.9 and 
6.10: 
 
 
Fig 6.7: The general structure of diguanides. 
The diguanide structure consists of 2 guanidine molecules bound together by a 
hydrocarbon chain of variable length.  
Fig 6.8: Structure of DG4 (arcaine)  
 179 
H2N
H
N
NH
N
H
NH2
NH
 
 
 
 
 
H2N
H
N
NH
N
H
NH2
NH
 
Fig 6.10: Structure of Synthalin A (DG10; decamethylene diguanide).   
 
 
In the 1920s, before the discovery of the antihyperglycaemic properties of 
biguanides, these diguanides were briefly evaluated as antidiabetic agents. 
The clinical goals of treatment at the time, very different from those prevailing 
today, were to induce insulin-like ‘hypoglycaemic’ effects, as at this time the 
notions of type 1 and insulin-resistant type 2 diabetes were yet to be 
developed. In this series, the hypoglycaemic effects were found to increase, 
in proportion with toxicity, up to a linker size of 10-12 carbons (Bischoff et al, 
1929). To achieve the maximum hypoglycaemic effect, the most potent and 
toxic diguanide, (N,N'-1,10-Decanediylbisguanidine, synthalin A, termed 
DG10 in this chapter, fig 6.10) was used in humans, before the magnitude of 
its toxicity was fully realised and clinical use ceased. Synthalin B, fig 6.11, 
which is not available commercially, was considered to be less toxic but less 
Fig 6.9:  Structure of DG6 (hexamethylene diguanide)  
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effective than synthalin A (Braun and Ludwig, 1937) and continued to be 
used in Germany until the 1940s (Bailey and Day, 2004). 
H2N
H
N
NH
N
H
NH2
NH
 
Fig 6.11: Structure of Synthalin B (DG12; neosynthalin; dodecylmethylene diguanide). 
 
The final commercially available compound studied is an alkylguanide (Fig. 
6.12). These are structurally similar to diguanides, except that they contain 
only one guanide group.  
 
 
H2N
H
N
NH  
Fig 6.12: Structure of dodecylalkylguanide (AG12; dodin). 
 
 
6.1.5 Comparison of biguanides and diguanides 
Although metformin (dimethyl biguanide) is still in clinical use and considered 
to be effective and nontoxic, its use is problematic for some people. It can 
cause gastrointestinal problems, which leads to cessation of use in 5-10% of 
patients (Garber et al, 1997). In those that do take the drug, resistance 
occurs after a few years (Turner et al, 1999). If its mechanism of action could 
be confirmed, it may be possible to modify the structure in such a way as to 
avoid these responses in people vulnerable to them, whilst retaining their 
clinical efficacy. Comparative studies are one potential avenue of 
investigation with respect to this aim. Metformin is most typically compared 
with phenformin and sometimes buformin but in this chapter we have 
 181 
compared metformin with diguanides. As a result of their early clinical failure, 
there has been little investigation of the diguanides in recent times but 
meanwhile understanding of the antihyperglycaemic action of metformin has 
greatly improved. Although the mechanism of antihyperglycaemic effects is 
incompletely understood for either drug class, inhibition of mitochondrial 
respiration has been observed in response to both diguanides (Pressman, 
1963) and biguanides (Owen et al, 2000). In addition, in the last decade, and 
as discussed in the Introduction, it has been found that metformin activates 
AMPK (Zhou et al, 2001); however, the role of AMPK in antihyperglycaemic 
responses to these drugs has been reassessed in more recent studies. For 
example, studies on genetic models indicate that the clinically important 
effect of metformin on hepatic glucose output was AMPK-independent 
(Foretz et al, 2010) and in addition, regulation of S6 by metformin, which was 
thought to be AMPK-dependent, does not require AMPK either (Kickstein et 
al, 2010; Kalendar et al, 2010). It is currently unclear whether or not these 
negative data are indicative of redundancy in regulatory mechanisms, or 
alternatively that AMPK acts simply as a biomarker of antihyperglycaemic 
drug administration (Miller and Birnbaum, 2010). Whichever is the case, the 
graduated responses to diguanides provide an excellent additional 
opportunity to study antihyperglycaemic drug action because cellular 
responses mediating (or gauging) the antihyperglycaemic effects of 
diguanides will be expected to occur at much lower concentrations in 
diguanides possessing longer linkers than in those with shorter linkers. In the 
current chapter therefore, we have investigated the impact of linker length on 
gluconeogenic gene regulation and especially AMPK and S6 regulation. We 
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started by studying the commercially available compounds described above, 
before synthesising, assessing the purity and then characterising the effects 
of a series of other diguanide compounds on these cellular outputs.  
 
6.2 Results 
6.2.1 A DG carbon chain length of 6 or more is sufficient for maximal 
response 
Firstly, the effects of commercially available diguanides on AMPK, ACC and 
S6 phosphorylation were investigated. H4IIE cells were treated with 25µM 
concentrations of each diguanide available and western blotting was carried 
out to detect phosphorylated ACC and AMPK, and dephosphorylated S6. 
This suggested a chain length of 6 carbons was sufficient to obtain maximal 
physiological effect. A fourth compound dodecylalkylguanidine (AG12) was 
also tested. AG12 is identical to DG12 except that it only contains one 
guanidine group (Fig. 6.12). This drug gave effects that were similar to those 
of DG10. These effects are similar to those achieved with metformin at 
millimolar, not micromolar concentrations. The data acquired is shown in Fig 
6.13: 
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   pACC 
 pThr172AMPK 
 pSer240/244S6 
  actin  
- + - - - - metformin 25µM 
 - - + - - - DG 4 25µM 
 - - - + - - DG 6 25µM  
 - - - - + - DG 10 25µM  
 - - - - - + AG 12 25µM  
 
Fig 6.13: Effect of diguanides on cell signalling in H4IIE cells 
Serum starved H4IIE cells were treated as above for 3hrs followed by lysis and SDS- PAGE 
as described in the chapter 2. Immunoblotting was carried out using two ACC antibodies- 
one which detects total ACC (ACC) and one which detects phosphorylated ACC (pACC), an 
antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK), two 
S6 antibodies- one which detects total S6 (S6) and one which detects Ser240/244 S6 
phosphorylation (pSer240/244 S6) and an actin antibody.  
 
 
6.2.2 Effect of a dose response of DG6 on AMPK, S6 and ACC 
phosphorylation. 
Cell culture and western blotting found that DG6 induced AMPK and ACC 
phosphorylation maximally and inhibited S6 phosphorylation almost 
maximally at 3.14µM. This is shown in Fig 6.14: 
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 - + - - - DG 6 1µM 
 - - + - - DG 6 3.14µM  
 - - - + - DG 6 10µM  
 - - - - + DG6 31.4µM 
Fig 6.14: Effect of DG6 on AMPK, ACC and S6 phosphorylation. 
Serum starved H4IIE cells were treated as above for 3hrs followed by lysis and SDS- PAGE 
as described in chapter 2. Immunoblotting was carried out using two ACC antibodies- one 
which detects total ACC (ACC) and one which detects phosphorylated ACC (pACC), an 
antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK), two 
S6 antibodies- one which detects total S6 (S6) and one which detects Ser240/244 S6 
phosphorylation (pSer240/244 S6) and an actin antibody.  
 
6.2.3 Effect of a dose response of DG10 on AMPK, S6 and ACC 
phosphorylation. 
Cell culture and western blotting found that DG10 (synthalin A) induced 
AMPK and ACC phosphorylation maximally and inhibited S6 phosphorylation 
at 3.14µM. This data is shown in Fig 6.15: 
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- + - - -  DG 10 314nM 
- - + - -  DG 10 1µM  
- - - + -  DG 10 3.14µM  
- - - - +  DG 10 31.4µM 
Fig 6.15: Effect of DG10 on AMPK, ACC & S6 phosphorylation 
Serum starved H4IIE cells were treated as above for 3hrs followed by lysis and SDS- PAGE 
as described in chapter 2. Immunoblotting was carried out using 2 ACC antibodies- one 
which detects total ACC (ACC) and one which detects phosphorylated ACC (pACC), an 
antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK), 2 S6 
antibodies- one which detects total S6 (S6) and one which detects Ser240/244 S6 
phosphorylation (pSer240/244 S6). 
 
Taken together, the results so far show that there is a threshold in efficacy in 
this drug class, as DG4 was unable to regulate the signalling pathways under 
investigation, whilst both DG6 & DG10 exhibited efficacy in the low 
micromolar range. To further substantiate and investigate the threshold, 
more diguanides in the series were synthesised in the laboratory. 
 
 
 
 
 
pACC 
ACC 
pThr172 AMPK 
pSer240/244 S6 
S6 
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6.2.4 Diguanide synthesis 
Diguanides were synthesised as described in Chapter 2 using the method 
adapted from Tricot et al (1990). Briefly, 1 mole of a diamine of the required 
length was mixed with 2 moles of methylisourea. The methylisourea was 
added to ice cold ultra-pure water (UPW) and pH increased to 10 using 5M 
KOH. The product, when diguanidylated, is not soluble at this pH and will 
precipitate out of solution. The diamine was added and this was incubated 
for three hours, performing 15 minute checks to ensure pH was maintained 
at 10. Precipitates were collected by centrifugation, washed with 10ml ice 
cold UPW, recentrifuged and this was repeated. Final precipitates collected 
were frozen at -20oC and freeze dried. MS was carried out by direct injection 
and MS2 fragmentation pattern obtained to confirm the required structure had 
been synthesised. This method has been used to guanidylate the amino acid 
lysine to facilitate ionisation and therefore observation of lysine containing 
peptides by matrix assisted laser depolarisation/ ionisation (MALDI) MS 
(Beardsley and Reilly, 2002).  
 
6.2.5 Synthesis method 
Cadaverine is the product of post mortem bacterial decarboxylation of the 
amino acid lysine as shown in Fig 6.16: 
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H2N
NH2
OH
O
                
H2N NH2  
Fig 6.16: Cadaverine is the consequence of post mortem decarboxylation of the amino acid 
lysine in mammalian cadavers. 
 
Using cadaverine as the diamine, it was assumed that DG5 would be 
generated with a molecular weight of 186. This reaction is shown in Fig 6.17: 
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H3C NH2
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The MS data suggested the required compound had been synthesised, as 
shown in Fig 6.18: 
Fig 6.17: Synthesis of DG from cadaverine 
Cadaverine, structural formula = C5H14N2 = 102amu;  DG5, C7H18N6 = 186 amu. 
 
decarboxylation 
 
cadaverine 
 
 O  
 
Cadaverine 
+ 
2  methylisourea 
 NH 
DG5 
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Fig 6.18: Mass spectrometry data for DG5 
In positive mode, the full MS data shows a molecule of 186 amu has been synthesized. The 
MS
2
 fragments probably represent the following neutral losses: 187 – 170 = 17 amu = NH3;  
187 – 145 = 42 = CH2N2;; 187 – 128 = 59 – CH4N3; 187 – 86 = 101 – C5H12N2. The figures in 
the top right corners are the full scale deflections of the MS detector. 
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DG7, DG8 and DG12 were then synthesised as shown in table 6.1, simply by 
replacing cadaverine with the following longer diamines: 
 
Substrate Product 
1,7 diaminoheptane DG7 
1,8 diaminoheptane DG8 
Spermine DG12 
 
Table 6.1: Table showing the substrates and the diguanides synthesised from them. 
 
The MS data suggested the required products had been synthesised, and 
MS2 data showed the predicted fragmentation pattern as shown in Figs 6.19:  
 
 190 
 
Fig 6.19A: Full mass spectra for DG7, DG8 and DG12.  
MS spectra were obtained by direct infusion of samples. Figures in the top right hand corner 
are the full scale deflections of the MS detector. The main signal is highlighted in bold and 
other signals may arise from in-source fragmentation of the main peak. 
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Fig 6.19 B: MS2 spectra of DG products  
Putative IDs: 
DG7: 215 – 198 = 17 (NH3); 215 – 173 = 42 (CH2N2). 
DG8: 229 - 212 = 17 (NH3); 229 – 187 = 51 (NH3 X 3). 
DG12: 287 – 270 = 17 (NH3); 287 – 253 = 34 (NH3 X 2). 
FSDs are shown at the top right of each panel. 
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6.2.6  Replacement of C4 of DG8 with a secondary amine.  
A DG8 analogue was synthesised from spermidine. The structure 
synthesised (DG8N), is identical to DG8 apart from the C4 being replaced 
with a secondary amine as shown in Fig 6.20: 
 
           H2N
H
N NH2
 
 
H2N N
H
H
N
NH
H
N NH2
NH  
Fig 6.20: Spermidine and DG8N  
 
 
LCMS analysis was carried out to check that the required compounds had 
been synthesised and that they were in excess of excess of 95% pure, as 
shown in Fig 6.21. The purified compounds gave MS2 fragmentation patterns 
consistent with DG structures. (Fig. 6.19b). 
 
 
 
 
 
 
 
 
spermidine 
DG8N 
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Fig 6.21: LCMS traces of DG5, 7, 8, 12, and DG8N 
The MS base peak signal for each sample is shown. Peak area analysis confirms that each 
sample was in excess of 97% pure. The M+H m/z value for each sample is given in bold. The 
figures in the top right hand corners are the full scale deflection of the MS detector. 
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It was found, as chain length progressed, that modifications to the synthesis 
protocol were required. When no product precipitated from 1,7-
diaminoheptane, it was thought that synthesis of a larger molecule may 
require extra energy therefore the diamine was heated to 37oC before 
addition of the methylisourea, and a precipitate formed. When a similar 
problem arose with 1, 8-diaminoheptane its melting point was noted to be 50- 
52oC, therefore the water bath was heated to this temperature for the 
duration of the synthesis, again with success. With respect to DG8N, this 
increase in temperature alone was unsuccessful, but it was found that 
overnight incubation at 4oC resulted in a successful outcome as the product 
precipitated out of solution. 
 
6.2.7 Effect of a dose response of DG5 on AMPK, S6 and ACC 
phosphorylation. 
DG5 was applied to cells to determine the effects on cell signalling. Cell lysis 
and western blotting showed DG5 induced the phosphorylation of AMPK and  
ACC at 10µM and dephosphorylation of S6 at 100µM. This data is shown in 
Fig 6.22: 
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 - + - - -  DG 5 1µM 
 - - + - -  DG 5 10µM  
 - - - + -  DG 5 100µM  
 - - - - +  DG5 1mM  
 
 
 
 
 
 
 
6.2.8 Effect of a dose response of DG7 & DG8 on AMPK, S6 and ACC 
phosphorylation. 
DG7 and DG8 were applied to cells to determine effects on cell signalling. 
Cell lysis and western blotting showed that DG7 and DG8 induced 
phosphorylation of AMPK and dephosphorylation of S6 at 3.14µM. This is 
shown in Fig 6.23:  
 
pACC 
ACC 
pThr172 AMPK 
pSer240/244 S6 
S6 
actin  
 
Fig 6.22: Effect of DG5 on phosphorylation of ACC, AMPK and S6  
Serum starved H4IIE cells were treated as above for 3hrs followed by lysis and SDS- PAGE 
as described in chapter 2. Immunoblotting was carried out using 2 ACC antibodies- one 
which detects total ACC (ACC) and one which detects phosphorylated ACC (pACC), an 
antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK), 2 S6 
antibodies- one which detects total S6 (S6) and one which detects Ser240/244 S6 
phosphorylation (pSer240/244 S6) and an actin antibody. This showed DG5 to 
phosphorylate AMPK and ACC and to dephosphorylate S6 at a concentration of 10µM. 
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   pACC 
   ACC 
   pAMPK 
   Actin 
    pS6 
   S6 
 0   1   10   25 100    0   1   10   25 100 
      DG7 (µM)           DG8 (µM)   
 
 
Fig 6.23: Effect of DG7 and DG8 on AMPK, ACC and S6. 
Serum starved H4IIE cells were treated as above for 3hrs followed by lysis and SDS- PAGE 
as described in chapter 2. Immunoblotting was carried out using two ACC antibodies- one 
which detects total ACC (ACC) and one which detects phosphorylated ACC (pACC), an 
antibody which detects AMPK only if it is phosphorylated on Thr172 (pThr172 AMPK), two 
S6 antibodies- one which detects total S6 (S6) and one which detects Ser240/244 S6 
phosphorylation (pSer240/244 S6) and an actin antibody.   
 
 
 
 
 
- + - - -    - - - - - DG 7 1µM  
- - + - -    - - - - - DG 7 10µM   
- - - + -    - - - - - DG 7 25µM   
- - - - +    - - - - - DG 7 100µM   
- - - - -    - + - - - DG 8 1µM   
- - - - -    - - + - - DG 8 10µM  
- - - - -    - - - + - DG 8 25µM  
- - - - -    - - - - + DG 8 100µM  
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6.2.9 Comparison of effects of DG8 and DG8N on cell signalling  
DG8N and DG8 were applied to cells side-by-side for direct comparison of 
their effects on cell signalling. Cell lysis and western blotting suggested that 
although DG8 was effective on AMPK by 5µM and 50µM with respect to 
ACC and S6, DG8N was ineffective at all concentrations tested. This data is 
shown in Fig 6.24. Separate experiments suggested that DG8N was 
ineffective at concentrations into the millimolar range (data not shown). 
 
 
 
 
 
 
 
+ - - - - - - 500nM DG8  
- + - - - - -  5µM DG8 
- - + - - - - 50µM DG8  
- - - + - - - 500nM DG8N  
- - - - + - - 5µM DG8N  
- - - - - + - 50µM DG8N  
Fig 6.24: Effect of replacement of C4 of DG8 with a secondary amine on cellular 
responses. 
Serum starved H4IIE cells were treated with/without DG8 or DG8N as above for 3hrs 
followed by lysis and SDS- PAGE as described in chapter 2. Immunoblotting was carried out 
using two ACC antibodies- one which detects total ACC (ACC) and one which detects 
phosphorylated ACC (pACC), an antibody which detects AMPK only if it is phosphorylated 
on Thr172 (pThr172 AMPK), two S6 antibodies- one which detects total S6 (S6) and one 
which detects Ser240/244 S6 phosphorylation (pSer240/244 S6) and an actin antibody.    
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6.2.10 Synopsis 
When the apparent minimum concentrations of each diguanide required to 
phosphorylate AMPK were compared, a ‘digital’ or threshold- type response 
was observed, in that DG4 was ineffective but DG6-10 affected AMPK, ACC 
and S6 in the low micromolar range. DG5 alone exhibited efficacy that was 
intermediate between these two extremes. Interruption of the hydrocarbon 
chain with a secondary amine abolished cell responses. The same trend was 
observed with dephosphorylation of S6, except that when a carbon chain 
length of 10 was reached, potency appeared to reduce.  
 
6.2.11 Glucose 6 phosphatase and cell toxicity 
As the accuracy of measurement of AMPK responses is limited by the 
photodynamic range of the photographic film used, a cell reporter assay to 
investigate DG responses was carried out. Previous studies showed that 
metformin represses glucose 6 phosphatase (G6Pase) expression (Foretz et 
al, 2010, Logie et al, 2012). Therefore effects of DGs on G6Pase expression 
were measured using a luciferase reporter assay and IC50 concentration 
calculated as described in chapter 2. These experiments provided further 
evidence that cellular responses occur at a threshold between DG4 and 
DG6, as shown in Table  6.2.  
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6.3 Discussion 
6.3.1 Potency and toxicity of the diguanides on AMPK, S6 phosphorylation 
and G6Pase expression, increases with hydrocarbon chain length 
The potency of the diguanides on AMPK, S6 and G6Pase increased with 
chain length. It was found that the response was ‘digital’ rather than 
‘analogue’ in that millimolar concentrations of DG4 were required to 
phosphorylate AMPK but DG5 to DG10 required a concentration in the low 
micromolar range to show this effect. The threshold in DG effects described 
above may be explained if there is a threshold of hydrophobicity that must be 
reached before these compounds can migrate into the plasma membrane 
and access the cell. The partition coefficients of each DG and DG8N are 
shown in Table 6.3: 
 
 
Compound IC50 for   G6Pase 
promoter activity 
(µM) 
Cell viability in 
WST-1 assay IC50, 
(µM) 
DG4 >100 166.90 
DG5 15 54.15 
DG6 1.6 3.62 
DG7 1.7 2.97 
DG8 0.75 1.62 
DG10 0.5 2.96 
Table 6.2: IC50 of DGs on G6Pase-luciferase expression and IC50 on cell 
viability. 
For comparison, the IC50 (concentration of drug required for 50% inhibition) for 
G6Pase in response to metformin was found to be 630µM. Metformin’s cell viability 
IC50 measured in the WST-1 assay was >5mM. These experiments were performed 
by Lisa Logie in the laboratory.  
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Diguanide Log P 
DG4 -1.423 
DG5 -0.917 
DG6 -0.412 
DG7 -0.093 
DG8 +0.598 
DG8N -1.717 
DG10 +1.609 
DG12 +2.619 
 
It can be seen that DG5-DG10 are all more hydrophobic than the inactive 
compounds DG4 and DG8N, suggesting that a threshold of hydrophobicity is 
required for these compounds to exhibit efficacy; however, it is important to 
keep in mind that the compounds might access the cells by alternative 
mechanisms, for example through drug transporters. Metformin uptake for 
example, is mediated by the transporter OCT1 (Shu et al,  2007). There are 
other possible explanations for the data. For example, a threshold of 
hydrophobicity might be required for the drug to enter a hydrophobic pocket 
on its protein target. The fact that AG12 is equally as active as DG10 
indicates that only one guanidine group is required, so the linker is unlikely to 
be required to separate the two guanidine groups in space.  
 
6.3.2 Possible mechanisms of DGs 
Studies on metformin indicate that effects of this drug on both AMPK and 
G6Pase both depend on inhibition of mitochondrial respiration. The similar 
threshold exhibited by these two responses in the DG series of compounds 
Table 6.3: Hydrophobicity of selected DG compounds. 
Log hydrophobicity (Log P) was modelled on molinspiration  
software 
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is supportive that AMPK and G6Pase regulation by DGs may also depend on 
a common mechanism such as mitochondrial inhibition. The ability of 
diguanides to reduce oxygen consumption is certainly consistent with this 
possibility (Pressman, 1963). The targets involved may be different however, 
as metformin is more than an order of magnitude less potent than diguanides 
and exerts effects on G6Pase without cellular toxicity. 
 
These results are similar to results on glycemia obtained in animal studies in 
the 1920s with these compounds, although these investigators did observe a 
slightly more graduated response. For example, they found that the 
hypoglycemic effect of DG5 was only five fold greater than DG4 and that 
DG6 was ten-fold more potent than DG5 and equally as potent as DG10 
(Kumagai et al, 1928). Taken together though, these studies suggest that in 
this series of compounds, effects either on AMPK activation, S6 inhibition or 
G6Pase repression are probably equally useful cellular markers of 
antihyperglycaemic activity.  
 
6.3.3 Conclusions  
6.3.3.1 Comparison of biguanides and diguanides 
A comparison of biguanides and diguanides was carried out. A variety of 
diguanides of incrementally increasing chain length were synthesised and 
purity confirmed using LCMS. In cell based assays, like the biguanides, 
diguanides induce AMPK phosphorylation, suppress S6 phosphorylation and 
repress G6Pase expression. Although diguanides of a chain length of six or 
greater were most effective, these compounds were also the most toxic as 
both efficacy and toxicity increased markedly above a threshold of 
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hydrophobicity. DG5 was the only DG whose toxicity was appreciably lower 
than the concentration required to phosphorylate AMPK and that of the IC50 
for G6Pase. These narrow therapeutic windows in cells contrast sharply with 
metformin and probably explain the lack of clinical utility of these DGs. 
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CHAPTER 7- CONCLUSIONS 
7.1 Introduction 
This project has highlighted several groups of compounds and individual 
compounds which have insulin-like properties in cell culture experiments, in 
that they induce the phosphorylation of and inactivation of the transcription 
factor FOXO1a. We also studied agents with metformin-like properties, which 
activate AMPK signalling and reduce phosphorylation of the ribosomal 
protein S6. Both these effects are believed ultimately to result in 
downregulation of gluconeogenesis. Additional drugs capable of restoring 
suppression of gluconeogenesis in T2D might be useful therapeutically. 
Drugs usually act on cells by ‘lock and key’ interaction with specific molecular 
targets but various factors have been shown to influence efficacy and 
toxicity, both at a cellular level and in the whole organism. These properties 
contribute to what makes a good drug. They include hydrophobicity (Lipinski 
et al, 2001), molecular size (Lipinski et al, 2001) flexibility (Veber et al, 2002), 
hydrogen bonding characteristics (Lipinski et al, 2001), transport properties 
and metabolic stability. Besides simply screening for compounds regulating 
AMPK and FOXO1a, the relationship of a few of these properties to drug 
action have been investigated.  
 
7.2 Plant extracts with insulin or metformin- like cell signalling properties 
When screening plant extracts, it was noted from MS data that 
proanthocyanidin (PAC) rich fractions were frequently those which induced 
phosphorylation of FOXO1a, AMPK and reduced phosphorylation of S6. We 
are unable to conclude that the active agents were PACs themselves 
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because we were unable to obtain pure preparations of the PACs.  Despite 
this difficulty, we were able to make the following observations: 
(i) Fractions containing B-type PACs were more effective inducers of 
FOXO1a phosphorylation than fractions containing A-type PACs, 
suggesting that if PACs are the active agents, B-type linkages may 
be required.  
(ii) Effects of PAC-rich fractions did not correlate closely with antioxidant 
properties of the fractions 
(iii) In GSE, which induced phosphorylation of FOXO1a and AMPK, there 
were more gallic acid and galloylated molecules than in PBE, 
which was much less active in our cell assays. 
 
7.3 Gallic acid analogues 
To circumvent the difficulties that we encountered when attempting to purify 
compounds with insulin or metformin-like activity from plant extracts, we 
adopted a candidate-approach that was partly based on the observations 
made during the fractionation work, where a higher proportion of galloylated 
molecules was detected in GSE than in PBE. As GSE  was also more active 
on FOXO1a and AMPK, it was decided to assay purified gallic acid itself for 
these effects on H42E cells. This resulted in a positive response on AMPK 
signalling. A variety of commercially available hydroxybenzoic acid (HBA) 
analogues of the GA structure were investigated for similar effects. This work 
found that GA and another HBA, salicylate, which has known 
antihyperglycaemic properties, were the only two compounds active on 
AMPK signalling. Structurally similar to the mitochondrial uncoupler 2, 4- 
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dinitrophenol, GA and salicylate are themselves uncouplers and the studies 
in this thesis are consistent with the possibility that this contributes to the 
effects on AMPK that were observed. A variety of other analogues were 
tested but further work will be required to determine the mechanisms 
underlying the structure/activity relationships observed.  
 
7.4 Diguanides 
With respect to phosphorylation of AMPK by diguanides, a chain length of 6 
carbons or more appeared to be required for maximal response, which 
probably reflects a hydrophobicity threshold required for efficacy. In many 
respects the responses to diguanides and biguanides were similar but the 
clinical experience is that diguanides are far more toxic in clinical use. We 
observed a similar difference in toxicity at the cellular level. It may be that 
diguanides are less specific than biguanides or alternatively, biguanides and 
diguanides might exploit different targets in the mitochondria altogether. 
Further work to explain this difference in toxicity might therefore enable 
better illumination of metformin’s mechanism of action.   
 
7.5 Discussion 
As the compounds and extracts that have been studied are capable of 
inducing insulin like effects on the IIS pathway and/ or biguanide like effects 
on AMPK, confirmation of their mechanism of action may lead to the 
development of additional pharmacological interventions for the treatment of 
the insulin insensitivity of type 2 diabetes. If unsuitable for clinical use, 
whether due to toxicity or lack of specificity, it may be possible to modify 
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these structures in such a way as to overcome these problems, or to identify 
other molecules with similar targets and properties.  
Despite the move to synthetic compound libraries in recent decades, plant-
derived compounds continue to be investigated for preventive and/or 
therapeutic properties in cancer (McDougall et al, 2008a), cardiovascular 
disease (Nigdikar et al, 1998), Alzheimer’s disease (Ferruzzi et al, 2009) and 
type 2 diabetes (Cameron et al, 2008). Type 2 diabetes has a particularly 
promising window of opportunity for treatment because it often precedes 
these other life threatening conditions which could possibly be prevented by 
more effective treatment of type 2 diabetes. For treatment of this condition, 
studies on plants have already contributed to the discovery of metformin and 
salicylates. The former is the most widely prescribed type 2 diabetes 
medicine in the world and the latter is not used clinically but has enjoyed 
renewed interest in recent years. To help reverse the unfolding epidemic of 
this disease, our studies on analogues of these drugs and other plant–
derived compounds suggest that it may be possible to identify further 
treatments for type 2 diabetes based on plant products.  
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